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Improving neurodevelopmental outcomes has become one of the biggest remaining 
challenges for infants born with congenital heart disease (CHD). Despite a dramatic 
reduction in CHD mortality over the past few decades, there have been comparatively 
modest improvements in neurodevelopmental outcomes. The burden of the problem 
is significant, affecting a wide range of developmental domains that impact upon 
future educational achievement, employability and quality of life for millions of children 
born with CHD. While it was initially assumed that adverse outcomes were due to 
brain injury sustained around the time of cardiac surgery, it is now clear that there is a 
complex interplay between the circulation and brain, involving both fetal and postnatal 
development. Promising early work has suggested the role of reduced cerebral 
oxygenation as a key factor in altered early brain development in CHD, although the 
precise mechanisms through which this is mediated remain unclear.  
This thesis aims to test the hypotheses that congenital heart disease is associated 
with impaired early brain development, and that reduced cerebral oxygen delivery in 
CHD is associated with impaired cortical development in newborn infants prior to 
surgery. This is achieved through the study of a new prospective cohort of newborn 
infants born with major CHD prior to surgery, and the use of both qualitative and 
quantitative magnetic resonance image analysis of brain tissue macrostructure and 
microstructure, in order to compare early brain development with age-matched 
healthy infants. 
Evidence is provided that complexity of cortical folding and cortical grey matter 
volumes are both reduced in newborns with CHD when compared to healthy age-
matched controls, and that the degree of impairment is associated with reduced 
cerebral oxygen delivery. At the microstructural level, fractional anisotropy (FA) is 
demonstrated to be elevated and cortical orientation dispersion index (ODI) reduced in 
a number of cortical regions compared to healthy controls, supporting the 
interpretation that dendritic arborisation in cortical grey matter may be the primary 
component that is negatively affected. Both findings are convergent with recent 
animal studies and provide support to the development of future interventional 
strategies to optimise cerebral oxygenation during early brain development. 
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1.1 BACKGROUND AND MOTIVATION 
Improving neurodevelopmental outcome has become one of the greatest remaining 
challenges for infants born with congenital heart disease (CHD). Despite dramatic 
improvements in mortality over the past few decades (Khairy et al., 2010), 
improvements in motor and cognitive neurodevelopmental outcomes have been 
comparatively modest (Gaynor et al., 2015). 
The burden of the problem is significant – CHD is the most common congenital 
abnormality affecting newborns (Bernier et al., 2010). Approximately one third will 
require surgery in their first year of life (Wernovsky and Licht, 2016) and roughly half of 
this group will currently experience some form of neurodevelopmental problem in 
childhood (Marino et al., 2012). Young children with CHD may exhibit deficits in 
multiple domains, including gross and fine motor, speech and language, memory, and 
visuospatial skills. Follow-up studies suggest that deficits persist into adolescence 
and adulthood (Bellinger et al., 2015b, 2015a, 2011; Schaefer et al., 2013; Tyagi et al., 
2017), with survivors of CHD found to experience deficits in specific domains 
including hyperactivity and inattention (Hansen et al., 2012) and executive function 
(Calderon and Bellinger, 2015), which can have widespread repercussions for later 
neurocognitive, behavioural and psychosocial development. This poses a serious 
threat to educational achievement, employability and later quality of life (and in many 
countries insurability) for millions of children born with CHD. 
As clinicians and researchers working with children born with CHD, our shared goal is 
threefold: 1) to understand the necessary environment in utero for normal brain 
development, and to develop appropriate interventions to ensure that this is possible 
in pregnancies complicated by CHD, 2) to undertake cardiac surgery while protecting 
the brain from acquired injury, and 3) for these children to thrive during childhood and 
live a fulfilled adult life with no significant difference in neurodevelopmental outcomes 
compared to their healthy peers. 
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The first step towards achieving these goals in a systematic way is to understand the 
underlying biological processes that are responsible for altered brain development in 
CHD. This knowledge will enable focused identification of candidate therapeutic 
options. We also need to define a set of measures, using magnetic resonance imaging 
(MRI) or other biological markers, that can reliably quantify early brain dysmaturation 
in CHD in vivo, allowing us to distinguish abnormal brain development. This provides 
the ability to perform intervention studies using these validated measures as primary 
outcomes to demonstrate efficacy in the neonatal period. Determining efficacy as 
early as possible is crucial, as it enables faster iteration of the clinical trials process, 
and will ultimately improve outcomes for children with CHD sooner. 
Despite a growing body of experimental work, our understanding of the biological 
mechanisms that underpin how CHD affects brain development remains limited. 
Nevertheless, there is converging evidence of the role of reduced cerebral 
oxygenation in abnormal neuronal development and migration that may be 
responsible in CHD (Dean et al., 2013; Morton et al., 2017; Ortega et al., 2017; Sun et 
al., 2015; Yuen et al., 2014). In the same way, although imaging studies in CHD have 
identified a number of measures of brain dysmaturation, including alterations of 
macrostructural brain growth and morphology, microstructural tissue differences, 
metabolic alterations, and structural and functional connectivity differences, our ability 
to define a quantifiable short-term primary outcome for an interventional trial is 
surprisingly inadequate. 
A systematic approach will take time to translate into tangible outcomes. In the 
meantime, there is an immediate opportunity to exploit the considerable differences in 
clinical practice between cardiac centres, using historical data that have been 
collected over many years. Injury rates vary considerably between cohorts (Mebius et 
al., 2017). The natural assumption is that such variation must be, at least in part, due 
to modifiable local differences in clinical management. 
In this thesis, I prospectively recruit, assess and describe a new contemporary cohort 
of infants born with CHD, and use a range of analysis techniques to assess 
differences compared to healthy controls. Through this work, I aim to both contribute 
to our understanding of brain dysmaturation in this important population and identify 
MR imaging measures that could be used to quantify brain dysmaturation in the 
context of future interventional trials. 
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1.2 HYPOTHESIS AND AIMS 
This thesis aims to test the following hypotheses: 
• Infants born with major congenital heart disease have impaired early brain 
development compared to healthy controls and are more susceptible to 
perinatal brain injury. 
• Reduced cerebral oxygen delivery in congenital heart disease is associated 
with impaired development of the cerebral cortex. 
This is conducted with the following aims: 
1. To describe the prevalence and types of acquired brain injury in newborn 
infants with congenital heart disease and identify clinical variables that are 
associated with injury. 
2. To use quantitative macrostructural measures to investigate developmental 
differences of the cerebral cortex between infants with CHD and healthy 
controls using structural MRI, and to determine if abnormalities are associated 
with reduced cerebral oxygen delivery. 
3. To use diffusion MRI to quantify microstructural changes in the cerebral cortex 
of infants born with CHD, and to investigate if cerebral oxygen delivery is 
associated with microstructural development. 
1.3 THESIS OUTLINE 
Chapter 2 introduces the fundamentals of MRI, diffusion-weighted imaging, phase 
contrast imaging, the challenges that are involved in scanning a vulnerable newborn 
population, and introduces methods of MR image analysis that are discussed in this 
thesis. 
In Chapter 3, I introduce the burden of neurodevelopmental problems in children with 
CHD and discuss evidence of abnormal early brain development in CHD. I consider 
different hypotheses for brain dysmaturation, including reduced cerebral oxygen 
delivery, and explore recent studies that have attempted to test these. I finish by 
considering the effect of cerebral oxygen delivery on neurodevelopmental outcomes. 
In Chapter 4, I determine the prevalence of lesions in a prospective cohort of infants 
born with CHD and characterise these lesions using a mixture of qualitative and 
quantitative methods. I then explore clinical risk factors that are associated with injury. 
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Macrostructural differences between a group of infants with CHD and a matched 
group of healthy controls are assessed in Chapter 5. I show that brain volumes and 
measures of cortical folding are both reduced in newborn infants compared to healthy 
age-matched controls, and that these measures are related to reduced cerebral 
oxygen delivery. 
In Chapter 6, I use diffusion MRI to investigate the cortical microstructural 
development of the brain in infants with CHD compared to healthy controls, and relate 
these changes to cerebral oxygen delivery. I finish by exploring the link between 
macrostructural appearance (using gyrification index as a quantitative measure) and 
microstructural measures of tissue development. 
Chapter 7 provides a summary of the work presented in this thesis, its limitations, and 





Three main methodological approaches are employed in this thesis. The first involves 
qualitative analysis of brain lesions of pre-surgical MR brain imaging of infants with 
CHD. The second uses quantitative methods to compare macroscopic differences in 
brain size and cortical folding between infants with CHD and healthy controls. The 
third uses diffusion MRI to assess the cortical microstructure of infants with CHD 
compared to healthy controls. 
In this chapter, I provide an outline of the general principles of MRI, including 
diffusion-weighted imaging and phase contrast angiography. I then explain the 
segmentation and cortical surface reconstruction methods that are used for the 
macrostructural analysis. This is followed by an outline of the methods used for 
assessing cortical microstructure, including image registration and the statistical 
methods that are employed to analyse group diffusion data. Specific methodological 
details for each study are provided in each experimental chapter. 
2.2 BIOPHYSICAL PRINCIPLES OF MRI 
Magnetic resonance imaging provides a unique opportunity to gain a better 
understanding of the structure and function of living biological tissue. Given that MRI 
does not involve ionising radiation and provides imaging with high spatial resolution 
and good tissue contrast, it has become a widely used tool. This section reviews the 
essential parameters of MRI acquisition, provides a conceptual overview of diffusion 
imaging and microstructural imaging, followed by the principles governing the analysis 
of structural, diffusion, and phase contrast data. 
2.2.1 Magnetic fields 
MRI is based upon the principle of nuclear magnetic resonance (NMR) discovered by 
Purcell and Bloch in the 1940s (Bloch, 1946; Purcell et al., 1946). All atomic nuclei 
possess the quantum property of spin. Different MRI techniques measure the effect of 
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altering the spin of specific atomic nuclei, such as hydrogen nuclei, which have an 
odd number of protons and/or neutrons, making them NMR active atomic isotopes. 
In the human body, there is an abundant source of protons in the form of hydrogen 
atoms (1H) present in the body’s water. Indeed, the mass of the human brain consists 
of approximately three-quarters water. Protons have a spin, and therefore the 
associated electrical charge of the protons also moves, inducing a small local 
magnetic field. As a result, the proton has its own magnetic field, and can be 
considered as a small bar magnet.  
In the absence of an external magnetic field, the protons are randomly orientated with 
no net magnetisation. However, in the presence of an external magnetic field, B0, the 
protons align themselves longitudinally with the field, either parallel (in line with the 
field) or anti-parallel (flipped in the opposite direction), as shown in Figure 1. 
If the spins of the protons are not completely aligned with the direction of the external 
magnetic field B0, the protons start to revolve or “precess” around the field’s 
longitudinal direction (Figure 1). The frequency with which the protons precess is 
called the resonance or “Larmor” frequency and is proportional to the strength of the 
magnetic field B0, measured in Tesla. 
Figure 1 Alignment of protons in a magnetic field - spin precession and alignment 
Protons in a strong magnetic field demonstrating alignment that is either parallel or anti-parallel to the 
external magnetic field B0. In this environment, protons develop a secondary spinning motion around the 







A spin can have different energy levels depending on the orientation of its magnetic 
moment in relation to the external magnetic field. For a simple spin system such as 
that of the proton, when the magnetic moment is aligned with the field it is in a lower 
energy state (the parallel position), while when it opposes the field (the anti-parallel 
position) it is elevated to a higher-energy state. The difference is however very small, 
and even normal thermal energy at room temperature is enough to flip spins. The 
signals generated in MRI are based upon this imbalance between energy states, and 
the small differences involved help explain why MR techniques are commonly limited 
by signal strength.  
Parallel and antiparallel protons cancel each other out, but there are slightly more 
parallel protons at the lower energy level, leading to a net magnetic moment along the 
direction of the applied magnetic field. However, magnetisation that is longitudinal to 
the external magnetic field cannot be measured directly. To allow direct measurement, 
a magnetisation that is transverse to the external magnetic field is necessary. 
2.2.2 Generating an MR signal 
Spins can be excited from a low energy state to high energy state by applying an 
oscillating radiofrequency (RF) pulse (Figure 2). This pulse consists of an oscillating 
electromagnetic field, B1, perpendicular to the static field B0. The most efficient 
transfer of energy occurs when the B1 pulse is delivered at the same frequency as the 
spin’s Larmor frequency (128 MHz for a proton in a 3 Tesla magnetic field, which is 
the field strength used in this thesis).  
The RF pulse has two main effects. Firstly, it lifts some protons to a higher energy 
level (flipping to anti-parallel), reducing the net magnetisation vector in the longitudinal 
direction. Secondly, it induces the protons to precess in phase, tipping the net 
magnetisation vector towards the transverse x-y plane (Figure 2, green arrow).  
When sufficient energy is provided to cause a 90° shift in net magnetisation, the flip 
angle is said to be 90°. A receiver coil orientated perpendicular to B0 measures the 





Figure 2 Generating an MR signal 
A radiofrequency (RF) pulse has two effects on the protons: 1. It lifts some protons to a higher level of 
energy (arrows pointing down in b), resulting in reduced longitudinal magnetisation along the z-axis; 2. It 
causes the protons to precess in step, or in ‘phase’, establishing a new transverse magnetisation in the x-
y plane, which moves around with the precessing protons. 
After the RF pulse is switched off, protons return to their lower state of energy, 
resulting in longitudinal magnetisation growing back to its original value. The energy 
gained from the RF pulse is lost in one of two ways. Firstly, the energy is  lost to 
surrounding tissue (the ‘lattice’), in a process called longitudinal relaxation or spin-
lattice-relaxation. The time taken for the longitudinal magnetisation to recover back to 
its original value is determined by a constant called by the longitudinal relaxation time, 
or T1. T1 can vary depending on the atomic structure of the material: for example, fat 
has a faster T1 than water because the carbon bonds in fat resonate close to the 
Larmor frequency, facilitating faster transfer of energy to the surrounding tissue.  
Secondly, protons lose energy to other nuclei, referred to as transversal relaxation, or 
spin-spin-relaxation. Transverse magnetisation decays against time at a rate 
determined by a constant called the transversal relaxation time, or T2. T2-relaxation 
occurs when protons get out of phase, a process that is caused by both 
inhomogeneities of the external magnetic field, and inhomogeneities of local magnetic 
fields within the tissues. If a substance is impure – e.g. containing larger molecules, 
there are bigger variations in local magnetic fields, causing greater differences in 
precession frequencies, and so protons become out of phase faster, causing a shorter 










and homogenous molecules in water results in smaller net differences in internal 
magnetic fields from location to location, allowing the protons to stay in step for a 
longer time, and hence resulting in a longer measured T2. 
These differences in T1 and T2 between different tissue compositions provide the 
contrast mechanism necessary to image the soft tissues of the brain. 
2.2.3 Image formation 
Placing a biological tissue such as the brain into a static B0 magnetic field will not 
allow a three-dimensional MR image to be generated, as all protons will be subjected 
to roughly the same magnetic field, and hence will emit identical frequencies, 
irrespective of the spatial location that it has been received from. 
To encode spatial information, a second magnetic field is required to allow slice-
selective excitation. Slice selection is achieved by varying the magnetic field gradients 
to cause variation in the precessional frequency in a linear fashion along a single axis 
of the coil (Lauterbur, 1973). The resultant MR signal is a mixture of precessional 
frequencies that are related to the position along the gradient axis x, a process that is 
termed ‘frequency encoding’. An additional gradient applied along the y axis can be 
used to alter the phase of the precessing spins, termed ‘phase encoding’. A 
combination of these allows the position of a signal to be encoded in a two-
dimensional plane, according to both the phase and frequency of the received signal. 
In order to build a three-dimensional image, an RF pulse is used to selectively excite 
spins at specific positions along the z-axis, where its oscillatory frequency matches 
the resonant frequency of the spins, and where differences in resonant frequencies 
are induced as a function of the varying gradient strength that has been applied. 
The characteristics of the gradients that are applied to the tissue determine the 
resolution of the acquired images. By increasing the gradients in a step-wise manner, 
it becomes possible to separate the sample into small cuboids, referred to as ‘voxels’. 
The size of the steps therefore determines the voxel size. Each voxel is subjected to 
the same frequency and phase encoding conditions, and so the biological 
components of the tissue within each voxel behave in the same way. It is therefore 
possible to adjust the scan resolution by varying the step size of the gradients. Lower 
resolution has the advantage of a better signal-to-noise ratio (SNR), but also the 
disadvantage of grouping a larger number of protons with potentially very different 
 26 
properties together, which could result in a misleading mixed signal. The choice of 
resolution for a particular application is ultimately a compromise between these two 
different factors. 
2.2.4 Scanning parameters 
Image contrast in MRI depends on both modifiable and non-modifiable parameters. 
Extrinsic parameters can be adjusted as part of the scan sequence, and include time 
to echo (TE), repetition time (TR) and flip angle. Intrinsic contrast parameters are 
related to the composition of the tissue being studied, and are therefore fixed – for 
example, T1 recovery and T2 decay. 
Repetition time (TR): The TR describes the amount of time between sequential 90° 
RF pulses, and determines the longitudinal relaxation, or T1 relaxation that occurs 
between pulses.  
Time to echo (TE): The TE determines the amount of T2 decay that occurs before the 
signal is received. By choosing different TEs, the signals can be T2-weighted to 
varying degrees. With very short TEs, T2 effects have not yet had time to appear. With 
longer TEs, the signal intensity difference between tissues will depend on their 
transversal relaxation times. 
For example, a short TR and TE will emphasise the T1 characteristics of tissue, 
producing a “T1-weighted” image. In contrast, a long TR and TE will emphasise T2 
characteristics of tissue, producing a “T2-weighted” image. 
Flip angle: To increase speed, it is possible to use pulses that cause flip angles 
smaller than 90°. In this case, longitudinal magnetisation is not totally abolished as 
would be the case with the full 90°, and there is still a substantial amount of 
longitudinal magnetisation left, which can be tilted by the next pulse. This gives a 
reasonable signal even if the next pulse is produced after a very short TR. 
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2.2.5 Diffusion MRI 
2.2.5.1 The concept of diffusion 
Diffusion MRI offers a unique insight into tissue microstructure. It is the most 
promising method to investigate tissue microstructure in vivo and provides 
quantitative measures of brain injury and development. It works by sensitising MRI 
measurements to the displacement pattern of water molecules undergoing diffusion.  
Each molecule in a fluid is in constant motion due to its thermal energy, and changes 
direction when it encounters a collision with another molecule. In a homogenous fluid, 
the path that a molecule takes describes a random walk – a chain of statistically-
independent steps – in a process that is now known as Brownian motion, named after 
Robert Brown, a botanist who first described the random motion of grains of pollen 
grains suspended in water under a microscope (Brown, 1828). This observed 
phenomenon was later formalised independently by both Albert Einstein and Marian 
Smoluchowski (Einstein, 1905; von Smoluchowski, 1906), demonstrating that the 
mean displacement of freely-diffusing particles is dependent on both the time taken to 
diffuse, and the diffusion coefficient (or diffusivity) of the medium in which they are in 
(Equation [2.1]). 
𝜆 = √6𝐷𝜏 [2.1] 
where l is the root mean square displacement of a molecule in three dimensions over 
time interval t, and D is the diffusion coefficient of the medium. In the case of water at 
body temperature, D is approximately 2.5 µm2/ms. This is particularly fortuitous, as 
with a different value of D, diffusion MRI would not be possible. With measureable 
diffusion times between 10-200 ms on modern MRI scanners, this diffusion coefficient 
provides a length scale in the order of 10-50 µm, which is far below imaging 
resolution, and enables us to probe the microstructure of living biological tissue 
microstructure on the micrometre scale. 
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Figure 3 Schematic of the longitudinal view of a myelinated axon 
Myelin, microtubules and neurofilaments are all longitudinally-orientated structures that hinder diffusion of 
water perpendicular to the length of the axon. This would cause the perpendicular diffusion coefficient  
D(⊥) to be smaller than the parallel diffusion coefficient D(‖). Adapted from Beaulieu 2002, with permission 
from John Wiley and Sons. 
Within a homogenous medium such as water, displacement due to diffusion can be 
described as ‘isotropic’. However, the brain is a heterogeneous organ, with various 
types of cellular compartments creating barriers to diffusion, and so reducing their 
mean displacement over time (Beaulieu, 2002). In addition, the organisation of long 
neuronal axons into tracts within the cerebral white matter preferentially favours 
diffusion along, rather than across, the length of the axons (Figure 3). 
Differential anisotropy within the brain was first demonstrated in the cat brain (Moseley 
et al., 1990), and has gone on to form the basis for clinical diffusion MRI. 
2.2.5.2 Diffusion-weighted imaging (DWI) 
A pulsed field gradient spin-echo sequence is commonly used to measure the 
magnitude of diffusion within the brain (Stejskal and Tanner, 1965), which measures 
diffusion of water molecules along the direction of diffusion gradient G. The sequence 
induces diffusion weighting through two pulsed gradients applied on either side of a 
180° RF pulse (Figure 4). Static spins will demonstrate the same MR signal following 
these gradients, as the two pulses will cancel each other out. However, spins that 
have moved will result in signal loss, allowing the macroscopic diffusion of water in 
each voxel to be measured. By applying different directions to the diffusion gradients, 








Figure 4 Pulse diagram of the Stejskal-Tanner acquisition sequence for diffusion-weighted imaging 
Initially all spins are aligned in a strong magnetic field B0. A 90° RF pulse maps the spins on to the 
transverse plane. A magnetic field gradient in direction G then causes dephasing of the proton spins. A 
180° RF pulse flips the proton spins to the opposite side of the transverse plane. A second diffusion 
gradient then causes rephrasing of the proton spins. Finally a signal read out at maximal rephrasing 
occurs – if diffusion has occurred, the proton spins are not completely refocused, resulting in signal loss. 
d = Duration of diffusion encoding gradient; D = diffusion time interval. 
Differences in diffusion signal can be seen across the various structures of the brain. 
In the cerebrospinal fluid (CSF) of the ventricles, diffusion is unhindered, and hence 
can be described as isotropic. In contrast, in the white matter, diffusion occurs 
preferentially along the white matter tracts, resulting in anisotropic diffusion. Signal 
differences observed between these two areas are not due to differences in the 
diffusivity of water in each compartment (which is approximately 2.3 x 10 mm2/s). 
Instead the apparent difference in diffusivity is due to constraints imposed on that 
water by various cellular barriers in the parenchyma, restricting diffusion, and 
therefore reducing signal attenuation. The apparent diffusion coefficient (ADC) is 
commonly used in diffusion MRI to describe the extent of water diffusivity, accounting 
for impedance due to cellular barriers. 
ADC is maximally sensitive to water diffusion occurring in the direction of the applied 
gradient and is unable to quantify diffusion in a perpendicular axis. This problem is 
overcome by applying three diffusion gradients (i.e. left-right, anterior-posterior and 
inferior-superior), and taking an average of the resultant ADC values. Alternatively, 
through application of several different diffusion-weighted gradient directions, it is 
possible to calculate rotationally-invariant estimates of tissue diffusivity. 










2.2.5.3 Diffusion tensor imaging (DTI) 
Diffusion tensor imaging is a sensitive probe of cellular structure that works by 
measuring the diffusion of water molecules using a Gaussian model. The diffusion 
tensor D is a symmetric, positive-definitive matrix, meaning that it has 3 orthogonal 
(mutually perpendicular) eigenvectors, and three positive eigenvalues. This can be 
used to characterise the anisotropy, magnitude and orientation of the diffusion tensor 
(Basser et al., 1994). The tensor is represented by a 3 x 3 matrix that describes the 
diffusion profile in a given voxel, as shown in Equation 2.2: 
𝐷 =	 ,𝐷-- 𝐷-. 𝐷-/𝐷-. 𝐷.. 𝐷./𝐷-/ 𝐷./ 𝐷//0 [2.2] 
where the diagonal elements Dxx, Dyy, and Dzz represent the diffusivity along the three 
orthogonal axes of the tensor, and the off-diagonal elements describe the correlation 
between these displacements. Together, the eigenvectors and eigenvalues of the 
diffusion tensor define an ellipsoid that represents an isosurface of the Gaussian 
diffusion probability. 
The elements of the tensor D are estimated from ADC measurements in a large 
number of gradient directions. This can be performed if at least 6 diffusion-weighted 
images are acquired in non-collinear gradient directions, in addition to at least one 
further image acquired at a different b-value, usually b=0 s/mm2. As the number of 
gradients increases, the estimate becomes more robust to noise, and it has been 
shown that at least 30 unique gradient directions are required to achieve a robust 
estimation of the tensor (Jones, 2004; Papadakis et al., 2000). For comparison, a 
diffusion acquisition with 300 directions is used in the microstructural study in Chapter 
6. 
2.2.5.4 DTI parameters 
A number of DTI scalar measures have been introduced from the eigenvalue 
decomposition that can be used as surrogate measures of underlying tissue 
microstructure. These measures depend only on the eigenvalues (and not 
eigenvectors), and hence are rotationally invariant. Commonly used quantitative 
measures include mean diffusivity (MD), fractional anisotropy (FA), axial diffusivity 
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(AD), and radial diffusivity (RD), demonstrated in Figure 5. MD is the average ADC 
across all directions. AD is calculated from the eigenvalue of the principle eigenvector, 
while RD is the mean ADC in the radial direction (i.e. the plane that is perpendicular to 
the principle direction). FA is computed from the three principle eigenvalues, and is a 
measure of the degree of anisotropy of water diffusion. For perfectly isotropic 
diffusion, FA equals 0, while in the case of a pencil-shaped tensor, FA approaches 1. 
 
Figure 5 Illustration of common metrics used in diffusion tensor imaging (DTI) 
Common diffusion tensor metrics calculated from diffusion-weighted images of a healthy control infant 
from Chapter 6, born at 38+4 and scanned at 38+5. 
2.2.5.5 High angular resolution diffusion imaging 
There are a number of limitations of standard DTI. Anisotropy indices based upon DTI 
are not only a function of microscopic tissue features, but are confounded by 
orientation dispersion and fibre crossings, both of which are ubiquitous in the brain 
(Schmahmann and Pandya, 2006). Therefore, it is not possible to confidently attribute 
changes in signal to intrinsic alterations in tissue microstructure, where they might 
instead have been caused by variations in the neural circuitry that have altered the 
neurite orientation distribution. DTI also ignores the presence of multiple tissue 
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compartments that might include neurones, neuroglia, and extracellular space – each 
compartmentalises water and may have different signal properties. 
A newer set of methods have therefore been developed that are based upon the high 
angular resolution diffusion imaging (HARDI) acquisition protocol (Tuch et al., 2002). In 
essence, this consists of measuring the diffusion-weighted signal using a much larger 
number of uniformly distributed gradient directions than is required for DTI, so as to 
capture the higher angular frequency features of the diffusion-weighted signal that are 
not adequately modelled by a single diffusion tensor. In such methods, the q-space is 
sampled on a single shell, with gradients of a fixed b-value in equally-distributed 
directions. High b values are used to maximise angular contrast, and acquisition 
sequences utilise as many directions as time allows. This is commonly around 60, but 
may be as many as 300, such as for the diffusion acquisition sequence used in this 
thesis. HARDI acquisitions enable the use of more advanced models than the diffusion 
tensor, which can better-delineate crossing fibres. It also becomes possible to 
quantify neurite morphology using more complex microstructural models, discussed in 
the next section, which require shells at a number of different b-values. 
2.2.6 Microstructural imaging 
It was recognised early in the development of diffusion MRI that it could potentially be 
used as a probe into neural tissue microstructure (Thomsen et al., 1987). These early 
findings gave rise to a variety of methods that have attempted to directly relate DWI to 
tissue microstructure, although such modelling techniques remain controversial and 
are a hotly-debated topic of research. 
Regional variation in ADC was described in human brains as early as 1987, with 
contrast noted between grey and white matter, and alterations in patients with 
infarction (Thomsen et al., 1987). Tissue differences were subsequently confirmed in 
the cat brain, with anisotropic diffusion described in white matter and isotropic 
diffusion in grey matter (Moseley et al., 1990). Similar findings were reported in the 
human brain, including anisotropic diffusion in the spinal cord and major fibre tracts in 
the brain (Hajnal et al., 1991). DTI is now a popular method used clinically for the 
assessment of pathological changes in brain microstructure. However, as discussed 
previously, DTI-based anisotropy indices are not only related to microscopic tissue 
features but are confounded by crossing fibres and orientation dispersion of fibres – 
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features that are ubiquitous in the brain. It is therefore difficult to understand the origin 
of an observed signal abnormality with DTI alone. 
Compartment models attempt to provide specific measurements including axon 
diameter and neurite dispersion by decomposing the DWI signal into two or three 
compartments. Typically, compartments include restricted intra-axonal diffusion, 
extracellular diffusion, and water trapped in glial cells or membranes. Examples 
include the two-compartment ball and stick model (Behrens et al., 2003), the 
composite hindered and restricted model of diffusion (CHARMED) (Assaf and Basser, 
2005), and later AxCaliber (Assaf et al., 2008). Criticisms have revolved around model 
assumptions that are difficult to justify, conclusions that are hard to validate, or 
practical complexity that makes them unsuitable for clinical practice (e.g. AxCaliber 
required many diffusion measurements perpendicular to the nerves, which required 
prior knowledge of the fibre orientation). 
2.2.6.1 Modelling fibre dispersion 
Early diffusion models assumed that there were one or more fibre populations with 
parallel axons in each voxel, and so could not accurately represent the widespread 
regions of fanning or bending fibre bundles in the brain. 
A model by Jespersen et al. attempted to capture the distribution of axons and 
dendrites both in white matter and grey matter (Jespersen et al., 2007). They used a 
two-compartment model with an isotropic tensor (ball) to represent diffusion in the 
extracellular space, and cylindrically-symmetric anisotropic tensors to describe intra-
axonal diffusion. Model predictions appeared to agree well with ex-vivo experimental 
data from a monkey brain. 
Zhang et al developed a model to estimate axon diameter in the presence of 
dispersion using a parametric Watson distribution – a cylindrically symmetric 
directional distribution, characterised by a single concentration parameter (Zhang et 
al., 2011). This technique could be performed in-vivo using just four b-values and 
multiple gradient directions (4 HARDI shells), due to a reduced number of model 
parameters. 
Zhang’s model was simplified in subsequent work to create neurite orientation 
dispersion and density imaging (NODDI), which was targeted at routine clinical 
imaging and required only two different b-values (Zhang et al., 2012). The model 
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attempts to recover the neurite orientation dispersion index (ODI) and neurite density 
index (NDI) by modelling the contribution of signal from three compartments: 1) intra-
neurite, represented by sticks following a Watson distribution; 2) extra-neurite, 
modelled by a cylindrically symmetric tensor; 3) CSF, which has free isotropic 
diffusion.  
While NODDI makes improvements on previous methods, some limitations remain. 
Due to the use of a single Watson distribution, it cannot model crossing fibres – a 
feature commonly found in the white matter. By default, it also assumes a fixed 
intrinsic diffusivity throughout the brain of 1.7 x 10-3 mm2 s-1 and across different 
protocols, which is perhaps unlikely, resulting in an overestimation of free water 
content in the white matter compared to that known from neuroanatomy studies 
(Nieuwenhuys et al., 2008). The use of NODDI has been demonstrated in healthy 
newborn imaging (Kunz et al., 2014), in encephalopathic infants  (Kansagra et al., 
2016), and longitudinally from infancy through to early childhood (Jelescu et al., 2015). 
Two neonatal papers report the NODDI parameters used, with both fixing axial 
diffusivity in the intra-axonal and extra-axonal space to a value of 2 x 10-3 mm2 s-1 
(Jelescu et al., 2015; Kunz et al., 2014), likely reflecting the higher water content of the 
neonatal brain compared to an adult (Dobbing and Sands, 1973). Quantitative 
estimates obtained from microstructural MR imaging studies remain heavily model-
dependent, exhibiting biases and limitations that are related to the model 
assumptions. The ultimate model that achieves an optimum compromise between 
precision and constraints is yet to be developed.  
2.2.7 Phase contrast MR 
Phase contrast angiography is a technique that is capable of encoding moving spins’ 
velocity in their phase and can be used to visualise moving fluid such as blood. Spins 
moving along a magnetic field gradient develop a phase shift that is proportional to 
their velocity. Bipolar gradients (two gradients in opposite directions but with equal 
magnitude) are applied to encode the velocity of the moving spins. Spins that are 
stationary will experience two equal and opposite changes in phase, resulting in no 
net change. Moving spins will experience two different gradients of different 
magnitude due to their different spatial position between each pulse, resulting in a net 
phase shift that is proportional to their velocity. Therefore, by measuring changes in 
phase, the velocity of the spins can be computed. 
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Bipolar gradients were originally applied along only one anatomic axis at a time, in 
order to provide flow sensitivity in that particular direction. However, by using flow-
encoding gradients along two or more axes simultaneously, it is possible to measure 
flow sensitivity along any arbitrary direction. This is the basis for phase contrast flow 
measurements that are most commonly used in cardiovascular imaging. 
 
Figure 6 The effect of bipolar phase-encoding gradients in phase contrast angiography (PCA) 
The net phase gain is zero for stationary spins (blue) but positive for spins that are moving in the direction 
of the gradients (red).  
The sequence’s sensitivity to slow or fast flows is determined by the amplitude, 
duration and spacing of the bipolar gradients. These are controlled by a parameter 
called velocity encoding (venc), which is critical to the performance of the study, and 
hence needs to be carefully chosen beforehand.  
As velocity is encoded in the spin’s phase, the measured velocity exhibits some 
particular characteristics. Phase measurements that vary by n*2p, where n is an 
integer, will be mapped back (or ‘aliased’) to the -p to p interval. Velocity 
measurements are therefore constrained to -venc to venc, where venc corresponds to a 
phase difference of p. Blood velocities that are higher than the venc parameter will be 
misrepresented in the final image, due to being incorrectly assigned back to the -venc 
to venc interval, resulting in ‘velocity aliasing’. This can be avoided by picking a value 








Data acquired using a phase contrast technique can be processed to obtain phase 
difference and magnitude images (Figure 7). In phase difference images, the signal 
obtained is proportional to the velocity of the spins moving along the direction of the 
gradient. Spins moving in one direction are given a bright signal (white), while spins 
moving in the opposite direction are assigned a dark (black) signal. Flow can then be 
inferred from a product of the average flow velocity and the cross-sectional area of 
the vessel. 
 
Figure 7 Transverse phase contrast angiography of the neonatal cerebral vessels 
a) Magnitude image from PCA acquired in a term infant in a plane perpendicular to both internal carotid 
and basilar arteries, at the level of the sphenoid bone. R-ICA = right internal carotid; L-ICA = left internal 
carotid. b) Phase image, where bright voxels indicate flow towards the head (positive velocity). c) Phase 
difference image where bright voxels indicate flow towards the head. 
Measurement accuracy is retained even if the measurement plane is not perfectly 
perpendicular to the velocity of blood flow, but instead deviated by a small angle b. An 
angulated plane results in alterations to both the velocity measurement and also the 
cross-sectional area. Blood velocity v will be underestimated, as v * cos b will be 
measured instead (Figure 8). Conversely, the cross-sectional area will be 
overestimated by a factor of 1/cos b, due to the oblique slice through the tubular 
vessel (Figure 8). These two effects cancel out each other to the first order. However, 
as the slice has a non-zero thickness, the angulated slice will suffer from more severe 
partial volume effects, resulting in decreased accuracy of flow measurements, as is 
outlined in the following section. 





Figure 8 The effect of measuring flow through a vessel at an oblique angle (b) to the direction of 
flow (v) using phase contrast angiography 
Illustration of the effect of introducing an angle b between the direction of flow (v) and the flow 
measurement direction (Z). While blood velocity will be underestimated, cross sectional area will be 
overestimated. Both effects cancel each other out. Figure adapted from (Bernstein et al., 2004). 
2.2.7.1 Random error in flow estimation using PCA 
The random error in PCA can be computed from the error in the phase images that are 
used to calculate flow velocity and is inversely related to the signal-to-noise ratio 
(SNR) of the magnitude image. Regions with very low signal intensity in the magnitude 
images, such as air and bone, will therefore result in very high uncertainty for phase 
measurement. The marked imprecision of phase measurements in these areas can be 
seen by the speckled pattern in Figure 7b. 
The variance of the error in velocity measurement is proportional to the velocity 
encoding (venc) parameter mentioned earlier, and so a lower venc will help to minimise 
this variance. For this reason, venc should be set carefully to the lowest possible level 
that will not lead to velocity aliasing as discussed previously. 
2.2.7.2 Systematic error in flow estimation using PCA 
There are a number of different types of systematic error in PCA flow measurements, 
which are described in detail elsewhere (Bakker et al., 1999; Wolf et al., 1993). As a 
brief summary, the primary sources of systematic error include: 
a. Intravoxel phase dispersion – the signal magnitude can be significantly 
reduced by intravoxel dephasing, caused in particular by turbulent flow. This is 
often caused by stenotic or otherwise diseased arteries, which is not a factor 
that is commonly a problem in newborn imaging. This source of error can be 
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b. Partial volume effects – flow measures in a vessel are inferred by a product of 
measured velocity and cross-sectional area. In the middle of a vessel, it is 
possible to be confident that the contents of the voxel in question is 
exclusively blood. However, at the peripheries of the vessel, a number of 
voxels may contain both blood and static vessel wall tissue. The degree to 
which this causes error depends on both the in-plane resolution and the 
diameter of the vessel. While there are other techniques including 
approximating the fraction of blood in the voxel, the most effective way to 
reduce the impact of partial volume effects is to increase the in-plane 
resolution. Previous studies have suggested that the minimum number of 
voxels required to make this error negligible is most commonly 16 
voxels/vessel area (Bakker et al., 1999, 1995), although another study found 
good agreement between PCA and Doppler ultrasound measurements in a 
canine femoral artery with only 3 voxels/vessel area (Hofman et al., 1995). In 
the experiments in this thesis, each cerebral vessel of interest contained 
approximately 20 – 30 voxels/vessel area. 
c. Vessel angulation – as discussed previously, if the velocity-encoding direction 
is at an angle to the direction of flow, the number of voxels affected by partial 
volume effects increases. The most effective way to reduce this error is to 
increase resolution both the in-plane resolution and slice thickness. Gradient 
moment nulling can also be used to minimise the effect of flow perpendicular 
to the velocity-encoding direction. The PCA sequence used in this thesis 
employed both approaches to reduce the effects of vessel angulation, along 
with careful (and exhaustive) adjustments to the placement of the acquisition 
plane to achieve the best results. 
d. Phase introduced by eddy currents – eddy currents are known to introduce 




2.2.7.3 Cardiac synchronisation 
In order to calculate average flow measurements across the cardiac cycle, the MR 
acquisition requires synchronisation with the cardiac cycle. Imaging is performed 
alongside an electrocardiogram (ECG), and the R-R interval is used as an easy way to 
measure the interval between QRS complexes. 
The most efficient way of performing synchronisation for PCA is retrospective gating, 
whereby data is continuously acquired along with an ECG recording of the subject’s 
cardiac cycle. MRI data is labelled with the duration since the most recent R wave, 
which marks the beginning of systole. The cardiac cycle is then divided into 
segments, or ‘phases’, and multiple measurements of repeated cardiac cycles can be 




2.3 NEONATAL MRI CONSIDERATIONS 
MRI is a relatively new and evolving technology – the first human scans were 
performed in the late 1970s (Brant Zawadzki et al., 1983), and the first neonatal brain 
scans followed shortly after in the early 1980s (Johnson et al., 1983). Since then, the 
typical magnetic field strength used in clinical scanners has increased from 
approximately 0.15 Tesla to 1.5 - 3 Tesla, making higher resolution imaging possible, 
which is particularly important for the small anatomical structures in the neonatal 
brain. Performing MRI scans in neonates can be technically challenging for a number 
of reasons: 
a) Size – the average brain volume of a term newborn is in the range of 200-600 
millilitres, in contrast to an average adult brain volume of greater than 1 litre 
(Allen et al., 2002; Makropoulos et al., 2016; Orasanu et al., 2014). To clearly 
delineate the smaller neonatal structures, the use of higher spatial resolution is 
required; 
b) Movement – motion corruption can lead to unusable images. Babies are 
unable to follow instructions to lie still, and the combination of a noisy machine 
and unfamiliar environment can make it difficult to remain asleep; 
c) Physiology – higher resting heart rates and respiratory rates in neonates 
require careful adaptation of cardiac and flow-based imaging; 
d) Biological differences – the immature brain has a higher water content with 
immature myelination of the white matter compared to adults, resulting in the 
inversion of MRI contrast when compared to adult brain scans (Prastawa et al., 
2005). These differences require careful optimisation of MR sequences for the 
neonatal brain, and also explain the use of T2-weighted rather than T1-
weighted imaging to be most commonly used for image processing in neonatal 
subjects. 
Scans acquired as part of this thesis used novel image acquisition and reconstruction 
techniques, and imaging hardware that had been designed specifically for neonatal 
imaging, as part of the Developing Human Connectome Project (Hughes et al., 
2017b).  
The resulting Neonatal Brain Imaging System (NBIS) brought together a number of 
innovations to improve the scanning procedure for neonates (Figure 9). A dedicated 
32-channel receive array coil and positioning device allows placement of the infant’s 
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head deep into the coil, to maximise the signal-to-noise ratio (Hughes et al., 2017b; 
Keil et al., 2011), enabling faster imaging at higher resolution. Disturbance to the infant 
is minimised by using a custom-designed MRI-compatible trolley to transport the 
settled infant and shell to the scanner for swift transfer onto the scanning bed. 
Sequences were optimised for neonatal scanning. To avoid startling the infant, a slow 
ramp-up in scanner noise was employed. Synthetic coil noise was used to fill in the 
usual gaps in gradient noise, in order to create continuous gradient sound while 
scanning. To work within time restraints (scan times greater than 60 minutes become 
difficult in natural sleep), multiband acquisitions were used for structural and diffusion 
imaging in order to acquire the greatest amount of data in the shortest possible time. 
 
 
Figure 9 Demonstration of the neonatal brain imaging system (NBIS) 
The system consists of three main components: the neonatal head coil (a,i), the frame (a,ii) and the 
positioning shell (a,iii). The coil is shown from the end view (b) and top view (c), where the black arrow 
denotes the inferior-superior length of the coil, and the green arrow indicates a 2 cm gap for respiratory 
aids. Positioning shell, consisting of a v-shaped base and round headpiece, with pocket for saturation 
monitor (d).  The base has a groove to allow it to be placed securely on the rails of the frame (e, red arrow). 
The headpiece has three openings to allow manipulation and visualisation of the infant’s position (e, f). The 
distance between headpiece and coil is <5 mm to maximise SNR. (h) shows a view of the system on the 
scanner table top, and (i) with an acoustic hood in situ, to block out additional scanner noise. Specially-
designed positioning and immobilisation devices consist of bead-filled cushions (j, orange arrow) backed 
by an inflatable air cushion (j, black arrow), and sit over the top of the ear muffs (j, k, green arrow). (l) shows 










Retrospective motion correction techniques can be employed to acquire optimal 
images in this population (Cordero-Grande et al., 2018). Traditionally, MR imaging has 
been exquisitely motion sensitive, often requiring oral sedation to achieve acceptable 
images in neonatal subjects. In our potentially-unstable population, parents and 
clinicians are understandably keen to avoid unnecessary use of sedation. Motion 
correction techniques now enable us to tolerate a baby’s natural head movement 
within the scanner, obtaining structural images (L Cordero-Grande et al., 2016) and 
diffusion-weighted images (Christiaens et al., 2018) with significantly reduced motion 
artefact. 
2.4 ANALYSIS OF MRI DATA 
Analysis of MRI data in this thesis was performed using a variety of image analysis 
techniques that I will introduce in the following section. Detailed methods for each 
study are provided in each experimental chapter. 
2.4.1 Image registration 
Group imaging studies rely on our ability to quantify differences between subjects, 
ideally using objective methods that provide robust, precise and reproducible 
measurements. 
Image registration is a fundamental part of a great variety of biomedical imaging 
applications (Toga and Thompson, 2001), and provides the ability to geometrically 
align one dataset with another. Registration is a prerequisite technique for any 
imaging study that aims to compare datasets across subjects, imaging modality, or 
across time. It also allows the creation of a group atlas, which acts as a reference 
system in which a group of brain images can be compared for statistical analysis. 
In general, the process of image registration can be split into three components: 
a) Transformation – estimating the mapping between the source (the image that 
will be transformed, or the ‘moving’ image) and a reference image (the ‘target’ 
image). This can be a linear or non-linear process, depending on the 
application and algorithm used. 
b) Similarity measurement – assessing the similarity between the transformed 
source image and the target image. Similarity can be defined in terms of 
geometric or intensity-based correspondence (Hajnal et al., 2001), and 
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typically works by identifying reliable anatomically-consistent landmarks 
(Bookstein, 1989) or by using anatomical surfaces such as ventricular borders 
or cortical surfaces (Thompson and Toga, 1996). Similarity metrics include 
cross correlation (CC), which is best for intra-modal registration (Hill et al., 
2001) and mutual information (MI), which is suitable for performing 
registrations between different image modalities (Pluim et al., 2003). 
c) Optimisation – identifying the global minimum or maximum of the similarity 
function, implying that the registration has achieved the best fit possible – for 
example, maximising MI. A common approach is to perform the registration in 
a multi-resolution fashion, starting with images that have been downsampled 
to a lower resolution and increasing gradually to higher resolution to fine-tune 
(Jenkinson and Smith, 2001; Rueckert et al., 1999; Woods et al., 1993). The 
advantage with this approach is that the registration can be initialised quickly 
at coarse resolution and improved through several resolution levels to finish 
with the finer anatomical detail. 
Image registration algorithms aim to maximise the similarity between the source and 
target image by optimising the parameters of the transformation algorithm in between. 
There are a number of algorithms now available, but they broadly fit into two 
categories: linear (‘rigid’ and ‘affine’) and non-linear.  
Linear transformations can account for global differences in size and shape between 
two images. For example, a rigid-body transformation includes 6 degrees of freedom 
(3 rotations and 3 translations) and is generally used for within-subject registration. An 
affine transformation includes 12 degrees of freedom (3 rotations, 3 translations, 3 
scalings, 3 skews/shears), and is often used to initialise non-linear registration. Non-
linear registration can additionally model local variations in anatomy. The non-linear 
transformation is usually described by a three-dimensional deformation-field (also 
called a “displacement-field”) that contains information on how each voxel in the 
subject volume should be warped to reach the target space. Non-linear deformations 
can be controlled by varying parameters including the number of degrees of freedom 
(fewer results in a smoother warp), warp resolution (lower results in a smoother warp) 




Figure 10 Image registration between a subject source and target template image. 
A source image from a single subject (a) is aligned to a target template (d) through the combination of an 
affine transformation (b) and non-linear transformation (c). The subject (a) is an infant with coarctation of 
the aorta, born at 37+3 weeks and scanned at 38+3 weeks. The target (d) is a population-average atlas 
created from a group of 10 infants with and 10 infants without CHD, generated using ANTs (B. B. Avants 
et al., 2008), and discussed in further detail in Chapter 4. 
An example of a subject being registered to template can be viewed in Figure 10, 
whereby the subject first undergoes an affine transformation to rotate, scale and 
translate the image into template space (Figure 10b). A non-linear transformation then 
warps local tissue differences to provide accurate correspondence between subject 
and template (Figure 10c). 
For the studies in this thesis, non-linear image registration between MR images is 
performed using Advanced Normalisation Tools (ANTs) (B. B. Avants et al., 2008). The 
symmetric image normalisation (SyN) algorithm that is implemented as part of ANTs 
was originally developed for the analysis of neurodegenerative brain disorders like 
dementia and Alzheimer’s disease. It is naturally suited to our neonatal population, 
who are experiencing similarly dramatic changes in brain morphology, albeit in 
reverse, and it has been shown to perform consistently in brain registration 
evaluations with high accuracy across subjects (Klein et al., 2009). 
2.4.2 Structural MRI analysis 
Morphometric analysis of brain MR images is widely used in research studies to 
quantify alterations in shape and volume of tissue. In this thesis, quantitative analysis 
of structural MRI data was performed using both tissue segmentation and geometric 
surface-based methods. 
a) b) c) d)
Subject Affine transformation Non-linear transformation Target template
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2.4.2.1 Segmentation 
Segmentation in brain MRI describes the process of partitioning an image into 
different regions of interest, according to intensity or anatomical characteristics. 
Segmentation is complicated by the fact that different brain structures often share 
similar intensity characteristics. Therefore, a priori information is generally required to 
guide the segmentation algorithm as to the expected location of the structures of 
interest. The most common way to supply this information to the algorithm is through 
the use of predefined rules or encoded in the form of atlases. 
Segmentation of neonatal brain MR images is widely considered to be a more 
challenging task than adult brain segmentation. This is due to the greater effect of 
partial volume between cerebral spinal fluid (CSF) and white matter, a lower contrast-
to-noise ratio compared to the adult brain, reduced contrast between grey and white 
matter, and the large changes in appearance that occur from preterm to term age. 
For all experiments in this thesis, we used a segmentation pipeline that has been 
created and optimised for our acquisitions (Makropoulos et al., 2018, 2016, 2014), 
which is based on the Expectation–Maximisation (EM) algorithm (Van Leemput et al., 
1999). Full technical details of the pipeline are available elsewhere (Makropoulos et al., 
2018), and a schematic version is displayed in Figure 11. 
To summarise the process, the segmentation pipeline begins with motion-corrected 
T2-weighted images being skull-stripped using the FSL Brain Extraction Tool (BET) 
(Smith, 2002), and corrected for intensity inhomogeneity using the N4 algorithm 
(Tustison et al., 2010). A spatiotemporal neonatal atlas is then registered to the 
subject’s image, and tissue probabilities are propagated to the subject space. Atlas 
priors are combined with subject-specific tissue priors (obtained using k-means) to 
allow a robust initialisation of the expectation maximisation (EM) algorithm (Van 
Leemput et al., 1999). An updated form of the original EM algorithm is utilised, with 
modifications including: a) the spatial proximity of brain structures modelled using a 
Markov Random Field (MRF) regularisation term; b) a prior relaxation scheme used to 
account for the large potential anatomical variability in neonatal subjects; c) 
mislabelled white matter voxels at the CSF-cortical grey matter interface corrected 
with connected component labelling and knowledge-based rules, d) another partial 
volume correction implemented for CSF-white matter boundary. 
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Figure 11 Outline of the tissue segmentation pipeline 
The subject’s T2-weighted image is brain-extracted and N4 bias field corrected. Atlas priors are 
propagated and combined with the subject-specific tissue priors. The EM algorithm is initialised with the 
combined tissue priors and results in the final labelling step. Adapted from Makropoulos et al., 2014.  
© 2014 IEEE. 
2.4.2.2 Geometric surface-based analysis 
The geometric shape of brain tissue can be of particular interest in certain patient 
groups. Gyrification index describes the complexity of cortical folding, and has been 
used to describe human brain development in a two-dimensional manner since the 
1980s (Armstrong et al., 1995; Zilles et al., 1988). To perform this analysis in three-
dimensions using a structural MR image, it is first necessary to extract the cortical 
surface from the scalar MRI volume as a geometric mesh. 
Differences in image properties obtained from adult and neonatal brains considerably 
limits the translation of adult image processing methods to neonatal subjects. In 
particular, the popular surface analysis framework FreeSurfer (Fischl, 2012) fails when 
Brain Extraction
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used on neonatal data, as it relies solely on fitting surfaces to intensity-based tissue 
segmentation masks (Dale et al., 1999). Adult MRI data have significantly different 
image intensity distributions to neonatal data, which also vary significantly with 
gestation. For this reason, it was necessary to develop a custom neonatal surface 
analysis pipeline (Makropoulos et al., 2018). 
The workflow of the surface reconstruction processing pipeline is summarised in 
Figure 13. The subject’s motion-corrected T2-weighted MR image is first bias 
corrected (Tustison et al., 2010) and the brain is extracted (Smith, 2002). The brain is 
then segmented into different tissue types using the segmentation framework 
discussed earlier (Figure 11).  
Once segmentation is completed, 
the white matter surface mesh is 
created first by fitting a closed, 
genus-0 (no holes), triangulated 
surface mesh (convex hull, Figure 
12) onto the inferred white-matter 
segmentation boundary. Tissue 
intensity information from the 
structural image is used to refine the 
shape of the mesh to regularise for 
the effects of partial volume and 
help avoid incorrect assignment of 
CSF voxels to either the grey or white matter. The pial surface is then created by 
deforming the white matter surface mesh towards the grey matter-CSF boundary, by 
searching for the closest cortical grey matter-CSF image edge outside of the white 
matter mesh. Full details of the surface reconstruction process have been published 
previously (Schuh et al., 2017). 
The pial surface is required for the calculation of the gyrification index (GI), which is 
used in Chapter 5 as a measure of cortical folding complexity. The GI is defined as the 
ratio of the surface area of the pial surface to the surface area of the superficial 
enclosing surface, where the superficial surface is reconstructed using marching 
cubes from the morphological closed combined cortical grey matter/white matter 
mask. Further details of this process are discussed in Chapter 5. 
 
Figure 12 A convex hull – the elastic band analogy 
The convex hull is the smallest convex set X of points 
in a Euclidean plane or space that contains X. For a 
two-dimensional plane, it is like stretching an elastic 
band so that it surrounds the entire set X and then 
releasing it, allowing it to contract around the points. 




Figure 13 Outline of the surface reconstruction pipeline 
Steps include: A) pre-processing, including brain extraction and N4 correction; B) tissue segmentation 
(output displayed here as a contour map); C) white matter mesh extraction; D) expansion of white matter 
surface to fit the pial surface; E) generation of quantitative measures including cortical thickness, 
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2.4.3 Diffusion MRI analysis 
Once data has been pre-processed and scalar maps generated using diffusion tensor 
fitting or another biophysical modelling technique such as NODDI, there are a number 
of approaches available to perform group-wise comparison studies. In this section, I 
will consider three common methods: region of interest (ROI), histogram, and voxel-
based analysis. 
2.4.3.1 Region of interest analysis 
This is a simple and intuitive method that involves delineation of a specific region of 
the brain across different subjects and extracting a summary measure of interest (i.e. 
mean) from the voxels within it (Mukherjee et al., 2002). An ROI can typically be either 
outlined and positioned manually on a subject’s image or positioned automatically 
using a segmentation algorithm. 
There are many pitfalls associated with an ROI-based approach. Manual placement 
requires expert knowledge to place the ROI accurately and is highly operator 
dependent, and so requires inter-/intra-operator reproducibility to be demonstrated as 
part of any study using this method. Equally, if ROIs are defined manually and directly 
on the parameter map of interest (e.g. FA), the intensity of the map may wrongly 
influence the choice of drawn boundary. For example, if a subject’s FA map 
demonstrates higher anisotropy in a particular region, a human rater may be biased to 
wrongly exclude voxels that should have been within the ROI, with the result of 
reducing true group differences. To avoid this problem, it is recommended to define 
ROIs on structural images, or use a b0 map with the same susceptibility-induced 
distortions as the diffusion-weighted images, but with contrast that is independent of 
diffusion (Jones and Cercignani, 2010). 
2.4.3.2 Histogram analysis 
Histogram analysis is another popular method for analysing quantitative MR images 
between groups. The histogram displays a graph of frequency distribution, showing 
the proportion of voxels within a certain range of values for a particular parametric 
map (e.g. FA). The shape of the histogram can be summarised using numerical 
features, and statistical comparison can be performed between a case and control 
group of subjects. This is commonly performed across the whole brain, and therefore 
determines global effects. It can also be performed for regions of interest. 
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Histogram analysis is also prone to various biases. CSF contamination is a key bias 
that is common in diffusion-weighted images as the resolution is often low resulting in 
potentially large partial volume effects. Registration to structural space can be difficult 
due to geometric distortions. Partial volume effects with CSF may be more substantial 
if one group of subjects has more atrophic brains than the other (e.g. preterm at term 
vs term, or CHD vs healthy). This could result in brain volume/morphometry having an 
undefined and erroneous contribution to differences in diffusion parametric maps. 
2.4.3.3 Voxel-based analysis 
Voxel-based analysis is becoming increasingly popular for comparing diffusion MR 
images between two or more groups of subjects to assess the association of diffusion 
parameters and clinical variables. Voxel-based methods are popular as they are 
generally highly automated and require minimal intervention from the user, reducing 
the effect of inter-/intra-observer variability. These methods rely on accurate co-
alignment of subject data in order to achieve reliable correspondence from voxel 
coordinates to the same anatomical structure of each subject within the study. Voxel-
based analyses are performed across the brain, removing the need for an a priori 
hypothesis and region of interest selection. 
There are various potential sources of bias in voxel-based analyses. Registration is 
more challenging with diffusion-weighted images, and there is choice about which 
image should be used to drive the registration. Using the b0 image is one option, 
although limited contrast may result in poor alignment. This is a concern as local 
misalignment could easily be interpreted as a signal change (Jones and Cercignani, 
2010). For white matter analysis, this source of error can be minimised by using an FA 
map to drive registration, or by using directionality information encoded within the 
diffusion tensor to more accurately align white matter tracts (Guimond et al., 2002; 
Zhang et al., 2006). 
Pipelines to achieve voxel-based analysis have many sequential steps, and choices 
made at each stage of the processing pipeline can have a significant influence on the 
statistical outcome. Such choices include degree of non-linear warping and amount of 
regularisation, choice of smoothing kernel and width, choice of statistical analysis 
method, and how to correct for multiple comparisons. Putting these multiple choices 
together in a compounding chain means that it is perhaps unsurprising that one study 
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found that when the same dataset was sent out to nine different research labs, they 
found nine different plausible results with minimal overlap (Jones et al., 2007). 
2.4.3.4 Tract-based spatial statistics 
Tract-based spatial statistics (TBSS) is a tool introduced as part of the FSL suite to 
aim to make voxel-based analyses more consistent and reliable (Smith et al., 2006). 
TBSS is not dependent on precise spatial alignment. It achieves this by introducing a 
novel step into the analysis pipeline that projects subject data onto an alignment-
invariant tract representation called the ‘skeleton’. For white matter, the projection is 
achieved by searching perpendicular to the skeleton for the maximum value in the FA 
image, which is assumed to represent the centre of the subject’s white matter tract in 
that region. The selected voxel is then projected back to the corresponding point on 
the skeleton (Figure 14). This method of projection removes the need for smoothing 
and increases the statistical power of the method by reducing the number of voxels 
that require correction for multiple comparisons. 
As with all other voxel-based methods of analysis, TBSS relies on robust registration 
of subject images to a common space. This can be challenging when anatomy is 
distorted due to pathologies or differing gestational age at scan. In this thesis, the 
initial steps of the traditional TBSS pipeline have been replaced with a registration 
method using Advanced Normalization Tools (ANTs) (B. B. Avants et al., 2008) to align 
each subject’s structural T2-weighted images that have been co-registered to the 
diffusion-weighted maps, for more accurate spatial alignment of the cortex. In 
 
 
Figure 14 The use of a mean skeleton for tract-based spatial statistics (TBSS) in the white matter and 
projection of subject data into a common space.  
A skeleton (shown in yellow) is generated from either an FA skeleton for white matter analysis (a) or a 
cortical map for grey matter analysis. The skeleton consists of either a “thick sheet” with a thin surface as 
its skeleton (c, left) or a “tube” with a line as its skeleton (c, right). Before analysis, individual subject’s data 
is projected (b, green arrows) onto an alignment-invariant tract representation (the “mean skeleton” shown 
in yellow) in a way that is not dependent on perfect non-linear registration (b). 
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addition, the white matter methodology has been adapted for grey matter analysis, by 
using a cortical mask generated from automated cortical grey matter segmentations 
to create a cortical grey matter skeleton (Ball et al., 2013). This grey matter-based 
spatial statistics (GBSS) method ensures that only diffusion measures from voxels that 
are most likely to be in the grey matter are projected to the skeleton for analysis. 
2.5 NEAR-INFRARED SPECTROSCOPY 
Near-infrared spectroscopy (NIRS) was introduced in 1977 as a technique that offers 
non-invasive, real-time, in vivo monitoring of tissue oxygenation (Jöbsis, 1977). 
The method relies upon the fact that biological tissue is relatively transparent to light 
in the near-infrared spectrum (700 – 1000 nm wavelength), and the differential 
absorption of near-infrared light by chromophores including haemoglobin, myoglobin, 
and cytochrome aa3. NIRS devices generally use wavelengths in the range of 700 – 
750 nm, where the absorption spectra of oxyhaemoglobin and deoxyhaemoglobin are 
maximally separated with limited overlap with water. 
The first application of NIRS in neonatal subjects was in 1985 to monitor cerebral 
oxygenation in preterm infants (Brazy et al., 1985), and was subsequently used to 
assess cerebral blood flow in 1988 (Edwards et al., 1988). It has since been used in a 
variety of neonatal applications including cerebral monitoring during congenital heart 
disease surgery (Andropoulos et al., 2004; Hirsch et al., 2009), guiding oxygen delivery 
during transition after birth (Pichler et al., 2014), monitoring cerebral oxygenation in 
preterm neonates (Hyttel-Sorensen et al., 2015; Pellicer et al., 2013), understanding 
brain perfusion changes in infants with hypoxic-ischaemic encephalopathy 
(Wintermark et al., 2014), guiding management of hypotension in preterm neonates 
(Bonestroo et al., 2011), and evaluating splanchnic perfusion in an attempt to detect 
early signs of necrotising enterocolitis (Sood et al., 2014). 
Despite a wide range of studies in a large number of conditions, the adoption of NIRS 
in the neonatal setting has been limited. This is likely to be due to the heterogeneity of 
reference values obtained from different patient populations and manufacturers, the 
lack of a clear threshold at which a reading is considered abnormal, and the multitude 
of different models on the market, all yielding different results. 
NIRS monitors are available from a number of different manufacturers, each with their 
own benefits and limitations. The INVOS oximeter was the first to be approved by the 
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US FDA in the 1990s. The INVOS 5100C uses two LED sources at 730 nm and 810 
nm and two photodetectors (Figure 15). The use of multiple emitter-detector 
distances, known as spatially-resolved spectroscopy (SRS), introduced the first cost-
effective NIRS implementation that attempted to provide an absolute measure of 
regional tissue oxygen saturation (rStO2). 
A newer generation of NIRS technology attempts to improve accuracy and reduce 
extracranial contamination of the measurement. For example, the Casmed Foresight 
Elite uses five LED wavelengths (680, 730, 770, 805 and 870 nm) to improve the 
accuracy of its tissue oxygenation measurements.  A study comparing three models 
(Invos 5100, Foresight 1st generation, and NONIN Equanox) concluded that the 
Foresight model had the best repeatability and lowest within-subject standard 
deviation (Hyttel-Sorensen et al., 2014). 
For the experiments in this thesis, I opted to use the Casmed Foresight Elite (2nd 
edition) with neonatal sensors. This was due to the fact that this system had the 
highest repeatability performance (Hyttel-Sorensen et al., 2014), which was the most 
important parameter for the spot measurements that I planned to take at the time of 
MRI scan in order to assess differences in cerebral tissue oxygenation caused by 




Figure 15 Summary of the original IN Vivo Optical Spectroscopy (INVOS) system 
The INVOS monitor uses two photodiode detectors and ‘subtracts’ the short distance signal from the 





Whether we are dealing with correction of congenital cardiac defects 
or developing rockets to the moon, we must not let the brilliant glare 
of technologic success obscure our long-term objective to promote 
the quality of life. 
Joseph K Perloff 





3 Background to neurodevelopment in 
congenital heart disease 
3.1 INTRODUCTION 
Children born with congenital heart disease (CHD) are at increased risk of developing 
neurodevelopmental problems across a range of different domains (Gaynor et al., 
2015; Marino et al., 2012). These include motor, cognitive, speech and language, 
behavioural, and executive functioning (Calderon and Bellinger, 2015; Klouda et al., 
2016), as well as impaired social communication and repetitive behaviours (Bellinger, 
2008; Brandlistuen et al., 2010; Nattel et al., 2017). 
Such neurodevelopmental problems are a relatively recent phenomenon, as 
historically the majority of infants with complex CHD did not survive into childhood. As 
recently as the 1950s, for all practical purposes, only patent ductus arteriosus, 
vascular rings and a very occasional case of coarctation of the aorta (CoA) or tetralogy 
of Fallot (TOF) could be treated surgically with an acceptable success rate in the 
neonate (Talner and Nadas, 1969). Before 1979, hypoplastic left heart syndrome 
(HLHS) could only be managed medically and was uniformly fatal, with mean survival 
time less than one month (Lang P and Norwood WI., 1983; Norwood et al., 1983). 
These factors led to very high mortality rates: one of the earliest epidemiology studies 
of CHD mortality in the 1940s from Birmingham, UK, estimated that of ten infants born 
alive with all forms of CHD, two would have died by the end of the first week, three to 
four by the end of the first month, and six by the end of the first year (Macmahon et 
al., 1953). Only three would survive to their tenth birthday. Another study from the 
1940s described mortality from CHD per diagnosis in Gothenburg until the age of 7 
years old (Carlgren, 1959), which graphically highlights the particularly bleak prognosis 
for infants born with CoA and transposition of the great arteries (TGA) before routine 
surgical correction was established (Figure 16). 
The last 40 years has seen remarkable surgical and medical advances in CHD (Khairy 
et al., 2008; Perloff, 1991; Perloff and Warnes, 2001; Wernovsky, 2008), with infant 
and childhood mortality decreasing by 31% from 1987 to 2005 alone (Khairy et al., 
 56 
2010), and achieving survival rates of 80-90% even for the most severe forms of CHD 
(Wernovsky, 2008). As a result, the number of surviving adults now exceeds the 
number of children with severe defects (Gilboa et al., 2016; Marelli et al., 2007). This 
contrasts disappointingly with the comparably modest improvements in 
neurodevelopmental outcomes in recent years (Gaynor et al., 2015). 
In this chapter, I introduce evidence from clinical studies of the burden of 
neurodevelopmental challenges in CHD, the timeline of their manifestation during 
childhood, and their relation to CHD diagnosis. I describe alterations in brain 
development and maturation in CHD, from fetal life through to childhood. I finish by 
considering current hypotheses of how CHD affects the normal development of the 
brain. 
3.2 THE BURDEN OF NEURODEVELOPMENTAL IMPAIRMENT IN CHD 
There are a large number of clinical studies that provide an insight into the specific 
neurodevelopmental deficits experienced by children with CHD. Research has 
predominantly focused on the more complex CHD patient groups, including single 
ventricle CHD (such as HLHS) requiring Fontan palliation, or in patients with major bi-




Figure 16 Incidence and mortality rate until 
7 years of age in individual types of 
congenital heart disease from 1941-1950. 
Mortality rates in CHD in the early days of 
surgical repair. Note mortality rate in TGA and 
CoA. Reproduced from Carlgren 1959, with 
permission of BMJ Publishing Group Ltd. 
Figure 17 Distribution of Age at Death in Patients With Congenital 
Heart Disease in 1987 to 1988 and 2004 to 2005 
Histogram bars depict the proportion of all deaths (x-axis) according to 
age at death (y-axis) in the Quebec cohort of patients with congenital 
heart disease 1987 to 1988 (left) and 2004 to 2005 (right). Black curves 
represent the corresponding age at death distribution in the general 
population. Reproduced from Khairy 2010, with permission of Elsevier. 
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The majority of studies have used the Bayley Scales of Infant and Toddler 
Development (BDIS II) or Bayley III at an age of 6 – 48 months, and frequently report 
average scores that sit within the normal range for healthy term infants (mean 100, 
standard deviation ±15). However, almost all studies report poorer 
neurodevelopmental outcomes in infants with CHD compared to healthy controls or 
normative data (Mebius et al., 2017). 
For the BSID II, the psychomotor development index (PDI) is usually more affected 
than mental developmental index (MDI). Mean composite scores for PDI have ranged 
from 69 – 103, and for MDI from 85 to 104 in infants with CHD (Hahn et al., 2016; Latal 
et al., 2015; Robertson et al., 2004; Williams et al., 2013; Zeng et al., 2015). For the 
Bayley III, mean cognitive scores have been reported between 91 – 105, mean 
language scores from 88 – 97, and mean motor scores from 86 – 97 (Andropoulos et 
al., 2014, 2012; Beca et al., 2013; Gunn et al., 2012b, 2012a; Masoller et al., 2016). 
Specific evidence for the different developmental domains are outlined in the following 
section and summarised in Figure 18. 
 
 
Figure 18 Summary of neurodevelopmental deficits observed in children who underwent corrective 
surgery for congenital heart disease 
Different domains of development can be divided up into four groups – 1. Executive function (red) 
encompassing cognitive skills required for behaviour regulation and goal-directed activity; 2. Speech / 
language and motor (blue) which both involve motor ability, coordination and planning; 3. Cognition and 
adaptive (brown) where adaptive refers to the ability to use cognition to learn and apply skills necessary for 
everyday life; and 4. Neuropsychiatric (green), including deficits related to autism spectrum disorder, 
behavioural and psychiatric conditions. ADHD = attention-deficit hyperactivity disorder; ADLs = activities of 
daily living. Adapted from Nattel et al., 2017, with permission from Elsevier. 
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3.2.1 Cognitive domains 
Children with CHD are at increased risk of cognitive difficulties compared to the 
healthy population, with consistent evidence that average intellectual quotient (IQ) in 
children with CHD is reduced by around 5 – 10 points (Bellinger et al., 2015a; Forbess 
et al., 2002; Goldberg et al., 2000; Krueger et al., 2015; Majnemer et al., 2008; Miatton 
et al., 2006; Schaefer et al., 2013). IQ scores for children with CHD overlap 
significantly with their healthy counterparts, with the entire distribution of scores 
shifted to the left in CHD, and those with a genetic abnormality shifted to an even 
greater degree (Latal, 2016). This implies that children with CHD may well perform at 
normal or even high-normal levels, although there will be a greater proportion of those 
with scores that are below clinically-relevant cut-off values in diagnoses of CHD 
(Figure 19). 
Majnemer et al. found that children who had undergone surgical repair in infancy had 
IQs within the low average range (90-94) at 5 years (Majnemer et al., 2008). Those with 
single ventricle repair may demonstrate IQs that are more markedly reduced, with a 
difference of up 10 points compared to matched controls (Forbess et al., 2002; 
Goldberg et al., 2000). This is reflected in MDI scores in one study at 14 months of 
 
 
Figure 19 Schematic demonstration of how the IQ of children with CHD with and without genetic 
abnormalities compare to those of healthy children. 
The distributions of IQs of children born with CHD are shifted to the left (poorer IQ), with considerable 
overlap between groups. This implies that children with CHD may well perform at the normal level or even 
high-normal level, but that there will be a greater number of infants below the clinically-relevant cut-off 
values (i.e. <70 represents 2 standard deviations from the mean) in children with CHD. Adapted from 








IQ 55 70 85 100 115 130 145
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age in HLHS, with 16% of subjects scoring <70 (equal to >2 SD below normal mean) 
and 36% of subjects scoring <85 (equal to >1 SD below normal mean) (Newburger et 
al., 2012).  Adolescents with TOF have IQs on average 6-10 points lower than 
controls, with TOF associated with genetic syndromes (e.g. 22q11) having significantly 
worse outcomes compared to non-syndromic TOF (Bellinger et al., 2015a). 
In adulthood, ‘executive function’ and other so-called ‘higher order’ cognitive skills are 
most impaired compared to the healthy population. Executive function refers to a 
family of mental processes that are needed to perform complex reasoning, problem 
solving and planning, with a general agreement that there are three core executive 
functions: 1) inhibition (self-control, selective attention, cognitive inhibition), 2) working 
memory, and 3) cognitive flexibility (Diamond, 2013). Executive function is of particular 
interest for ensuring long-term wellbeing in survivors of CHD, as specific deficits in 
these domains may cause difficulties in their future lives when performing prerequisite 
activities of daily living, such as managing finances, and general problem solving. 
In adulthood, one recent study that assessed survivors of all subtypes of CHD at a 
mean age of 33 found that average Wechsler IQ was within the normal range (Tyagi et 
al., 2017). The authors concluded that this result perhaps emphasises the limitation of 
generalised measures of cognitive function such as IQ. They did however find 
significant specific deficits in executive function, divided attention (the ability to 
respond to multiple tasks simultaneously), and motor function (using the Grooved 
Pegboard test). Interestingly, total composite scores were worst in TGA, followed by 
single ventricle physiology, then TOF. Evidence of impaired executive function has 
also been observed as early as 5-7 years of age, with significant delays in inhibition, 
cognitive flexibility, despite normal working memory (Calderon et al., 2014) 
On average, academic achievements of children with CHD lag behind their healthy 
peers. A large population-based cohort study of children aged 8 – 9 years old in the 
US found that children with CHD had 1.24x the odds of not meeting assessment 
standards in either reading or mathematics (95% CI 1.12 – 1.37), with 44.6% of 
children with CHD not meeting standards in at least one of these subject areas 
compared to 37.5% of those without CHD (Oster et al., 2017). Children with complex 
CHD (including HLHS, TGA, CoA, TOF, pulmonary atresia, tricuspid atresia, truncus 
arteriosus) required special educational support more frequently than those with 
simple CHD (adjusted odds ratio 1.46, 95% CI 1.15 – 1.86). 
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3.2.2 Motor domains 
In early childhood, motor development appears to be the most affected 
developmental domain in CHD. Most studies that assess this domain have found a 
degree of gross or fine motor impairment, although severe disability is uncommon. 
Early in childhood, one study described functional motor impairment at 12 and 18 
months following open heart surgery (Limperopoulos et al., 2001). Another study 
identified motor scores that were 11% below average at 6 – 37 months of age in a 
mixed cohort of CHD (Mussatto et al., 2015). There is a high prevalence of motor 
problems in HLHS, with 44 – 48% of children at 12-14 months of age showing 
significantly abnormal motor performance with scores greater than 2 standard 
deviations below the mean (Newburger et al., 2012; Tabbutt et al., 2008). 
Early motor abnormalities appear to persist into late childhood. Following a cohort of 
infants who underwent open surgery with cardiopulmonary bypass and assessed at a 
mean age of 19 months, 42% demonstrated delays in gross or fine motor skills 
(Limperopoulos et al., 2002). At 5 years of age, these delays persisted with 49% 
showing gross motor delays, and 39% fine motor delays (Majnemer et al., 2006). In 
this study, poorer gross motor scores were found if palliative (vs corrective) surgery 
had been performed, or in the presence of microcephaly at initial surgery (defined as 
(head circumference <2nd percentile for age and gender). Poorer fine motor scores 
were associated with longer deep hypothermic circulatory arrest time, palliative 
surgery, microcephaly and number of hospitalisations (Majnemer et al., 2006). Another 
study assessing children at 7 – 12 years of age who had undergone cardiac surgery in 
the first year of life, found that 43% had motor problems, compared to 7% in the 
healthy matched control group (Holm et al., 2007). Similar findings were reported in a 
study of 194 children with mixed CHD, assessed at 10 years of age, which found 
moderate motor abnormalities in 27% and severe disturbances in 32%, significantly 
worse than their healthy control group (Bjarnason-Wehrens et al., 2007). 
3.2.3 Speech and language domains 
Expressive language delays in CHD are common in CHD (Bellinger et al., 1999, 1997; 
Brosig et al., 2007; Hövels-Gürich et al., 2008). This has been specifically shown in 
HLHS at 3.5 – 6 years of age (Brosig et al., 2007), and in TGA at 2.5 years of age 
(Bellinger et al., 1997).  
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Receptive language appears to be less affected. At school age, receptive language 
was found to be intact at 5 years of age in one study that followed children who had 
undergone open heart surgery (Majnemer et al., 2008). 
Reading ability has been shown to be delayed in adolescents with TOF aged 13-16 
years old (Bellinger et al., 2015a), and in adolescents with corrected TGA at 16 years 
of age (Bellinger et al., 2011). 
3.2.4 Adaptive functioning 
Adaptive functioning is an age-based construct that describes the ability to learn and 
use the skills necessary for everyday life (Marino et al., 2012). Children with CHD have 
lower adaptive functioning scores that persist into adulthood (Warnes et al., 2008). 
Infants with HLHS are known to be particularly affected (Goldberg et al., 2000; Kern et 
al., 1998), with one study demonstrating poorer performance in all adaptive behaviour 
subsets, including worse spatial integration (Goldberg et al., 2000). 
3.2.5 Behavioural problems 
Children with CHD appear to exhibit a high prevalence of ‘internalising’ problems 
(which includes anxiety, depression, and withdrawal) and ‘externalising’ problems 
(which includes attention problems and aggression). Parents of children with CHD 
report these features at similar rates across different studies, ranging from 15 – 25% 
(Bellinger et al., 2011, 2009; Hövels-Gürich and Konrad, 2002; Hövels-Gürich et al., 
2007; Majnemer et al., 2008). 
Interestingly the children themselves do not self-report their behavioural or emotional 
problems, in contrast to their parents. In one study, parents reported increased 
perceived behavioural or emotional problems in their children aged 7 – 17 with 
diagnoses including TGA, VSD and pulmonary stenosis, while the children themselves 
self-reported no impairment (Spijkerboer et al., 2008). A similar finding was made in 
328 Fontan survivors, with parents rating their children significantly lower than their 
children’s self-reported measures of physical functioning, emotional and behavioural 
problems, general behaviour, self-esteem, and general health perceptions (Lambert et 
al., 2009). 
Inattention, impulsivity and hyperactivity have all been reported in children with CHD, 
with an increased risk of attention dysfunction being particularly reported in TGA and 
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TOF (Hövels-Gürich and Konrad, 2002; Hövels-Gürich et al., 2007; Shillingford et al., 
2008; Shillingford and Wernovsky, 2004). 
There have also been a number of studies suggesting that infants with CHD are more 
likely to exhibit features consistent with autism spectrum disorder (ASD) (Hultman et 
al., 2002; Wier et al., 2006). ASD describes a group of developmental disabilities that 
includes impaired socialisation, communication, and repetitive and unusual 
behaviours (American Psychiatric Association, 2000). Children with CHD have been 
reported to have communication impairment (Miatton et al., 2007), and reduced social 
competence (Bellinger, 2008), with higher risk observed in those with 22q11 deletion 
(Antshel et al., 2007). One study of 195 children at 4 years of age found higher rates of 
‘possible’ autism spectrum disorders than national rates (3.2% vs 1.47%), with risk 
factors including delayed sternal closure, prematurity, positive genetic findings and 
various socioeconomic and cultural variables (Bean Jaworski et al., 2017). 
Another more specific interpretation is that infants with CHD have problems with 
‘theory of mind’ (their ability to appraise and interpret another’s mental state), and 
alexithymia (difficulty understanding and describing their own emotions), both of 
which are particularly recognised in CHD (Bellinger, 2008). 
3.2.6 Timeline of manifestations of neurodevelopmental impairment 
The approximate order in which different neurodevelopmental domains become 
apparent as a child is summarised in Figure 20. Motor delays are generally the first 
domain to be affected, with hypotonia, motor asymmetries and feeding difficulties 
most prevalent (Limperopoulos et al., 2000). At one year of age, the risk of motor 
delay is greater than the risk of cognitive disability (Snookes et al., 2010). Cognitive 
impairments start to become more apparent at school age (Miatton et al., 2006), with 
expressive language, memory impairments, and lower IQ (Bellinger et al., 2015a; 
Forbess et al., 2002; Goldberg et al., 2000; Krueger et al., 2015; Majnemer et al., 2008; 
Miatton et al., 2006). Behavioural problems become increasingly apparent with 
progressing maturity, as discussed previously (Shillingford et al., 2008). Cognitive and 
motor impairments persist into adolescence, and do not appear to be outgrown as a 
result of maturational processes (Schaefer et al., 2013). Different combinations of 
neurodevelopmental challenges for each child with CHD lead to a requirement for 
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some form of special education support in approximately half of those who have 
undergone neonatal cardiac surgery aged 5 – 10 years old (Shillingford et al., 2008). 
3.2.7 Clinical factors that adversely affect neurodevelopmental outcome 
A number of outcome studies have attempted to identify perioperative clinical factors 
that correlate with poorer neurodevelopmental outcome. Lower socioeconomic status 
is a commonly associated factor (Forbess et al., 2002; Goldberg et al., 2000; Mussatto 
et al., 2015; Newburger et al., 2012), along with maternal education level (Gaynor et 
al., 2015). Longer post-repair ICU stay is consistently reported (Forbess et al., 2002; 
Limperopoulos et al., 2002; Mussatto et al., 2015; Newburger et al., 2012, 2003), 
which is intuitive as increased ICU stay is generally required to stabilise 
haemodynamics following more complex surgery, and may additionally involve 
lengthy exposure to sedatives. Other factors that relate to severity of case and 
complications and have been associated with impaired neurodevelopmental 
outcomes include longer length of hypothermic circulatory arrest (Forbess et al., 2002; 
Goldberg et al., 2000; Majnemer et al., 2008), bypass time (Hövels-Gürich et al., 2007), 
perioperative seizures (Goldberg et al., 2000), postoperative low cardiac output (Galli 
et al., 2004; Garcia Guerra et al., 2013; Miller et al., 2007), reduced systemic venous 
oxygen saturation (Hoffman et al., 2005), need for atrial septostomy (McQuillen et al., 
 
 
Figure 20 Schematic overview of developmental domains affected in CHD, with their temporal 
occurrence and estimated prevalence 
Adapted from (Latal, 2016) with permission from Elsevier Inc. 
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2006), more cardiac surgeries and tube feeding at discharge (Mussatto et al., 2015). 
Poorer outcomes have also been associated with constitutional factors such as 
birthweight less than 2.5 kg (Newburger et al., 2012), microcephaly (Majnemer et al., 
2008), and 22q11 (Forbess et al., 2002). In contrast, one study found no association 
with any perioperative factors in 88 children with HLHS (Tabbutt et al., 2008). 
Overall, these studies suggest a cumulative impact of pre-operative, perioperative and 
post-operative factors that are responsible for increasing the risk of brain injury and 
subsequent neurodevelopmental impairment in later life. 
3.2.8 Advances in surgical and perioperative factors associated with 
neurodevelopmental impairment 
Trials performed over the past 40 years have greatly improved our understanding of 
how cardiac surgery techniques and associated medical management can impact 
upon brain injury in the neonatal period. As a result, new strategies have been 
implemented that have improved outcomes for children with CHD. 
The Boston Circulatory Arrest study was a very influential study that compared the 
incidence of perioperative brain injury in infants with TGA who were randomised to 
one of: a) deep hypothermic circulatory arrest (DHCA) or b) low-flow cardiopulmonary 
bypass (Newburger, 1993). In the postoperative period, they found that DHCA was 
associated with greater ‘central nervous system perturbation’, including seizures, 
abnormal EEG monitoring, higher creatine kinase, and longer recovery time to first 
reappearance of EEG activity following surgery (Newburger, 1993). In infancy and 
early childhood, follow-up found that children who underwent DHCA were at a higher 
risk of neurodevelopmental abnormalities at 1 and 4 years of age (Bellinger et al., 
1999, 1995). At 8 years of age, DHCA was associated with worse neurodevelopmental 
outcomes with longer durations of circulatory arrest (>41 minutes), although there was 
little effect on shorter durations (Wypij et al., 2003). More recently at 16 years of age, 
few significant variables were found between treatment groups, with occurrence of 
postoperative seizures being most related to poorer neurodevelopmental outcomes. 
Despite the eventual similarity between groups at 16 years of age, the scores of both 
treatment groups were lower than normative populations (Bellinger et al., 2011). Long-
term studies like this are extremely valuable in understanding the true extent of 
modifications to our clinical practices, and this study in particular demonstrates how 
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early changes in neurodevelopmental outcomes do not necessary reflect longer-term 
findings. 
The effect of regional cerebral perfusion compared to DHCA was compared in infants 
who underwent the Norwood procedure, which was found to make no difference to 
neurodevelopmental outcome at 1 year of age (Goldberg et al., 2007). Similarly, in 
aortic arch repair, comparison between antegrade cerebral perfusion and DHCA 
showed no difference at 2 years of age, although central infarctions occurred only in 
the antegrade cerebral perfusion group (Algra et al., 2014). 
Various blood parameters have been studied in the perioperative period. One trial 
studied the effect of two acid-base management strategies during hypothermic 
cardiopulmonary bypass in a mixed cohort of CHD using an alkalotic alpha-stat 
strategy and a hypercarbic pH-stat strategy (du Plessis et al., 1997). The pH-state 
strategy was found to be associated with lower postoperative mortality, shorter 
recovery time, and shorter length of intubation and intensive care stay. 
Another group of trials considered haematocrit levels during cardiopulmonary bypass, 
finding that haematocrit levels of less than 24% during surgery were associated with 
worse neurodevelopment psychomotor development index scores at 1 year of age 
(Jonas et al., 2003; Newburger et al., 2008; Wypij et al., 2008). 
Assessment of perioperative glycaemic control has shown that tight glycaemic control 
does not affect neurodevelopmental outcomes at 1 year of age, length of hospital 
stay, mortality, or infection rates (Agus et al., 2014, 2012; Sadhwani et al., 2016). 
The optimisation of anaesthesia is another area that has been gaining interest in 
recent years. Cardiac surgery generally necessitates an anaesthetic agent, but the 
choice of agent and duration of exposure are variables that are potentially modifiable. 
Preclinical data suggest that general anaesthetics can affect brain development 
(Jevtovic-Todorovic et al., 2013), although a short duration of anaesthetic (less than 1 
hour of sevoflurane) is not thought to affect neurodevelopmental outcome at 2 years 
of age (Davidson et al., 2016). However, CHD surgery often takes a number of hours, 
and ongoing anaesthesia may also be required during the post-operative period on 
intensive care. 
A recent study of infants with HLHS found that cumulative volatile anaesthetic agent 
exposure was associated with worse full-scale IQ and verbal IQ scores at 4-5 years of 
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age, after correcting for relevant covariates (Diaz et al., 2016). Another study of a 
mixed cohort of infants undergoing complex cardiac surgery found that volatile 
anaesthetic agent exposure was associated with lower cognitive scores at 12 months 
of age (Andropoulos et al., 2014). Evidence remains limited at present, but the limited 
number of studies to date do raise concern that exposure of neonates to volatile 
anaesthetic agents may affect their longer term neurodevelopmental outcome. A 
prospective randomised trial is now required to understand the true effect of these 
agents. 
There are a vast number of modifiable factors in the management of infants with CHD. 
Studies highlighted above are responsible for improving our knowledge of a number of 
modifiable perioperative factors that may affect neurodevelopmental outcomes in 
children undergoing surgery for CHD. Future studies exploring other components of 
the treatment pathway will allow us to make further improvements for children in the 
future. 
3.2.9 Effect of CHD on quality of life and family impact 
Adverse neurodevelopmental outcomes can have a damaging effect on future quality 
of life (QOL). QOL reflects a measure of the standard of health, comfort, and 
happiness experienced by an individual. It captures three domains that include 
physical health and physical functioning, psychological status, and social functioning 
(Drotar, 2004). QOL can be collected from children as young as 7 years of age, and a 
number of studies have studied the effect of CHD on QOL scores (Marino et al., 2016). 
The greatest negative impact of CHD on QOL has been reported in the areas of social 
and education functioning (Mussatto and Tweddell, 2005). Severity of heart disease 
has been related to perceived worse physical and psychosocial QOL by parents 
(Uzark et al., 2008), and although most children reported good overall QOL scores, 
20% of children with CHD reported significantly impaired psychosocial scores, which 
also included those with mild and moderate CHD. 
The diagnosis of CHD can have a profound impact upon a family. One study 
performed a Parental Function Status-II of 100 parents with CHD and showed that 
18% scored below one standard deviation, with concerns associated with financial 
stress, severity of the child’s CHD, and lower child functioning (Garcia et al., 2016). In 
addition, issues including anxiety, depression, and post-traumatic stress disorder 
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have been reported in the child and family in the years following a diagnosis of CHD 
(Marino et al., 2016). 
3.2.10 Recent improvements in neurodevelopmental outcomes 
Despite the highlighted advances in surgical, perioperative care and medical 
management, the largest aggregated cohort of neurodevelopmental outcomes that 
has been reported to date in CHD was unable to identify significant improvements in 
outcomes from 1996 – 2009, even when restricting analyses to homogenous 
diagnostic subgroups including TGA, TOF and HLHS (Gaynor et al., 2015). After 
adjustment for patient and preoperative medical factors, both MDI and PDI improved 
significantly although by only a modest degree (approximately 5-6 points over 14 
years) (Figure 21). The analysis suggested that more patients at greater risk for 
neurodevelopmental impairment are undergoing CHD surgery, and that high-risk 
patients are surviving more often, creating a growing population that will require 
significant societal resources. Gaynor and colleagues also (somewhat gloomily) 
concluded that innate factors (such as genetic syndromes, prematurity, 
socioeconomic status) may outweigh the impact of modifiable management factors in 
determining neurodevelopmental outcomes in this population.  
 
Figure 21 Standardised PDI and MDI by year of birth from 1996 – 2009 
Standardised Psychomotor Development Index (PDI) and Mental Development Index (MDI) means by 
year of birth. The standardised means plot the predicted PDIs and MDIs and standard error bars based 
on a model with year of birth category adjusting for centre, cardiac class, and other statistically significant 
predictors at the mean value of the covariates. Overlaid are standardised means plots based on 
continuous year of birth. The horizontal dotted line represents the normative mean of 100 for both PDI 
and MDI. Reproduced from Gaynor et al., 2015, with permission of American Academy of Pediatrics. 
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3.3 EVIDENCE OF ALTERED EARLY BRAIN DEVELOPMENT IN CHD 
By now, it is clear that children with CHD are at greater risk of long-term 
neurodevelopmental deficits. In contrast, the underlying cause for such deficits 
remains less clear. A growing number of histology and neuroimaging studies have 
shown evidence of altered early brain development in the fetal and neonatal period. 
This section describes changes in brain development that have been reported in fetal 
life, and how neonatal MR imaging has contributed to our understanding of this field. 
3.3.1 Post-mortem findings 
Post-mortem examinations in the late 80s and early 90s provided an insight into early 
brain development and the progression of cortical folding during fetal life, both in 
normal brain development (Armstrong et al., 1995; Zilles et al., 1988) and in those with 
CHD (Glauser et al., 1990a, 1990b). Findings from a cohort of autopsies of infants with 
HLHS found an ‘immature cortical mantle’ in 21% of cases, microcephaly in 27% 
(defined as  below 2nd centile for gestational age), and ‘specific recognisable patterns 
of malformation’ in 17% (Glauser et al., 1990b). Acquired lesions were also found in 
45% of those with HLHS, of whom half had undergone some form of cardiac 
procedure, with a combination of hypoxic-ischaemic lesions, periventricular 
leukomalacia, brainstem necrosis, and intracranial haemorrhage (Glauser et al., 
1990a). 
Similar findings have been reported in 38 infants dying after cardiac surgery between 
1988 – 1992, with white matter damage in virtually all infants and grey matter damage 
in 68% (Kinney et al., 2005). White matter damage predominantly comprised 
periventricular leukomalacia (PVL; defined as focal or coalescing foci of necrosis in the 
white matter associated with diffuse astrogliosis in the surrounding white matter) in 
61%, or diffuse white matter gliosis (defined as reactive astrocytes without associated 
focal necrosis) in 79%. Interestingly, although the clinical profile was virtually identical 
between both types of white matter lesion, a history of resuscitation at birth was 
significantly more common in infants with diffuse gliosis (70%) vs. PVL (36%). Grey 
matter injury tended to be diffuse, implying generalised hypoxic-ischaemic injury. 
There were few focal infarcts as a result of embolic-related ischaemic events, and no 
ischaemic events in vascular border zones due to hypotension. The major lesion in the 
cortex tended to be acute neuronal necrosis, suggesting a timing in the agonal stages 
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of dying after surgery, while gliosis (indicative of older injury, including before surgery) 
tended to be present in the thalamus and brainstem. 
Overall, these findings suggested that brain development in CHD does not follow a 
normal trajectory in utero and is associated with increased vulnerability to hypoxic-
ischaemic injury during the pre-, intra-, and post-operative periods. 
3.3.2 Head circumference 
It is well-established that newborn infants with CHD are at greater risk of impaired 
growth. The rate of microcephaly in different cohorts varies from 12 – 55% (Glauser et 
al., 1990b; Hinton et al., 2008; Licht et al., 2004; Limperopoulos et al., 1999; 
Shillingford et al., 2007). The definition of microcephaly varies slightly by publication, 
with some using less and or equal to the third centile (Hinton et al., 2008; 
Limperopoulos et al., 1999; Shillingford et al., 2007), less than or equal to the second 
centile (Glauser et al., 1990b), or more than two standard deviations below the mean 
(Licht et al., 2004). Small for gestational age birth weight is noted in approximately one 
fifth of infants (Hinton et al., 2008; Shillingford et al., 2007).  
Head circumference represents a simple and widely-available proxy of prenatal brain 
growth. The American Heart Association acknowledged microcephaly as one of the 
few recognised risk factors for impaired neurodevelopment in children with CHD 
(Marino et al., 2012), and has been associated with poorer longer-term outcomes 
through infancy and school age (Gaynor et al., 2007; Limperopoulos et al., 1999; 
Matos et al., 2014). Low birth weight was also found to eclipse perioperative 
measures as the strongest predictor of a worse neurodevelopmental outcome (Gaynor 
et al., 2007). 
A large nationwide cohort study of Danish singleton infants reported smaller head 
circumference in many types of CHD including HLHS, truncus arteriosus, major 
ventricular septal defect (VSD), TGA, TOF and anomalous pulmonary venous return 
(Matthiesen et al., 2016). Only TGA was associated with a smaller head circumference 
relative to birthweight, which had been noted earlier in a smaller group (Rosenthal, 
1996), suggesting that impaired fetal cerebral growth may only be an isolated cerebral 
phenomenon in infants with TGA. 
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3.3.3 Fetal and neonatal imaging 
Cranial ultrasound is a widely-available bedside tool that can be used to assess 
cerebral abnormalities in the term CHD population (Latal et al., 2015; Rios et al., 2013; 
Te Pas et al., 2005; van Houten et al., 1996). Ultrasound has been shown to have both 
a high sensitivity for cerebral lesions such as periventricular leukomalacia and 
intraventricular haemorrhage, and has predictive validity to predict major 
neurodevelopmental impairments in preterm infants (De Vries et al., 2004). The same 
does not appear to be true for the CHD population, with ultrasound demonstrating 
very poor sensitivity and specificity for lesions compared to paired MRI in one large 
study (Rios et al., 2013). Preoperative brain lesions were present in 26% of infants 
with CHD using MRI, while only 3% showed evidence of lesions in cranial ultrasound, 
and 80% of these ultrasound-detected lesions were false-positive results. The pattern 
of brain injury was predominantly white matter injury, with stroke and haemorrhage 
being much less common (Rios et al., 2013) – a very different pattern to that observed 
in the preterm population where ultrasound is more effective. Abnormalities detected 
using ultrasound tend to be mild, consisting of diffuse brain oedema, periventricular 
white matter injury, and ventricular dilatation, and no significant relationship appears 
to exist between these and early neurodevelopmental outcome at 1 year of age (Latal 
et al., 2015).  
Advances in MRI have provided new insights into the effect of CHD on brain 
development. Magnetic resonance spectroscopy is a useful tool to assess metabolic 
integrity of neurones in particular brain regions. Developmental abnormalities have 
been noted in CHD fetuses using MR spectroscopy in the form of a lower N-
acetylaspartic acid (NAA):Choline ratio during the third trimester, when key neuronal 
connections are forming (Limperopoulos et al., 2010). The same finding has been 
noted postnatally, with a 10% reduction in the NAA:Choline ratio in a cohort of 
newborn infants prior to surgery with TGA and SV physiology (Miller et al., 2007). An 
abnormally low NAA:Choline ratio in preterm infants has been shown to be predictive 
of worse motor outcomes (Kendall et al., 2014), but the same has not been reported in 
CHD. 
A derailed trajectory of brain growth in CHD has been elegantly illustrated by studies 
using fetal ultrasound (Zeng et al., 2015) and fetal MRI (Clouchoux et al., 2013; 
Limperopoulos et al., 2010), with examples shown in Figure 22. Limperopoulos et al.’s 
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pivotal fetal MRI study demonstrated how the brain volumes of a cohort of fetuses 
with HLHS began to deviate away from normal growth rates in the third trimester 
(Limperopoulos et al., 2010) (Figure 22b). Similar findings have also been shown using 
three-dimensional fetal ultrasound, with an impaired trajectory of intracranial volume 
growth appearing at around 28 weeks in a mixed cohort of CHD (Zeng et al., 2015) 
(Figure 22a). Limperopoulos’s group built upon their initial results to describe 
significant reductions in cortical volume, cortical gyrification, surface area and white 
matter volume in the third trimester (Clouchoux et al., 2013). Reduced total brain 
volume, grey matter volume, and white matter volume have also been shown in a 
cohort of 24 fetuses with TOF using fetal MRI (Schellen et al., 2015). Fetal studies 
such as these have convincingly shown that the origins of abnormal brain 
development in CHD begin in utero. 
Smaller brain volumes continue to persist after birth (Hinton et al., 2008; Ibuki et al., 
2012; Miller et al., 2007; Shillingford et al., 2007; von Rhein et al., 2015), with MR 
imaging measures corroborating the smaller head circumferences that have been 
noted for many years. Interestingly, one study found that while infants with both TGA 
and single ventricle physiology had significantly reduced brain volumes at 1 year of 
age, by 3 years of age infants with repaired TGA demonstrated normal brain volumes 
 
 
Figure 22 Evidence of altered brain growth trajectories using both ultrasound and fetal MRI 
(a) Scatterplot of total intracranial volume measured using 3D fetal ultrasound. After the 28th week, the 
global and regional brain volumes became progressively smaller in CHD fetuses (open circles) relative 
to controls (closed circles) (Zeng et al., 2015). Reproduced with permission of John Wiley and Sons.  
(b) Relationship between total brain volume and gestational age between infants with CHD (closed 
diamonds) vs healthy controls (open diamonds) (Limperopoulos et al., 2010). Reproduced with 
permission of Wolters Kluwer Health, Inc. 
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while infants with palliated single ventricle physiology remained reduced (Ibuki et al., 
2012). This may be evidence for the value of early corrective surgery. In addition to 
volumes, brain ‘maturity’ and cortical folding complexity can be assessed using both 
semi-quantitative radiological scoring methods (Childs et al., 2001) and fully-
quantitative objective methods such as gyrification index (Armstrong et al., 1995). 
Recent studies have demonstrated reduced cortical folding complexity using both 
methods in newborn infants prior to surgery (Andropoulos et al., 2010; Claessens et 
al., 2016; Licht et al., 2009; Ortinau et al., 2013), and have suggested that white matter 
injury is the predominant injury type from qualitative radiological assessment (Mebius 
et al., 2017). Of note, cortical folding ‘immaturity’ has been shown to correlate with 
both pre- and post-operative brain injury (Andropoulos et al., 2010) and eventual 
outcome (Beca et al., 2009). 
The use of more advanced techniques such as neonatal diffusion MRI has enabled 
new insights into the development of neuronal tissue in this population. Fractional 
anisotropy (FA) is a measure of the directionality of water diffusion that increases in 
value as the maturing white matter becomes more organised during normal 
development. This makes it a valuable marker for white matter maturation. Newborn 
infants with CHD have been shown to have lower white matter FA compared to 
healthy controls (Dimitropoulos et al., 2013; Miller et al., 2007; Mulkey et al., 2014; 
Sethi et al., 2013) with changes that persist into adolescence (Rivkin et al., 2013). 
Network analysis of functional MRI data has suggested reduced regional functional 
connectivity involving critical brain regions in newborns with CHD prior to surgery, 
albeit in the presence of an intact overall global network topology (De Asis-Cruz et al., 
2017). Further studies will be required to ascertain the prognostic ability and 
diagnostic value of such analyses. 
3.4 THE EFFECT OF HAEMODYNAMIC ABNORMALITIES ON BRAIN 
DEVELOPMENT IN CHD 
Circulatory abnormalities as a result of structural defects in CHD can result in altered 
cerebral blood flow haemodynamics. The earliest quantitative measurements of the 
distribution of the fetal circulation was performed by Dawes, who used intravascular 
flow probes in exteriorised fetal lambs to obtain blood saturation measurements from 
various chambers and vessels, estimated cardiac output, and blood volumes ejected 
by both left and right ventricles (Dawes et al., 1954). Subsequent work by Rudolph 
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and Heymann used radionuclide-labelled microspheres to measure organ blood flows, 
cardiac output, the distribution of blood ejected by the left and right ventricles, also in 
fetal lambs but under more physiological conditions (Rudolph and Heymann, 1967). 
This led to some pioneering work to describe alterations in the fetal blood circulation 
in CHD (Heymann and Rudolph, 1972), and these animal experiments remain the 
basis for our current understanding of fetal circulation in CHD today.  
Recent work using fetal MRI has begun to confirm and build upon this animal work, 
with phase contrast angiography in 40 late-gestation human fetuses found to confirm 
flow estimates made by Rudolph using fetal lamb experiments (Prsa et al., 2014). T2 
mapping techniques have also been shown to correlate well with conventional blood 
gas measurements (Nield et al., 2005), which uses the same principle as BOLD MRI 
(Ogawa et al., 1990) where magnetic properties of blood vary with changes in the 
oxygen saturation of haemoglobin. The recent combination of phase contrast 
angiography and T2 mapping has allowed reproducible measurements to be 
performed on the larger fetal vessels of human fetuses in a non-invasive manner in 
vivo, and so gain a unique insight into the effect of CHD on cerebral haemodynamics 
(Sun et al., 2015). However, a limitation of work to date is the relatively heterogenous 
nature of CHD groups studied, making it difficult to draw conclusions about different 
diagnostic groups. 
This section first describes the wide spectrum of CHD diagnoses in the context of 
three main physiological categories and explains how each may affect cerebral blood 
flow and oxygen delivery. The evidence for cerebral autoregulation in CHD is 
discussed, concluding with the effect of both cyanosis and impaired CDO2 on brain 
development and neurodevelopmental outcomes. 
3.4.1 Disturbed preferential streaming of the normal fetal circulation 
In a normal fetus (Figure 23a), there is preferential streaming of oxygenated venous 
return from the placenta to the fetal circulation via the ductus venosus and foramen 
ovale, resulting in the most highly oxygenated blood being diverted to the brain. 
Disturbed preferential streaming occurs in lesions such as TGA and double outlet right 
ventricle (DORV). In TGA, preferential shunting of oxygenated blood into the left atrium 
and left ventricle is retained and given the lack of obstruction to either vessel, TGA 
results in normal flow. However, with the aorta arising from the right ventricle, the 
 74 
benefits for selective cerebral blood flow are not realised, resulting in lower 
oxygenation of blood perfusing the heart, brain and upper body (Figure 23b).  
3.4.2 Right ventricular outflow tract obstruction 
Right ventricular outflow tract obstruction includes lesions such as TOF, tricuspid 
atresia, pulmonary atresia with intact ventricular septum, and critical pulmonary valve 
stenosis (Figure 23c). To maintain descending aortic flow, blood normally carried by 
the main pulmonary trunk and ductus arteriosus is now handled by the left ventricle, 
ascending aorta and aortic isthmus, in addition to the flow that is normally carried by 
them. The aortic arch would therefore be expected to have a wider diameter than in 
the normal fetal circulation. In TOF, oxygenated blood streams across the foramen 
ovale into the aorta as usual, but this can be diluted by deoxygenated blood shunting 
from right to left across the ventricular septal defect. 
3.4.3 Obstruction to the left heart 
Obstruction to the left heart includes lesions such as HLHS, critical aortic stenosis, 
aortic atresia, and coarctation of the aorta (Figure 23d). In some fetuses with 
 
 
Figure 23 Alterations in fetal blood flow patterns in different forms of CHD. 
Blood flow patterns in (a) a healthy fetus and (b) an infant with transposition of the great arteries (TGA). In a fetus with TGA, the 
pO2 of the blood perfusing the heart, brain and upper body would be lower than normal. (c) In pulmonary atresia, blood flow is 
compromised from the right ventricle to pulmonary trunk, resulting in compensatory increased flow in the aortic isthmus.  
(d) In lesions such as hypoplastic left heart syndrome or aortic atresia, little or no blood is ejected by the left ventricle into the 
ascending aorta. Therefore, in these cases, coronary, cerebral and upper body blood flow must be provided in a retrograde 
manner from the main pulmonary trunk through the ductus arteriosus. Figures adapted from Heymann and Rudolph, 1972 with 
permission from Elsevier Inc. 
 (Heymann and Rudolph, 1972) 
 
 
d) Combined ventricular output (%) in aortic atresia
c) Combined ventricular output (%) in pulmonary atresiaa) Blood flow pattern in a fetus with 
a normal heart
b) Blood flow pattern in a fetus with 
transposition of the great arteries
Note: numbers in circles represent percent oxygen saturation; other numbers 
are pressures in mmHg; m = mean pressure.
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coarctation of the aorta, coronary, cerebral and upper body flow must be provided in 
a retrograde manner from the main pulmonary trunk through the ductus arteriosus, 
with retrograde flow in the aortic arch. The presence of retrograde flow in the aortic 
arch can be seen on fetal echocardiography and measured using fetal cardiac MRI. In 
all cases, the aortic isthmus is relatively small, with varying degrees of hypoplasia. In 
combination with an overall reduction in combined ventricular output, the whole fetal 
circulation is supplied by blood of the same oxygen content, resulting in reduced 
cerebral blood flow and oxygen delivery. 
3.4.4 Reduced fetal cerebral oxygen delivery in CHD 
Oxygen delivery to the brain in utero relies on both the oxygen content of the blood in 
the ascending aorta and the cerebral blood flow. There are at least three mechanisms 
responsible for reduced fetal cerebral oxygen delivery (CDO2) in CHD. Firstly, 
structural circulatory defects can cause alterations in normal blood flow that have 
material effects on the saturation of the blood supplying the brain (Figure 24). As 
already discussed, structural abnormalities can result in the inability of the fetus to 
effectively stream oxygenated blood across the foramen ovale towards the cerebral 
circulation. In TGA, this results in well-oxygenated blood being redirected to the 
pulmonary circulation rather than the brain, while blood supplying the brain is largely 
deoxygenated blood returning from the body via the caval veins. In TOF, streaming 
occurs as normal, but the well-oxygenated blood is diluted by deoxygenated blood 
 
 
Figure 24 Fetal blood oxygenation in representative examples of transposition of the great arteries 
(TGA), hypoplastic left heart syndrome (HLHS), and tetralogy of Fallot (TOF).  
Reproduced from Sun et al., 2015 with permission of Wolters Kluwer Health, Inc. 
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shunting across the ventricular septal defect. In HLHS, there is only one functional 
ventricle, and so the whole body (including the brain) receives blood of the same 
oxygen content. 
Secondly, suboptimal cardiac output has the potential to cause a reduced total CDO2. 
For example, in HLHS, the lack of two functional ventricles results in a reduced 
combined ventricular output. This has two potential effects: a) the heart is unable to 
compensate for reduced cerebral oxygenation by increasing cardiac output 
sufficiently (Donofrio et al., 2003), and b) placental blood flow is likely to be reduced, 
as the principle driver of placental blood flow is fetal blood pressure (which is 
dependent on fetal cardiac output), leading to reduced total fetal oxygen delivery in 
cases with single ventricle hearts (Sun et al., 2015). 
Thirdly, umbilical vein oxygen saturations have been shown to be reduced in fetuses 
with CHD in vivo using fetal MRI (Sun et al., 2015), resulting in an overall reduction in 
oxygen content of the blood delivered to the fetus. This may suggest a degree of 
abnormal placental function in CHD, and a higher prevalence of a range of placental 
abnormalities has indeed been reported in infants with CHD (Goff et al., 2011). A 
histological study of 18 placentas from fetuses with HLHS and 18 gestational age-
matched controls found that placentas from pregnancies complicated by fetal HLHS 
were smaller (447 g vs 538 g, p=0.02), and exhibited abnormal parenchymal 
morphology, with both structural and vascular changes in the villous tree, consistent 
with placental immaturity (Jones et al., 2015). In addition, this study found an increase 
in intraparenchymal fibrin deposition, indicating abnormal trophoblast secretion, which 
could lead to a reduction in available surface area for nutrient and oxygen exchange. 
In contrast, an MR imaging study of placental volume between 18 and 39 weeks 
gestation, in a group of 41 fetuses with mixed CHD vs. 94 healthy controls, found little 
evidence that placental volume differed between CHD and healthy fetuses during 
gestation (Andescavage et al., 2015). There were no significant differences in placental 
volume based on lesion type, cyanotic or acyanotic heart disease, single vs. two-
ventricle disease, or reversed/bidirectional flow at the aortic isthmus or ductus. 
However, with only 8 infants with HLHS, it was arguably underpowered to confirm 
findings from Jones et al. 2015. The full extent of the effect of CHD on the placenta 
and its importance therefore remains largely unknown. 
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3.4.5 Autoregulatory response to reduced cerebral oxygenation 
In response to reduced CDO2, it has been suggested that autoregulatory mechanisms 
in the fetal brain can vary cerebrovascular resistance to ensure delivery of an 
appropriate supply of oxygen and other metabolic substrates. Sheep models have 
shown that arterial oxygen content is an important factor influencing cerebral blood 
flow (Jones et al., 1981), while fetal hypoxia has been shown to cause a decrease in 
cerebrovascular resistance in both animal models (Cohn et al., 1974; Kjellmer et al., 
1974) and human fetuses (Vyas et al., 1990), resulting in preservation of CDO2 in the 
setting of acute hypoxia (Hudak et al., 1986).  
In human fetuses subjected to placental insufficiency, studies have shown the 
presence of an adaptive response known as the ‘brain-sparing effect’, which involves 
both an elevated umbilical artery resistance and a lower resistance of the cerebral 
vasculature in order to maintain adequate cerebral blood flow (Scherjon et al., 1993; 
Wladimiroff et al., 1987). 
Evidence for brain sparing using the cerebral-to-placental resistance ratio (CPR) in 
CHD has been mixed. Donofrio et al. found that brain sparing occurs in CHD fetuses, 
with single ventricle conditions most affected (Donofrio et al., 2003). The incidence of 
CPR <1 was greatest in hypoplastic left ventricle and hypoplastic right ventricle. In 
contrast, Kaltman et al. found that CPR was similar to normal in CHD (Kaltman et al., 
2005), but questioned if this ratio was even appropriate to be used in CHD. The brain 
sparing effect was originally described in fetuses with placental insufficiency, in 
fetuses that had structurally normal hearts, and with downstream resistance that was 
not influenced by fetal haemodynamic effects of obstructive cardiac lesions. Kaltman 
et al. therefore suggested that caution should be exercised in this population. 
Cerebrovascular resistance is measured using the pulsatility index (PI) of the middle 
cerebral artery (MCA), which is a measure of vascular resistance in the circulatory bed 
downstream from the point of Doppler sampling. Cerebral vasodilation is detected as 
a reduction in the pulsatility of blood flow in the MCA. MCA-PI has been shown to be 
reduced in fetal CHD using Doppler ultrasound (Donofrio et al., 2003; Kaltman et al., 
2005). Kaltman et al. showed that fetuses with HLHS had decreased MCA-PI 
compared to normal fetuses, while fetuses with right-sided obstructive lesions had 
increased MCA-PI, compared to fetuses with HLHS (Kaltman et al., 2005). They 
suggested that decreased cerebrovascular resistance in HLHS is a mechanism to 
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increase cerebral blood flow to compensate for otherwise decreased CDO2. They also 
theorised that the increased cerebrovascular resistance in right-sided obstructive 
lesions is an autoregulatory mechanism to reduce excessive cerebral blood flow 
resulting from the larger percentage of combined ventricular output that passes 
through the aorta (since venous return is directed away from the right side). While 
aortic oxygen saturation in a fetus with a right-sided lesion may be reduced due to 
intra-cardiac mixing, they suggested that the increased aortic blood flow may actually 
over-compensate for the decreased arterial oxygen content, requiring autoregulatory 
mechanisms to increase resistance to compensate. 
A retrospective multi-centre study of infants with HLHS found that a lower MCA-PI 
predicted a better neurodevelopmental outcome at 14 months of age using the BSID II 
(Williams et al., 2013). This suggests that an autoregulatory response to reduce 
impedance in the cerebral vasculature and allow increased blood flow in the setting of 
HLHS may indeed help to compensate for a state of chronic hypoxia. 
Quantitative MRI studies of cerebral blood flow (CBF) have had mixed findings. Using 
arterial spin labelling (ASL), CBF was initially found to be reduced in a cohort of mixed 
CHD (Licht et al., 2004). However, using phase contrast imaging in fetal subjects, CBF 
has more recently been shown to be normal in mixed CHD compared to healthy 
controls (Sun et al., 2015), which is supported by a postnatal study of newborns with 
mixed CHD that also demonstrated no difference (Lim et al., 2016). The discrepancy 
may be due to differences in study population case mixes, differing physiology 
between anaesthetised and sedated subjects, or intrinsic limitations of the two 
different MR methodologies. A more recent ASL study agreed that global CBF is 
unchanged in single ventricle neonates compared to controls (Nagaraj et al., 2015), 
although there were reductions in regional perfusion in the basal ganglia. 
Overall, there appears to be consistent evidence that MCA-PI is reduced in CHD in 
utero, which supports the presence of autoregulatory mechanisms attempting to 
maintain adequate supply of oxygen and other substrate to the brain. Quantitative 
cerebral flow studies appear to slightly contradict these findings, with a consensus 
that fetuses and infants with CHD do not have a significantly different CBF compared 
to controls, and that reductions in oxygen content of blood supplied to the cerebral 
circulation are responsible for reduced CDO2. At present, heterogeneous study groups 
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and small sample sizes, particularly at the subgroup level, make it hard to draw firm 
conclusions about cerebral blood flow haemodynamics in CHD. 
3.4.6 The impact of reduced cerebral oxygen delivery on brain development 
Reduced CDO2 in utero has been shown to correlate with reduced fetal brain size in 
third trimester fetuses with CHD (Sun et al., 2015). These findings build upon a 
previously described study of fetal brain volumes that showed a slowing trajectory of 
brain growth during the third trimester, which the authors suggested may be a result 
of acute or chronic oxygen deprivation during this crucial period of development 
(Limperopoulos et al., 2010). 
During the third trimester, there is both a dramatic increase in synapse formation and 
activity, and an acceleration of cerebral myelination, with increasing demand for 
metabolic substrate required to support this process (Brody et al., 1987; Hüppi et al., 
1998), and blood flow to the brain estimated to represent one quarter of total 
ventricular output by this stage (Rudolph, 2009). In particular, the cerebral cortex 
displays accelerated growth and organisation during the third trimester, with dendritic 
outgrowth, synapse formation and developing cortical connectivity (Kostović and 
Jovanov-Milosević, 2006), along with a marked three-fold increase in cerebral oxygen 
consumption and blood flow over the third trimester of gestation in fetal sheep 
(Gleason et al., 1989). These processes result in an escalating demand on the 
cardiovascular system to provide adequate resources for normal cerebral 
development, and an inability to do so will likely slow growth and impair cortical 
myelination and organisation. 
Following birth, CDO2 continues to be significantly lower than healthy controls (both in 
absolute value and indexed to brain volume), with the most significant reductions in 
single ventricle conditions and TGA (Lim et al., 2016). This is perhaps to be expected, 
as both conditions are known to result in significant cyanosis prior to surgical repair or 
palliation. 
The causative mechanism as to how oxygen might impair brain development in CHD 
remains unclear, although a number of recent studies have provided new insights into 
the underlying biology. Important work in the neonatal mouse brain has shown that 
oxygen tension is an essential regulator of postnatal myelination, mediated via 
oligodendrocyte precursor cells (OPCs) (Yuen et al., 2014). Oligodendrocytes (OLs) 
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are the myelinating cells of the central nervous system, and play a finely balanced role 
in producing normal myelination and angiogenesis. OPC-encoded hypoxia-inducible 
factor (HIF) function, is an essential regulator of postnatal myelination. Constitutive 
HIF1/2α stabilisation results in OPC maturation arrest through autocrine activation of 
canonical Wnt7a/7b. OPCs also show paracrine activity that induces excessive 
postnatal white matter angiogenesis and directly stimulates endothelial cell 
proliferation (Yuen et al., 2014). Poor myelination constrains axon outgrowth and 
synaptogenesis (Fünfschilling et al., 2012), and the integrity of developing axons will 
be subsequently affected. In addition, mature oligodendrocytes provide metabolic 
support for axons by supplying ATP, glycolytic substrates, and nutrients (Fünfschilling 
et al., 2012).  
Failure of OPCs to function normally results in cell death, axon damage, and cystic 
white matter injury, along with severe loss of axons in the corpus callosum (Yuen et 
al., 2014). Reduced cerebral oxygenation thus results in microstructural abnormalities 
leading to reduced white matter volume with an overall reduction in size of the brain, 
associated abnormalities in cortical and deep grey matter, as well as disordered 
angiogenesis and vascular function. Furthermore, inadequate vascular investment and 
possible lack of trophic factors for axons in a baby with CHD may result in an 
immature brain that is more vulnerable to injury during cardiac surgery than a brain 
that has developed in an environment with normal CDO2. 
The effect of hypoxia on the developing cortex has also been recently investigated 
using a piglet model with promising results (Morton et al., 2017). The subventricular 
zone (SVZ) represents the largest source of neural stem/progenitor cells (NSPCs) 
(Sanai et al., 2005). Morton and colleagues demonstrated that hypoxia reduces 
proliferation and neurogenesis in the SVZ, which was accompanied by reduced 
cortical growth. Brains from piglets exposed to perinatal chronic hypoxia had a 
smaller total brain volume, with a significant reduction in cortical grey matter volume. 
Animals exposed to hypoxia also had a reduced gyrification index compared to 
controls, which the authors state were almost identical to those noted in human 
fetuses with CHD by Clouchoux et al. 2013. 
Early progress has been made towards understanding the link between consistent 
observations of impaired brain development across many decades using numerous 
different methods and more recent findings of reduced CDO2 in CHD. Continuing this 
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work and identifying potential therapeutic targets will be crucial to improving the 
future neurodevelopmental outcomes in this population.  
3.4.7 The impact of cyanosis on neurodevelopmental outcome 
While it has only been possible to measure CDO2 in vivo relatively recently, the impact 
of cyanosis on neurodevelopmental outcomes has been debated for many years. 
Helen Taussig, in her magnum opus, ‘Congenital Malformations of the Heart’ (which is 
generally considered to represent the genesis of paediatric cardiology as an 
independent field), states that ‘extreme anoxaemia does not cause mental retardation’ 
(Taussig, 1947). Campbell and Reynolds reported early data from Guy’s Hospital in 
London about the physical and mental development of children with CHD, finding that 
degree of cyanosis had a dose-dependent impairment on weight, height, age at 
walking and age at talking (Campbell and Reynolds, 1949): “in general, the greater the 
degree of cyanosis, the greater the effect on the patient”. However, in terms of 
intellectual development, they state that “congenital heart disease does not produce 
any mental deficit or permanent backwardness”. 
Linde et al. observed that cyanotic children with CHD showed a greater disturbance in 
growth in weight and height (Linde et al., 1967a). The study also reported “central 
nervous system disturbance” in cyanotic CHD due to the finding that puberty in these 
children began as much as 3-4 years after the expected age, and in “very deeply 
cyanotic” children that puberty had not begun by 18 years of age. A comparison with 
delayed onset of puberty in children in the Peruvian Highlands led the authors to 
hypothesise that decreased arterial oxygen saturation may be to blame. 
Linde et al. continued to study mental development in CHD, noting that “cyanotic 
patients scored lower at all ages, particularly in the earlier years, with tests involving 
gross motor abilities” (Linde et al., 1967b). Overall, cyanotic children performed worse 
in IQ tests than acyanotic children, who in turn performed worse compared to healthy 
children and healthy siblings of children with CHD. Linde was keen to mention that 
while mean IQ scores were reduced, some cyanotic children attained a ‘very superior 
level of intelligence’. The study reports a positive correlation between arterial blood 
saturation and IQ for children with cyanotic CHD and concludes that lowered arterial 
oxygen saturation may be a ‘primary factor in delay in early mental development’. 
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A more recent prospective study considered the difference in cognitive function 
between cyanotic and acyanotic children aged 3.5 – 17 years old before and after 
surgery (Wray, 2001). They found that children with cyanotic lesions had lower overall 
IQ scores than acyanotic children, with lower ability levels for mathematics, reading 
and spelling. The fact that differences between acyanotic and cyanotic children 
appeared to worsen with age led the authors to suggest that there might be a critical 
age for correction of cyanotic lesions, after which ‘cyanosis and its consequences 
have deleterious effects on development and cognition’ (Wray, 2001). 
Confusingly acyanosis has also been found to be a worse predictor of developmental 
and functional limitations in a prospective study of infants undergoing surgical repair, 
followed up at 5 years of age (Majnemer et al., 2008). In this study, children with 
acyanotic lesions had a lower IQ than those with cyanotic lesions. This was attributed 
to the possibility that acyanotic lesions may be associated with poor cerebral blood 
flow, beginning in the fetal period and extending until surgical correction. In a separate 
study, no difference was found in the behaviour and quality of life in 20 children with 
cyanotic CHD (tetralogy of Fallot) compared to 20 children with acyanotic CHD (VSD), 
of whom all were operated in infancy, assessed at 7.4 years of age (Hövels-Gürich et 
al., 2007). Similarly, no difference in neurodevelopmental outcome was noted between 
acyanotic and cyanotic children in a study assessing 59 children at a median age of 
almost 14 years of age (Schaefer et al., 2013). 
While individual studies through childhood offer conflicting results, a greater 
consensus is reached in adulthood, although the evidence base is smaller. A recent 
systematic review identified only five studies of adult survivors of CHD (Tyagi et al., 
2014). A consistent finding in four of these studies was that cyanosis and more 
complex disease were associated with a lower IQ (Daliento, 2005; Utens et al., 1998, 
1994; Wernovsky et al., 2000), while the fifth study is less specific and reports only 
that the CHD group in general had significantly lower IQ scores than healthy controls 
(Eide et al., 2006). In one of these studies that considered TOF, a history of cyanosis in 
infancy was associated with greater deficits in executive functioning and complex 
processing speed (Daliento, 2005). In a more recent mixed cohort of CHD assessed at 
18-49 years of age, only those with severe cyanosis performed worse in a range of 
cognitive tests, while the others were no different on any cognitive measure compared 
to normative data (Klouda et al., 2016). 
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3.5 CONCLUSION 
Children with CHD are at greater risk of developing neurodevelopmental problems 
across a range of specific domains. As mortality rates have fallen, and the cohort of 
CHD survivors grows, such problems have become of increasing importance. Deficits 
cover domains including motor, cognitive, adaptive functioning, speech and language, 
and behavioural, with particular prominence in adulthood given to executive function. 
Despite substantial improvements in surgical and medical care of infants and children 
with CHD, improvements in neurodevelopmental outcome have been more muted. 
Evidence of abnormal early brain development in CHD has progressed from early 
autopsy findings and head circumference measurements through to sophisticated 
ultrasound and fetal MRI measures of brain structure, function, and metabolism. 
Evidence from multiple sources shows a faltering trajectory of brain growth and 
development in the third trimester at a time when the brain experiences a dramatic 
increase in metabolic demands. Current explanatory hypotheses converge upon 
reduced CDO2 in utero. Early work using fetal MRI has suggested that ascending aorta 
saturations are reduced in CHD in the third trimester, while animal studies have shown 
that chronic hypoxia result in reduced myelination, reduced angiogenesis, and 
reduced proliferation and neurogenesis in the SVZ. Cyanosis has been frequently 
linked to poorer cognitive and executive function outcomes, and the recent ability to 
measure CDO2 in vivo offers exciting new opportunities to test these hypotheses. 
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Chapter 4 
4 Brain injury in congenital heart disease 
4.1 ABSTRACT 
Objectives Neurodevelopmental impairment has become the most important 
comorbidity in infants with congenital heart disease (CHD). We aimed to: a) investigate 
the burden of brain lesions in infants with CHD prior to surgery, and b) explore clinical 
factors associated with injury. 
Study design Prospective observational study. 
Setting Single centre UK tertiary neonatal intensive care unit. 
Patients 70 newborn infants with major CHD underwent brain MRI prior to surgery. 
Main outcome measures Prevalence of cerebral injury including arterial strokes, 
punctate white matter lesions and haemorrhage; clinical variables associated with 
injury. 
Results Brain lesions were observed in 39% of subjects. Punctate white matter 
lesions were identified in 33%, subdural haemorrhage without mass effect in 33%, 
cerebellar haemorrhage in 9%, and arterial infarction in 4%. Punctate lesions were 
distributed widely throughout the brain, particularly involving the frontal white matter, 
optic radiations and corona radiata. Punctate lesions exhibited restricted diffusion in 
48% of cases and were associated with lower arterial cord pH (7.22 vs 7.30; p=0.03) 
and days of mechanical ventilation (0-3 vs 0-7 days; p=0.004). Arterial infarction was 
associated with balloon atrial septostomy (77% vs 23%), lower 1-minute (median 6 vs 
9) and 5-minute Apgar scores (8 vs 9), and days of mechanical ventilation (IQR 0-0 vs 
2-7 days). 
Conclusions Cerebral injury in newborns with CHD prior to surgery is common. 
Collaborative work between institutions to investigate variation in injury rates may 
reveal modifiable factors to improve neurodevelopmental outcomes in this population. 
 
  This chapter is based upon:, Kelly CJ, Arulkumaran S, Tristão Pereira C, Cordero-Grande L, Hughes EJ, 
Teixeira RPAG, Steinweg JK, Victor S, Pushparajah K, Hajnal JV, Simpson J, Edwards AD, Rutherford MA, 
Counsell SJ. Prevalence of brain lesions in newborns with congenital heart disease prior to surgery: an 
observational study. Submitted. 
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4.2 INTRODUCTION 
Congenital heart disease (CHD) is the most common congenital defect, (Hoffman and 
Kaplan, 2002) affecting approximately 1% of newborns (EUROCAT, 2015). Historically, 
few infants born with major CHD survived to adulthood (Mitchell et al., 1971), but 
advances in diagnostic, interventional and surgical techniques over recent decades 
have led to dramatic increases in survival (Wren, 2001). Neurodevelopmental 
impairment has become the most important co-morbidity in this population, with up to 
half of children with complex CHD experiencing a distinct pattern of 
neurodevelopmental and behavioural impairment, characterised by mild cognitive 
impairment, impaired social and communication skills, inattention, and later, deficits in 
executive function (Marino et al., 2012). 
The aetiology of neurodevelopmental impairment in CHD remains poorly understood. 
It has become clear that neurological insult in CHD begins before surgery, with altered 
neurological state in the newborn period (Limperopoulos et al., 1999), population 
studies demonstrating reduced birth weight and head circumference (Matthiesen et 
al., 2016), and in-utero imaging studies showing a derailed trajectory of brain growth 
in the third trimester (Clouchoux et al., 2013; Limperopoulos et al., 2010). 
Studies of brain injury in pre-surgical newborns have reported lesions including 
punctate white matter lesions (PWMLs), periventricular leukomalacia, and stroke with 
a prevalence that varies considerably from 19-52% of cases (Mebius et al., 2017). The 
cause for such variation between cohorts remains unclear. This study aimed to: 1) 
characterise brain lesions using MR imaging in a contemporary UK cohort of 
newborns with major CHD prior to surgery, and 2) assess which clinical factors are 
associated with brain injury. 
4.3 METHODS 
4.3.1 Study design and participants 
We recruited a prospective cohort of 70 infants with CHD expected to require surgery 
within one year, born September 2014 – November 2017, from the Neonatal Intensive 
Care Unit at St Thomas’ Hospital, London. Neonates were excluded if there was 
suspected or confirmed congenital infection or genetic malformation syndrome. The 
study was approved by the National Research Ethics Service West London committee 
(07/H0707/105). Informed written parental consent was obtained.  
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4.3.2 MR imaging 
MR imaging was performed on a 3-Tesla system (Philips Achieva, Best, Netherlands), 
situated on the Neonatal Intensive Care Unit at St Thomas’ Hospital, as soon as the 
infant could be safely transferred to the scanner. All examinations were supervised by 
an experienced paediatrician, and scanned in natural sleep without sedation, as 
described previously (Hughes et al., 2017b). MRI sequences are described in Table 1, 
and included a 5 second initial slow ramp-up in acoustic noise to avoid eliciting a 
startle response. T1-weighted and T2-weighted images were motion-corrected post 
hoc using a dedicated motion-corrected reconstruction (Cordero-Grande et al., 2018; 
Lucilio Cordero-Grande et al., 2016; Kuklisova-Murgasova et al., 2012). 






voxel size (mm) 
Reconstructed 
voxel size (mm) Other parameters 
Sept 2014 – Nov 2015 (n=18, 26%), Adult 32-channel head coil  
T1-weighted 
(magnetisation prepared 
rapid acquisition gradient 
echo) 
17 4.6 13° 0.82 x 0.97 x 1 0.82 x 0.82 x 0.5 TI:  1465 ms 
T2-weighted (fast-spin 
echo) 14,473 160 90° 1.15 x 1.18 x 2 0.86 x 0.86 x 2 - 




32 25 12° 0.45 x 0.45 x 1.8 0.4 x 0.4 x 1.8 - 
Venogram 18 6.7 10° 0.9 x 0.9 x 2 0.44 x 0.44 x 1 Phase contrast velocity 15 cm/2 
Nov 2015 – Nov 2017 (n=52, 74%), Neonatal 32-channel head coil and positioning device (Hughes et al., 2017b) 
T1-weighted 
(magnetisation prepared 
rapid acquisition gradient 
echo) 
11 4.6 9° 0.81 x 0.8 x 0.8 0.76 x 0.76 x 0.8 TI:  714 ms 
T2-weighted multi-slice 
turbo spin echo, sagittal 
and axial, combined in 
reconstruction 
12 156 90° 0.81 x 0.82 x 1.6 0.8 x 0.8 x 0.8 - 
Diffusion-weighted 
imaging (Hutter et al., 
2015) 
3800 90 90° 1.5 x 1.5 x 3, slice gap -1.5 mm 
1.17 x 1.17 x 3, 
slice gap -1.5 mm 
300 directions, b=0, 




32 25 12° 0.45 x 0.45 x 1.8 0.4 x 0.4 x 1.8 - 
Venogram 18 6.7 10° 0.9 x 0.9 x 2 0.44 x 0.44 x 1 Phase contrast velocity 15 cm/2 
Table 1 MRI sequence parameters 
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4.3.3 Image Review 
Images were reported by two neonatal neuroradiologists. All images were 
subsequently re-reviewed to ensure consistency, and lesions classified (arterial 
infarction, cerebellar haemorrhage, intraventricular haemorrhage, PWMLs). The 
location and properties of lesions on T1- and T2-weighted imaging, susceptibility-
weighted imaging (SWI) and apparent diffusion coefficient (ADC) map were recorded. 
Arterial infarcts were defined as occurring within the territory of a major cerebral 
artery, with restricted diffusion demonstrated as low signal on the ADC map 
(Rutherford, 2001). 
4.3.4 Generation of PWML maps 
PWMLs were segmented by a single reader (CTP) from T1-weighted images using 
ITK-SNAP (Yushkevich et al., 2006), and confirmed by consensus of three authors 
(SC, CK, CTP). PWMLs were defined as discrete areas of high signal intensity on T1-
weighted imaging, usually accompanied by low signal intensity on T2-weighted 
imaging (Kersbergen et al., 2014; Miller et al., 2003; Wagenaar et al., 2017). T2- and 
T1-weighted images for each subject were co-registered using a rigid body 
registration (FLIRT) (Jenkinson and Smith, 2001). A group template was then created 
from both modalities using symmetric diffeomorphic normalisation for multivariate 
neuroanatomy and a cross-correlation similarity metric using ANTs (B. Avants et al., 
2008). T1-weighted images were non-linearly registered to the template using 
symmetric diffeomorphic normalisation. These registrations were then used to 
transform individual lesion maps into template space. Finally, a probabilistic map was 
calculated from the mean of all lesion maps in template space, visualised using 
MRtrix3 (Tournier et al., 2012). Descriptive statistics were generated using MATLAB 
(2015b, MathWorks, US). Total brain volume was calculated using a previously-
validated neonatal-specific segmentation pipeline (Makropoulos et al., 2018). 
4.3.5 Statistical analysis 
Categorical clinical variables were compared using Fisher’s exact tests. Continuous 
variables were tested for normality using the Shapiro-Wilk test. For normally 
distributed continuous variables, we determined means and standard deviations, and 
compared groups with the Student’s t-test. For non-normal continuous and ordinal 
 88 
variables, we determined medians and interquartile ranges, and compared groups 
using the Mann-Whitney U test (P values were not reported for sample sizes less than 
5). All analyses were performed using SPSS, V24 (IBM, New York). 
4.4 RESULTS 
4.4.1 Subject data 
We enrolled 70 infants, all of whom were scanned prior to surgery. T1- and T2-
weighted images were acquired in 100% of subjects, ADC map in 99% (1 motion 
corrupted), SWI in 93% (2 motion corrupted, infant awoke in 3), and MRV in 80% (13 
awoke before protocol end, 1 poor quality). The median gestational age (GA) at birth 
was 38.3 weeks (IQR 37.4 – 38.7), and at scan was 39.0 weeks (IQR 38.4 – 39.7). The 
average age at scan was 5 days (IQR 2-7). Clinical variables are presented in Table 2. 
No patients experienced birth asphyxia. Antenatal diagnosis of CHD was made in 
97% (n=68), of whom all were born at our institution. Both postnatally-diagnosed 
cases were outborn.  
4.4.2 Preoperative brain injury in CHD 
Cerebral lesions were identified in 39% (n=27) of cases, including PWMLs in 33% 
(n=23, Figure 25a), cerebellar haemorrhage in 9% (n=6, Figure 25d), and arterial 
infarction in 4% (n=3, Figure 25c). Two infants with PWMLs (TGA, pulmonary atresia) 
had a larger discrete lesion in the deep white matter (Figure 25b). Forty-three infants 
(61%) had no evidence of lesions, while seven (10%) had more than one lesion type. 
All cases of arterial infarction were clinically silent, and were located in the left middle 
cerebral artery territory. There were no cases of sinus venous thrombosis. 
Asymmetrical transverse sinus flow was noted in 31% of infants (n=22), with reduced 
left-sided flow in 91% of these (n=20), a common normal anatomical variant (Ayanzen 
et al., 2000). There were no cases of intraventricular haemorrhage. Other intracranial 
findings included subdural haemorrhage without mass effect in 33% (n=23, Figure 
25e), subependymal cysts in 11% (n=8), cerebellar vermis rotation in 7% (n=5), and 




Variable Total (n=70) No lesion (n=43) Any lesion (n=27) P value 
Sex    1.0 
 Female 33 (47%) 20 (61%) 13 (39%)  
 Male  37 (53%) 23 (62%) 14 (38%)  
Delivery method     
 Normal vaginal delivery 27 (39%) 15 (56%) 12 (44%) 0.46 
 Forceps vaginal delivery 6 (9%) 4 (67%) 2 (33%) 1.0 
 Ventouse vaginal delivery 6 (9%) 3 (50%) 3 (50%)  
 Emergency caesarean 19 (27%) 14 (74%) 5 (26%) 0.27 
 Elective caesarean 12 (17%) 7 (58%) 5 (42%) 1.0 
Induction of labour 41 (59%) 25 (61%) 16 (39%) 0.67 
Prenatal diagnosis 68 (97%) 42 (62%) 26 (38%) 1.0 
Outborn 2 (3%) 1 (50%) 1 (50%) 1.0 
Gestational age at birth (weeks) 38.3 (37.4-38.7) 38.3 (37.4-38.7) 38.4 (37.6-38.9) 0.45 
Gestational age at preoperative MRI 
(weeks) 39.0 (38.4-39.7) 39.0 (38.3-39.6) 39.3 (38.4-39.9) 0.35 
Age at scan (days) 5 (2-7) 5 (2-7) 6 (3-9) 0.15 
Birth weight (kg) (mean, SD)* 2.94 (0.57) 2.95 (0.61) 2.94 (0.52) 0.96 
Head circumference (cm) 33.5 (32.2-34.5) 33.0 (32.3-34.5) 33.5 (32.0-34.5) 0.91 
Apgar score     
 1 min 9 (7-9) 9 (8-9) 9 (7-9) 0.33 
 5 min 9 (9-10) 9 (9-10) 9 (9-10) 0.42 
Cord Arterial pH (mean, SD)* 7.29 (0.082) 7.30 (0.065) 7.22 (0.11) 0.030 
Prostaglandin E2 31 (44%) 16 (52%) 15 (48%) 0.15 
Cardiac arrest 0 (0%) 0 (0%) 0 (0%) n/a 
Days mechanical ventilation 0 (0-1) 0 (0-0) 0 (0-2) 0.029 
Balloon atrial septostomy 13 (19%) 6 (46%) 7 (54%) 0.23 
 Umbilical 6 (46%) 3 (50%) 3 (50%) 0.67 
 Femoral 7 (54%) 3 (43%) 4 (57%) 0.42 
Heart lesion     
 Transposition of the great 
arteries (TGA) 28 (40%) 18 (64%) 10 (36%) 0.80 
 Tetralogy of Fallot (TOF) 13 (19%) 10 (77%) 3 (23%) 0.34 
 Coarctation of aorta (CoA) 11 (16%) 4 (36%) 7 (64%) 0.092 
 Pulmonary atresia 5 (7%) 2 (40%) 3 (60%) 0.37 
 Hypoplastic left heart 
syndrome (HLHS) 4 (6%) 3 (75%) 1 (25%) 1.0 
 Pulmonary stenosis 3 (4%) 1 (33%) 2 (67%) 0.56 
 Truncus arteriosus 3 (4%) 2 (67%) 1 (33%) 1.0 
 Tricuspid atresia 2 (3%) 2 (100%) 0 (0%) 0.52 
 Large VSD 1 (1%) 1 (100%) 0 (0%) 1.0 
Table 2 Clinical characteristics of the CHD cohort.  
Data are n (%) or median (IQR), unless otherwise specified. Percentages are column-wise for totals and row-wise for 
subgroups. “Any lesion” includes arterial infarcts, punctate lesions and cerebellar haemorrhage (there were no cases 
of intraventricular haemorrhage, and subdural haemorrhage was not included). *denotes normally-distributed 





Figure 25 Examples of lesions identified in the congenital heart disease cohort 
a) Single punctate white matter lesion in the posterior periventricular white matter (TGA, scanned at 39+6); b) 
larger punctate white matter lesion in the centrum semiovale (pulmonary atresia, scanned at 37+2); c) left middle 
cerebral artery infarct (TGA, scanned at 39+5); d) cerebellar haemorrhage (CoA, scanned at 39+3); e) subdural 
haemorrhage (TGA, scanned at 39+2), f) extradural haemorrhage (CoA, scanned 39+3). 
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4.4.3 Risk factors for preoperative brain injury 
There were no differences in GA at birth between infants with and without any cerebral 
lesion (p=0.45), PWMLs (p=0.32), or arterial infarcts (p=0.51). There were no 
differences in the proportion of cases with or without any cerebral injury in infants with 
abnormal mixing (e.g. TGA; n=34), left-sided lesions (e.g. HLHS, CoA; n=14) and right-
sided lesions (e.g. TOF, pulmonary atresia; n=22). However, the only arterial infarcts 
were in infants with TGA, all of which followed balloon atrial septostomy, but the 
increase in infarct risk with septostomy was not statistically significant (p=0.09). 
Arterial infarction occurred in 33% (n=2/6) of infants with septostomy performed via 
the umbilical vein, compared to 14% (n=1/7) via the femoral vein (Supplemental Table 
2). Infants with arterial infarction experienced more days of mechanical ventilation (IQR 
2-7 vs 0-0), lower Apgar scores at 1 minute (IQR 6-6 vs 8-9) and 5 minutes (IQR 6-8 vs 
9-10). Subdural haemorrhage occurred more frequently with induction of labour (49% 
vs 10%; p<0.001), normal vaginal delivery (52% vs 21%; p=0.01), ventouse delivery 
(83% vs 28%; p=0.013), and later GA at birth (p=0.005). Emergency caesarean was 
associated with reduced risk of subdural (5% vs 43%; p=0.003), with a similar trend 
observed in elective caesarean (8% vs 38%; p=0.09). PWMLs were associated with 
increased days of mechanical ventilation (IQR 0-2 vs 0-0; p=0.004) and lower arterial 
cord pH (7.22 vs 7.30; p=0.03). We did not identify any clinical variables associated 
with cerebellar haemorrhage. 
Genetic testing was performed as part of routine clinical care in 83% of infants (n=58). 
Microarray was normal in 88% (51/58), with benign copy variant in 7% (4/58) and 
22q11 deletion in 5% (3/58). Of those with 22q11, cerebellar haemorrhage was noted 
in 2/3, cerebellar vermis rotation in 1/3, and PWMLs in 1/3. 
4.4.4 Quantitative punctate lesion maps 
Quantitative punctate maps were generated from 22 cases (1 infant excluded due to 
slight motion). PWMLs were distributed widely throughout the brain, involving the 
frontal white matter, optic radiations, centrum semiovale, and corona radiata (Figure 
26). PWMLs exhibited both restricted (48%) and normal (52%) signal on ADC maps, 
with no significant difference in days of age at scan between groups (p=0.35). There 
were no cases of haemorrhagic PWMLs identified using SWI. Punctate lesion volume 
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was not statistically associated with any clinical variable, which persisted after 
removing two outliers with large punctate burdens (CoA n=1, TGA n=1).  
4.5 DISCUSSION 
To our knowledge, this is the first prospective observational neuroimaging study in the 
UK of infants with CHD prior to surgery. We found cerebral lesions in 39% of cases. 
Punctate white matter injury was the predominant lesion type, with few arterial 
 
 
Figure 26 Location of punctate lesions (n=22 included), superimposed onto a T1-weighted group template. 
Lesions are demonstrated throughout the white matter including the frontal white matter, optic radiations, centrum 
semiovale, and corona radiata. A three-dimensional representation of this figure is available at http://goo.gl/uRFaMR  
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infarcts. PWMLs occurred at a rate over three times higher than in healthy term infants 
scanned at our institution (Hughes et al., 2017a), with a widespread distribution 
including frontal white matter, optic radiations, and corona radiata. Brain injury 
occurred at similar rates in each diagnostic subgroup, and injury was associated with 
risk factors likely to reflect haemodynamic stability at birth, including arterial cord pH, 
days of mechanical ventilation, and lower 1 and 5-minute Apgar scores.  
Comparisons between cohorts are complicated by the heterogeneity of CHD studies 
but can be simplified by considering only infants with TGA, who are both well-
represented in pre-operative imaging studies and associated with fewest 
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Table 3 Comparison of TGA injury rates and characteristics across cohorts 
A summary of the TGA components of recent MRI studies to compare injury prevalence across cohorts. 
 
 
(Peyvandi et al., 2017)  (Brossard-Racine et al., 2016) (Desai et al., 2015) (Bertholdt et al., 2014) (Mulkey et al., 2013) (Dimitropoulos et al., 
2013) (Block et al., 2010) (Beca et al., 2009) (McQuillen et al., 2006) 
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comorbidities (Table 3). The rate of PWMLs in infants with TGA in this study is 
consistent with other cohorts, which range from 14%-32% (Beca et al., 2009; 
Bertholdt et al., 2014; Desai et al., 2015; Peyvandi et al., 2017). The incidence of 
arterial infarcts has been reported between 5%-29% (Beca et al., 2009; Bertholdt et 
al., 2014; Block et al., 2010; Dimitropoulos et al., 2013; Peyvandi et al., 2017), with our 
cohort at the lower end of this range.  
We found no cases of venous sinus thrombosis. The placement of central venous 
catheters in the internal jugular vein has been associated with increased risk of venous 
sinus thrombosis (Claessens et al., 2017). In contrast to that study (Claessens et al., 
2017), our neonatal unit does not place subclavian or internal jugular vein catheters 
preoperatively, preferring instead umbilical venous catheters or peripherally-inserted 
long lines. The absence of venous sinus thromboses in our cohort supports the view 
that internal jugular vein lines should be avoided in this population. We hypothesise 
that similar differences in clinical practice may reveal other important potential 
modifiable factors. 
The higher burden of PWMLs in our study may be explained, at least in part, by a scan 
resolution that is higher than many comparable studies, potentially allowing smaller 
lesions to be discerned. However, this would not explain our low incidence of arterial 
stroke. Different local definitions of stroke, focal stroke, white matter injury, 
periventricular leukomalacia, and punctate white matter injury may be responsible, 
and accurate comparisons are difficult without a consistent approach across 
institutions.  
We evaluated clinical parameters associated with cerebral lesions. We found that 
PWMLs were associated with lower arterial cord pH, and that arterial infarction was 
associated with lower 1 and 5-minute Apgar scores, days of mechanical ventilation 
until time of scan, and balloon atrial septostomy. Comparison of clinical variables with 
published cohorts is limited by detail available from previous studies. In our cohort, 
almost all infants were inborn at a tertiary cardiac centre and prenatally diagnosed. 
Infants with prenatal diagnoses of complex CHD are known to have significantly less 
preoperative brain injury, thought to be due to improved cardiovascular stability 
following delivery (Peyvandi et al., 2016). 
Subdural haemorrhage is common during term delivery, with an overall incidence of 8 
– 15% (Hughes et al., 2017a; Whitby et al., 2004), and up to 28% in complicated 
 95 
instrumental deliveries (Whitby et al., 2004). In our cohort, subdural haemorrhage 
occurred five times more frequently than reported in healthy normal vaginal delivery, 
and ten times more frequently in ventouse delivery (Whitby et al., 2004). At our 
institution, mothers who do not live locally are induced at around 38 weeks’ gestation, 
while spontaneous labour is preferred for those living nearby. Induction was 
associated with a rate of subdural haemorrhage almost five times higher than in 
spontaneous onset of labour, which may partly be related to instrumental delivery 
being used over three times more frequently in this group. This association between 
induction and instrumental delivery contrasts with studies of healthy infants (Caughey 
et al., 2009), and may be explained by a lower threshold for instrumental intervention 
in labours complicated by CHD, or potentially the use of induction at earlier GAs. 
The timing of pre-operative injury in CHD remains uncertain. Fetal MRI studies have 
not yet reported arterial strokes in utero, and few studies have identified white matter 
abnormalities prenatally (Brossard-Racine et al., 2016; Limperopoulos et al., 2010). 
However, perinatal and postnatal injury is likely preceded by a period of abnormal 
brain development in utero, with reduced cerebral substrate (Rudolph, 2016) and 
oxygen delivery (Lauridsen et al., 2017; Sun et al., 2015), altered metabolism 
(Limperopoulos et al., 2010), and a derailed trajectory of fetal brain development in the 
third trimester (Clouchoux et al., 2013; Limperopoulos et al., 2010). Following birth, 
there are continued metabolic disturbances (Miller et al., 2007, 2004) and alterations in 
cerebral oxygen delivery (Kelly et al., 2017; Lim et al., 2016). This chronic impairment 
may increase susceptibility to ischaemic injury around the time of delivery, a timeline 
that is supported by the finding that half of our cases exhibited PWMLs with restricted 
diffusion. If ischaemic, this would suggest an acute insult, although other aetiologies 
are possible for restricted diffusion, including clusters of activated microglia resulting 
in increased cellularity (Niwa et al., 2011; Rutherford et al., 2010). 
PWMLs were distributed throughout the white matter, in contrast to preterm infants 
where PWMLs are predominantly observed in the centrum semiovale and 
corticospinal tracts (Nanba et al., 2007; Tusor et al., 2017). While inflammatory and 
hypoxic-ischaemic injury to susceptible premyelinating oligodendrocytes (Segovia et 
al., 2008) may be responsible in both groups, it is possible that spatial differences in 
lesion distribution reflect developmental differences in the regional vulnerability of 
premyelinating oligodendrocytes between preterm infants and term infants with CHD. 
This vulnerability may be compounded by ischaemic vulnerability due to 
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periventricular vascular anatomy, or by vascular congestion in the path of the 
medullary veins, leading to small venous infarcts, which may be responsible for the 
imaging appearances in the two infants with larger PWMLs. 
Interestingly, all arterial infarcts in our study occurred following balloon atrial 
septostomy. There was no statistically increased risk of infarction in this group, 
although samples sizes were too small to form strong conclusions. Septostomy has 
been associated with an increased risk of cerebral infarction in some published 
studies (Dimitropoulos et al., 2013; McQuillen et al., 2006), but not in others (Beca et 
al., 2009; Bertholdt et al., 2014; Petit et al., 2009). All three arterial infarcts in our group 
were in the left middle cerebral artery territory, consistent with previous findings (Beca 
et al., 2009; Block et al., 2010). Prediction of hypoxemia by prenatal echocardiography 
has proved difficult (Vigneswaran et al., 2017), and need for septostomy is generally 
assessed postnatally by the clinical team.  It is therefore plausible that infants 
requiring septostomy will have experienced the greatest burden of hypoxia and 
cardiovascular instability after birth, and are most at risk of cerebral injury. The use of 
the umbilical vein has been implicated in displacement of pre-existing thrombus from 
the ductus venosus or hepatic vein during septostomy, increasing the risk of arterial 
embolic infarction (Chandar and Wolfe, 1994). In this study, the umbilical route was 
associated with a greater proportion of arterial stroke compared to femoral, although 
sample sizes were small. Previous studies showed no clear difference between the 
use of the femoral or umbilical vein (Dimitropoulos et al., 2013; McQuillen et al., 2006). 
There were limitations to our study. The heterogeneous nature of the cohort and 
relatively small subgroup sample sizes hampered our ability to compare risk factors 
across groups. All infants were from a single centre, and almost all infants had been 
diagnosed antenatally and were inborn. Comparisons of our results to other centres 
were made difficult by the variable detail of clinical parameters in previous studies, 
and variability in radiological definitions across sites. 
4.5.1 Conclusions 
Cerebral lesions in newborns with CHD prior to surgery are common and are likely to 
reflect acute injury to a vulnerable brain around the time of delivery. Injury rates show 
considerable variability between different centres, and large multicentre collaborations 
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to compare practices may reveal important modifiable factors to improve 
neurodevelopmental outcomes in this at-risk population. 
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Chapter 5 
5 Impaired development of the cerebral cortex 
in infants with congenital heart disease is 
correlated to reduced cerebral oxygen 
delivery 
5.1 ABSTRACT 
Neurodevelopmental impairment is the most common comorbidity associated with 
complex congenital heart disease (CHD), while the underlying biological mechanism 
remains unclear. We hypothesised that impaired cerebral oxygen delivery (CDO2) in 
infants with CHD is a cause of impaired cortical development, and predicted that 
cardiac lesions most associated with reduced CDO2 would demonstrate the greatest 
impairment of cortical development. We compared 30 newborns with complex CHD 
prior to surgery and 30 age-matched healthy controls using brain MRI. The cortex was 
assessed using high resolution, motion-corrected T2-weighted images in natural 
sleep, analysed using an automated pipeline. CDO2 was calculated using phase 
contrast angiography and pre-ductal pulse oximetry, while regional cerebral oxygen 
saturation was estimated using near-infrared spectroscopy. We found that impaired 
cortical grey matter volume and gyrification index in newborns with complex CHD was 
linearly related to reduced CDO2, and that cardiac lesions associated with the lowest 
CDO2 were associated with the greatest impairment of cortical development. These 
findings suggest that strategies to improve CDO2 may help reduce brain 
dysmaturation in newborns with CHD, and may be most relevant for children with 
CHD whose cardiac defects remain unrepaired for prolonged periods after birth. 
This chapter is based upon: 
C. J. Kelly, A. Makropoulos, L. Cordero-Grande, J. Hutter, A. Price, E. Hughes, M. Murgasova, R. P. A. G. 
Teixeira, J. K. Steinweg, S. Kulkarni, L. Rahman, H. Zhang, D. C. Alexander, K. Pushparajah, D. Rueckert, 
J. V. Hajnal, J. Simpson, A. D. Edwards, M. A. Rutherford, S. J. Counsell, Impaired development of the 
cerebral cortex in infants with congenital heart disease is correlated to reduced cerebral oxygen delivery., 
Sci. Rep. 7, 15088 (2017). 
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5.2 INTRODUCTION 
Congenital heart disease (CHD) is the most common congenital disorder in newborns, 
affecting approximately 1% of births (van der Bom et al., 2011). Of these, 
approximately half will have severe or moderately severe forms of CHD that require 
expert cardiology care at birth (Hoffman and Kaplan, 2002). Survival rates through 
adolescence have improved dramatically (Wernovsky, 2008), and neurodevelopmental 
impairment has now become the most important comorbidity in this growing 
population of survivors. Up to half of children with complex CHD experience a distinct 
pattern of neurodevelopmental and behavioural impairment, characterised by mild 
cognitive impairment, impaired social and communication skills, inattention, impulsive 
behaviour and later, impaired executive function (Marino et al., 2012). 
Understanding of the biological mechanisms underlying neurodevelopmental delay in 
this population remains limited. Early animal catheterisation studies suggested that 
fetal cerebral oxygen delivery (CDO2) is reduced in CHD, particularly in transposition of 
the great arteries (TGA) and left-sided lesions (Heymann and Rudolph, 1972). 
Advances in fetal MRI have since demonstrated a 10% reduction in ascending aortic 
saturations in a mixed group of CHD (Sun et al., 2015), which may impair normal 
oligodendrocyte maturation in the developing brain (Yuen et al., 2014). 
Brain “immaturity” has been described in CHD before surgery (Licht et al., 2009) using 
a radiologist-graded scoring system (Childs et al., 2001), and has been associated 
with impaired neurodevelopment at 2 years of age in children with CHD (Beca et al., 
2013). An objective marker of the developing brain’s cortical folding is the gyrification 
index, first described in the context of autopsy specimens (Elias and Schwartz, 1969; 
Zilles et al., 1988), and has been shown to increase markedly over the third trimester 
and during early infancy (Armstrong et al., 1995). Gyrification index may be an 
important metric when studying neurodevelopment in this population: reduced 
gyrification index of newborns with CHD has been demonstrated in autopsy 
specimens (Glauser et al., 1990b), fetal MR imaging studies (Clouchoux et al., 2013), 
and neonatal MR imaging studies (Claessens et al., 2016; Ortinau et al., 2013), 
although all studies to date have required varying degrees of manual input, and 
neonatal studies to date have not attempted to quantify regional differences or to 
correlate cortical development with cerebral oxygenation delivery. 
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We hypothesised that impaired CDO2 in infants with CHD is a cause of impaired 
cortical development, and predicted that cardiac lesions most associated with most 
reduced CDO2 would demonstrate the greatest impairment of cortical development. 
We aimed to compare the cortex of newborns with CHD prior to surgery versus 
healthy control infants, assessing cortical folding, cortical grey matter volumes and 
cerebral blood flow calculated from high resolution magnetic resonance imaging 
(MRI). 
5.3 METHODS 
The project was approved by the National Research Ethics Service West London 
committee (CHD: 07/H0707/105, Controls: 14/LO/1169) and informed written parental 
consent was obtained prior to imaging. All methods and experiments were performed 
in accordance with relevant guidelines and regulations. 
5.3.1 Participants 
A prospective cohort of 33 infants born with complex CHD requiring surgery within 
one year was recruited from the Neonatal Intensive Care Unit at St Thomas’ Hospital, 
London. Two infants were found to have neonatal arterial ischaemic stroke on MRI 
(left parietal stroke (n=1) and left frontal stroke (n=1); both TGA post-septostomy) and 
were excluded from this analysis. A further infant (TGA) was excluded due to unknown 
date of last menstrual period and lack of ultrasound dating scan. 
We therefore studied 30 infants with CHD, born at a median (range) gestational age 
(GA) of 38+3 (34+6-40+4) weeks. A group of healthy controls was matched by GA at birth 
and at scan, contemporaneously recruited from the postnatal ward at St Thomas’ 
Hospital through the Developing Human Connectome Project (Hughes et al., 2017b), 
born at a median (range) GA of 38+6 (35+2-40+6) weeks. The median GA at imaging was 
39+2 (37+3 - 41+4) weeks for the CHD group and 39+1 (36+1 - 41+6) weeks for the control 
group. 
5.3.2 MR imaging 
T2-weighted, T1-weighted and phase contrast angiography MR imaging was 
performed on a Philips Achieva 3 Tesla system (Best, The Netherlands) with a 32-
channel neonatal head coil and neonatal positioning device (Hughes et al., 2017b), 
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situated on the neonatal intensive care unit at St Thomas’ Hospital, London. All 
examinations were supervised by a paediatrician experienced in MR imaging 
procedures. All infants were scanned in natural sleep without sedation. Pulse 
oximetry, respiratory rate, temperature and electrocardiography were monitored 
throughout. Ear protection comprised earplugs moulded from a silicone-based putty 
(President Putty, Coltene Whaledent, Mahwah, NJ, USA) placed in the external 
auditory meatus, neonatal earmuffs (MiniMuffs, Natus Medical Inc, San Carlos, CA, 
USA) and an acoustic hood positioned over the shell. All sequences included a 5 
second initial slow ramp-up in acoustic noise to avoid eliciting a startle response. 
T2-weighted images were acquired using a multi-slice turbo spin echo (TSE) 
sequence, acquired in two stacks of 2D slices (in sagittal and axial planes), using 
parameters: TR: 12 s; TE: 156 ms, flip angle: 90º, slice thickness: 1.6 mm acquired 
with an overlap of 0.8 mm; in-plane resolution: 0.8x0.8 mm, scan time: 3:12 min per 
stack. The T1-weighted volumetric magnetisation prepared rapid acquisition gradient 
echo (MPRAGE) acquisition parameters were as follows: TR: 11 ms, TE: 4.6 ms, TI:  
Variable Control Newborns  n = 30 
Newborns with Congenital 
Heart Disease, n = 30 p value 
Gestational age at birth (weeks) 38.9 (38.1 – 39.3) 38.4 (37.9 – 38.9) 0.07 
Post-menstrual age at scan (weeks) 39.1 (38.7 – 39.7) 39.3 (38.7 – 39.6) 0.81 
Male 16 8 0.06 
Birth weight (g) 3220 (2920 – 3550) 3125 (2800 – 3500) 0.37 
Birth weight z-score -0.02 (-0.39 – 0.5) -0.17 (-0.77 – 0.49) 0.69 
Birth head circumference (cm) 34.5 (33 – 35.5) 34 (33 – 35) 0.24 
Birth head circumference z-score 0.72 (-0.06 – 1.20) 0.05 (-0.49 – 0.76) 0.11 
Heart lesion – no. (%)    
- Transposition of the great arteries 
(TGA) - 14 (47)  
   - TGA requiring septostomy (% TGA)  5 (36)  
- Coarctation of the aorta - 4 (13)  
- Hypoplastic left heart syndrome - 3 (10)  
- Tetralogy of Fallot - 3 (10)  
- Pulmonary atresia - 3 (10)  
- Pulmonary stenosis - 2 (7)  
- Truncus arteriosus - 1 (3)  
 
Table 4 Cohort characteristics for macrostructural analysis 
GA at birth and PMA at scan are presented as median (interquartile range). Apgar scores reflect condition at 
birth, ranging from 0 to 10, with lower scores indicating a worse clinical condition. p values calculated using 
Mann-Whitney U test for continuous data, and Fisher's exact test for categorical variables. z-scores for head 
circumference and birth weight calculated using UK-WHO 2006 reference data. 
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713 ms, flip angle: 9º, acquired voxel size: 0.8 × 0.8 × 0.8 mm, FOV: 145 × 145 × 108 mm, 
SENSE factor: 1.2, scan time: 4:35 min. Quantitative flow imaging was performed using 
velocity sensitised phase contrast imaging, with a single-slice T1-weighted fast field 
echo sequence. Scan parameters were: field of view (FOV): 100x100 mm2, acquisition 
resolution: 0.6x0.6x4.0mm2, TR: 6.4 ms, TE: 4.3 ms, flip angle: 10º, 20 repetitions, 
maximal encoding velocity (vENC): 140cm/s, scan time: 71s. 
5.3.3 Structural image reconstruction 
T2-weighted images were reconstructed following the scan using a dedicated motion 
correction algorithm. Retrospective motion-corrected reconstruction (Cordero-Grande 
et al., 2018; Cordero-Grande et al., 2016) and integration of the information from both 
acquired orientations (Kuklisova-Murgasova et al., 2012) were used to obtain 0.8 mm 
isotropic T2-weighted volumes with significantly reduced motion artefacts. 
5.3.4 Brain region and tissue segmentation 
Motion-corrected T2-weighted images were segmented into tissue type and 87 brain 
regions using an automated, validated, neonatal-specific pipeline (Makropoulos et al., 
2016, 2014) based on the Expectation–Maximisation (EM) technique (Van Leemput et 
al., 1999), which was optimised for our acquisition parameters. For more details on the 
individual parts of the segmentation pipeline, we refer the reader to  (Makropoulos et 
al., 2018, 2016, 2014). Each tissue segmentation was manually inspected for accuracy 
using ITK-SNAP (Yushkevich et al., 2006), and minor corrections performed if 
necessary. 
5.3.5 Gyrification index calculation 
Gyrification index was defined as the ratio of the cortical pial surface area and the 
surface area of the superficial surface enclosing the pial surface (Armstrong et al., 
1995; Luders et al., 2006; Zilles et al., 1988). This ratio was calculated for each subject 
using pial surfaces constructed from the combined grey/white matter mask derived 
from the segmentations, using a previously-published method (Schuh et al., 2017), as 
demonstrated in Figure 27. Final cortical surfaces were cleaned using median filtering 
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and Laplacian smoothing. The superficial surface was reconstructed using marching 
cubes from the morphologically closed combined grey/white matter mask. 
Morphological closing (performed by 3 dilations followed by 2 erosions) removed 
small sulci and generated a mask that enclosed the original cGM/WM mask. The 
gyrification index was calculated initially for the whole brain, and then separately for 
each major brain region (frontal, parietal, temporal, occipital), using appropriate 
combinations of the 87 segmented brain regions (Makropoulos et al., 2018). 
5.3.6 Cerebral blood flow and cerebral oxygen delivery 
To calculate cerebral blood flow, we used a previously-published scanning protocol, 
acquired in a plane perpendicular to both internal carotid and basilar arteries, at the 
level of the sphenoid bone (Varela et al., 2012), as demonstrated in Figure 28.  
Regions of interest were drawn manually around the three vessels, using Segment 
v2.0 R4800 (Heiberg et al., 2010), and flow curves generated (Figure 28). An estimate 
of total cerebral blood flow (CBF) was calculated from the sum of these vessels. This 
disregards blood flow to some areas of the cerebellum, which is provided by branches 
of the vertebral arteries and constitutes less than 3% of the total flow to the brain in 
healthy adults (Nagasawa et al., 2000). 
 
 
Figure 27 Demonstration of the calculation of gyrification index. 
a) Original description of gyrification index in histology setting (Zilles et al., 1988), b) Neonatal brain-extracted T2 volume, 
c) Automatic segmentation, d) Pial surface mesh (green) and superficial surface (red) created from the segmentation, 
used to calculate the gyrification index. Figure 3a reproduced from The human pattern of gyrification in the cerebral 
cortex, Zilles, K., Armstrong, E., Schleicher, A. & Kretschmann, H. J.  Anat. Embryol. (Berl). 179, 173–179 (1988). 
Copyright Springer-Verlag 1988. With permission of Springer. 
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Haemoglobin (Hb) levels were measured as part of routine clinical care in all patients 
at a median of 4 days (range 0 – 10 days) prior to the scan. All newborns with more 
infrequent Hb monitoring were clinically stable, and we believe all Hb measurements 
used were representative of levels at time of scan. Arterial oxygen saturation (SaO2) 
was measured at the time of scan using a Masimo Radical-7 monitor (Masimo Corp, 
Irvine, CA) applied to the right hand. 
Cerebral oxygen delivery (CDO2) was calculated using the following formulae 
(McLellan and Walsh, 2004): 
CDO2 (ml O2/min) = SaO2 x [Hb] (g/dL) x 1.36 x [CBF] (ml/min) 
where 1.36 is the amount of oxygen bound per gram of haemoglobin at 1 atmosphere 
(Hüfner's constant) (Lim et al., 2016). 
 
 
Figure 28 Phase contrast measurements of the cerebral vessels in the neonatal brain. 
The plane is planned from a 3D non-contrast angiogram in both coronal (a) and sagittal planes (b, aiming 
for the C4 segment of the internal cerebral arteries (ICA) where all three vessels are running approximately 
parallel). Following the scan, regions of interest are drawn around the three major cerebral vessels: left 
(green) and right (red) ICAs, and basilar artery (blue), and these regions are propagated through the 
cardiac cycle (c). Flow curves can then be derived across the cardiac cycle (d). 
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5.3.7 Regional cerebral oxygen saturation (rScO2)  
All newborns had near-infrared spectroscopy rScO2 estimations performed 
immediately after the scan using a FORE-SIGHT Elite cerebral oxygenation monitor 
(Casmed, Branford, CT, USA) with neonatal sensor, which was placed over the left 
frontal region. Measurements were taken for at least three minutes with a sampling 
frequency of 2 seconds. The output was analysed to obtain mean and standard 
deviation using a script written in Python (Python Software Foundation, 
https://www.python.org/). To assess repeatability, the measurement was repeated in a 
subset of subjects, by disconnecting and removing the sensor from the baby, and 
reapplying it in a similar location. 
5.3.8 Statistical analysis 
We automatically matched healthy newborns with babies born with congenital heart 
disease using an automated method that minimises overall group Euclidean distances 
between GA and PMA, written in Matlab (R2016, The MathWorks, Inc., Natick, MA, 
US). We compared group characteristics in newborns with CHD to the healthy control 
group with the Mann–Whitney U test for continuous data, and Fisher’s exact test for 
categorical variables. Analysis of Covariance (ANCOVA) tests were performed to 
assess volumetric measurements and gyrification index differences between groups; 
PMA at scan was included as a covariate. For subsequent regional analyses, outside 
of the primary hypothesis test, multiple comparisons correction was not performed. 
Agreement between consecutive readings of rScO2 was analysed using Pearson 
correlation. Regression analysis was used to compare CDO2 to brain parameters. Z-
scores for birth weight and head circumference were calculated using the SITAR R 
package (Cole, 2017), using UK-WHO 2006 population reference data (Cole et al., 
1998; World Health Organisation, 2006). Statistical analysis was performed with SPSS 
Statistics v24 (IBM) and graphs were prepared using R Studio (v1.0.136, RStudio Inc, 





There were no significant differences in GA at birth or at scan between newborns with 
CHD and healthy controls. There were no significant differences in birthweight, 
birthweight z-score, head circumference at birth, head circumference z-score, and sex 
between groups. There were no sex-based differences in total grey matter volume, 
gyrification index, CDO2 or regional cerebral oxygen saturations. A summary of CHD 
diagnoses can be seen in Table 4. 
5.4.2 Cerebral oxygen delivery (CDO2) is positively associated with brain volume 
and gyrification 
Phase contrast measurements, preductal arterial saturations and haemoglobin levels 
were successfully obtained in 24 of 30 babies with CHD (mean 161, SD 21 g/L). 
Calculated CDO2 (median 1638 ml O2/min, range 1011 – 3023 ml O2/min) showed a 
positive association with total brain volume (R2=0.42, p<0.001), grey matter volume 
(R2=0.48, p<0.001, Figure 29a), and whole brain gyrification index (R2=0.279, p=0.008, 
Figure 29b). A secondary analysis included days of mechanical ventilation and 
requirement for prostaglandin E2 in the regression model with no significant effect on 
the results for brain volume, grey matter volume or gyrification. Indexing CDO2 per unit 
of brain volume retained the same trends as without indexing, but weakened both the 
association with grey matter volume (R2 = 0.199, p = 0.029, Figure 29c) and with 
gyrification index (R2 = 0.127, p = 0.087, Figure 29d). 
To understand the relative contribution of CBF and oxygen saturations to CDO2, we 
compared correlations between both factors and CDO2 (Supplementary Figure S1). 
CBF was more strongly correlated with CDO2 (R2=0.643, p < 0.001) than arterial 
saturations (R2 = 0.107, p = 0.119), suggesting that blood flow contributed more to the 
values seen for CDO2. Subgroup analysis of cerebral haemodynamics by lesion 
physiology was hampered by small sample sizes, although there was a trend towards 
higher cerebral blood flows and oxygen delivery in right sided lesions and lower in 
CHD with abnormal mixing. 
Regional cerebral oxygen saturation (rScO2) was measured in all 30 babies with CHD. 
Consecutive repeat measurements were obtained in 24 of the 30 babies, 
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demonstrating good repeatability (linear R2=0.86, p<0.001). rScO2 showed a modest 
correlation with both whole brain gyrification index (R2=0.17, p=0.023, Figure 29e), and 




Figure 29 Plots of cerebral oxygen delivery (CDO2) against measures of cortical development 
Cerebral oxygen delivery (CDO2) demonstrates a positive association with grey matter volume (a) and 
whole brain gyrification (b). These trends persist after indexing CDO2 per 100ml brain volume (c and d). 
Regional cerebral oxygen saturation has a limited positive relationship with gyrification index (e). 
Abnormal mixing lesions and left sided lesions demonstrate a significantly lower gyrification index, while 
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5.4.3 Cortical volumes are reduced in newborns with CHD 
Infants born with CHD had smaller total brain volumes (p<0.01) and smaller cortical 
grey matter volumes (p<0.01). Other brain volumes were also smaller, including deep 
grey matter (p<0.001), white matter (p=0.01), and cerebellar volume (p<0.001). 
Ventricular volume was not significantly different between groups (p=0.09). Extra-
cerebral CSF space was increased in the CHD group (p=0.011). Volumetric results are 
summarised in Table 5. 
5.4.4 Gyrification index is globally reduced in newborns with CHD 
Brain gyrification was reduced in infants with CHD (p<0.01, Figure 30a). Regional 
analysis showed significantly reduced gyrification index in the temporal (p=0.002), 
parietal (p=0.005) and occipital (p=0.018), and a trend towards reduction in the frontal 
lobes (p=0.052). Regional gyrification differences between groups are described in 
Table 6, with plots displayed in Figure 30(b-e) and a visualisation on a representative 
cortical surface in Figure 30(f). 
Region Volume (ml), mean (SD) ANCOVA 
CHD, n=30 Control, n=30 p value 
Whole brain 308 (29.3) 335 (33.9) < 0.001 * 
Cortical grey matter 122 (14.4) 132 (17.4) 0.003 * 
Frontal grey matter 41 (5.0) 44 (5.6) 0.011 * 
Parietal grey matter 28 (3.2) 31 (4.5) 0.002 * 
Temporal grey matter 25 (3.3) 28 (3.9) < 0.001 * 
Occipital grey matter 19 (2.7) 21 (2.8) 0.014 * 
Cerebellum 20 (2.3) 22 (2.5) 0.073 Ns 
Extra-axial CSF space 78 (20.8) 68 (10.8) 0.011 * 
 
Table 5 Volume differences between newborns with congenital heart disease and healthy controls.  
Comparison of groups performed with multivariate general linear models, with PMA included as a 
covariate. Exploratory regional analyses displayed with * = significance and Ns = not significant. 
Significance did not change with the addition of weight at scan as a covariate. 
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5.4.5 Gyrification varies between different CHD types 
To explore differences further, newborns with CHD were divided into three main 
physiological groups: 1) Abnormal mixing (i.e. transposition of the great arteries, 
double-outlet right ventricle), 2) Left sided lesions (i.e. hypoplastic left heart syndrome, 
coarctation of the aorta), and 3) Right sided lesions (i.e. pulmonary atresia or stenosis), 
and each group compared to its matched controls. Compared to healthy newborns, 
gyrification was reduced in mixing (p=0.011) and left sided lesions (p=0.019), but not 
in right sided lesions (p=0.136) (Figure 29f). 
5.4.6 Requirement for septostomy is not associated with cortical volume and 
gyrification differences 
Infants with TGA required septostomy in 5 of 14 cases (36%). We repeated analyses 
with this as a co-variate in the statistical analysis and found results were unchanged. 
Within the TGA group, we compared infants with and without a requirement for 
septostomy, and found no difference in terms of brain volume (p = 0.825) or 
gyrification (p = 0.19). 
  
Region 
GI mean (SD) ANCOVA 
CHD, n=30 Control, n=30 p value 
Whole brain 2.373 (0.127) 2.464 (0.144) 0.003 * 
Frontal lobes 2.112 (0.114) 2.164 (0.124) 0.052 Ns 
Parietal lobes 2.820 (0.155) 2.930 (0.194) 0.005 * 
Temporal lobes 2.233 (0.145) 2.338 (0.151) 0.002 * 
Occipital lobes 2.355 (0.167) 2.454 (0.179) 0.018 Ns 
 
Table 6 Differences in gyrification index between newborns with congenital heart disease and 
healthy controls 
Comparison of groups performed with multivariate general linear models, with PMA included as a 
covariate. For regional comparisons, p=0.0125 used as a Bonferroni correction threshold, with * 






Figure 30 Gyrification index differences between newborns with complex congenital heart disease 
Plots showing differences between infants with congenital heart disease (blue) and healthy controls 
(orange), in the whole brain (a) and exploratory regional analysis (b-e). The cortical surface visualisation  
(f) demonstrates regions where gyrification is reduced in newborns with congenital heart disease 
compared to healthy term controls, from the left lateral side (i) and from above (ii); colours represent p 
values from multivariate general linear models, using postmenstrual age as a covariate; no multiple 
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Reduced CDO2 in newborns with CHD before surgery is associated with impaired 
cortical development. Cortical grey matter volumes and gyrification index were lower 
in newborns with complex CHD when compared to healthy matched controls. The 
degree of cortical impairment was most significant in mixing and left-sided lesions, 
which may relate to the fetal cerebral circulatory impairment that has been 
demonstrated in these groups (Heymann and Rudolph, 1972; Sun et al., 2015). 
A recent study of a similar number of infants showed reduced CDO2 in newborns with 
mixed complex CHD compared to controls, with the lowest CDO2 measured in infants 
with transposition (Lim et al., 2016). Lim and colleagues found that arterial saturations 
had the greatest influence on CDO2, and that there were no significant CBF 
differences between CHD and control infants (Lim et al., 2016). We were unable to 
replicate these findings due to lack of flow measurements in our control group, but our 
results suggest that CBF had a greater contribution to the variation of CDO2 within our 
CHD cohort. Ascending aorta oxygen saturations were found to be 10% lower in 
fetuses with CHD when compared to healthy controls using fetal MRI (Sun et al., 
2015). Animal studies have shown that a lower oxygen tension environment affects 
mechanisms that coordinate myelination and angiogenesis during the early phase of 
brain development (Yuen et al., 2014), and causes diminished proliferation and 
neurogenesis in the subventricular zone, accompanied by reduced cortical growth 
(Morton et al., 2017). Taken together with our results, these findings suggest that the 
developing brain may be adversely affected by the lower oxygen tension environment 
that is observed in CHD in both fetal and postnatal life. 
A limited number of studies have reported altered cortical folding in fetuses and 
newborns with CHD. An “immature cortical mantle” was first described in an early 
post-mortem study from a cohort of 41 infants with hypoplastic left heart syndrome 
(Glauser et al., 1990b). Delayed cortical folding has been described using a radiologist 
scoring system (Childs et al., 2001) in pre-surgical newborns with CHD, starting at 
around 30 weeks of gestation (Licht et al., 2009). The same finding in post-surgical 
infants has been shown to be a strong predictor of later neurodevelopmental outcome 
(Beca et al., 2013). Specific analysis of the gyrification of the opercula was performed 
in a cohort of newborns with HLHS and TGA prior to surgery, and demonstrated that 
opercula in CHD was more “open” and exhibited reduced folding complexity (Awate 
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et al., 2009). Gyrification index in fetuses with HLHS was found to be reduced 
compared to controls using a semi-automated analysis technique, and these group 
differences increased progressively with advancing gestational age (Clouchoux et al., 
2013). Our study adds weight to these findings in a more diverse group of CHD. 
Cortical development follows a predictable timeline (Armstrong et al., 1995). Most gyri 
become well defined between 26-28 weeks, becoming more prominent and deeply 
infolded during the third trimester, with subsequent development of secondary and 
tertiary gyri (Chi et al., 1977). The frontal third of the brain commences its gyrification 
slightly before the intermediate and caudal thirds, but also takes longer to reach its 
adult degree of cortical folding by 48 weeks (compared to 44 and 43 weeks 
respectively) (Armstrong et al., 1995). We found that gyrification index in our CHD 
group was most reduced in parietal and temporal regions, and least in the frontal 
region. This may be due to later completion of gyrification in the frontal region, but 
also that the pace of gyrification is greatest in parietal, temporal and occipital regions 
during the time window of our study (Armstrong et al., 1995). Impaired gyrification in 
infants with CHD may therefore be most apparent in these regions. 
To understand gyrification differences further, we examined three subgroups using a 
cardiac physiology-based categorisation: abnormal mixing, left sided lesions. and 
right sided lesions. We found significant gyrification differences in the abnormal 
mixing group, but were unable to form strong conclusions from our left- and right-
sided lesion groups due to small subgroup numbers. We were unable to study infants 
with hypoplastic left heart syndrome separately, a condition known to impair fetal 
brain development (Clouchoux et al., 2013). There are limited previous studies for 
comparison, with no pre-surgical neonatal studies for reference. In a previous study of 
post-surgical infants with transposition, gyrification was reported to be similar to 
controls (Claessens et al., 2016), which may be explained by smaller group sizes and 
less closely matched postmenstrual ages at scan. There was unfortunately no control 
group for their pre-surgery infants for direct comparison. 
Our finding of reduced brain volumes in newborns with transposition fits with a recent 
large population study of 924,422 Dutch liveborn singletons, which found that in 
contrast to other forms of CHD where both head circumference and birth weight of 
infants were reduced, only infants with transposition had smaller head circumference 
relative to birth weight (Matthiesen et al., 2016). Reduced head circumference at birth, 
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the most widely available proxy of impaired fetal brain growth (Cooke et al., 1977), has 
often been reported in CHD, most consistently in HLHS and TGA (Donofrio et al., 
2003; Limperopoulos et al., 1999; Rosenthal, 1996; Shillingford et al., 2007), but also 
in tetralogy of Fallot, ventricular septal defects, common arterial trunk, and anomalous 
pulmonary venous return (Matthiesen et al., 2016). In contrast to other studies, we 
found that there was no difference in the z-scores of head circumferences between 
CHD and healthy groups in our cohort. However, brain volumes were significantly 
reduced in CHD. The discrepancy between head circumference and brain volume is 
explained by a larger extra-cerebral CSF volume in the CHD group, in the presence of 
comparable ventricular volumes. 
Brain growth trajectories in CHD have been shown to diverge from healthy fetuses in 
the third trimester, during a period where there is usually an acceleration of energy-
demanding brain growth (Limperopoulos et al., 2010), using both fetal ultrasound 
(Zeng et al., 2015) and fetal MRI (Clouchoux et al., 2013; Limperopoulos et al., 2010; 
Sun et al., 2015). A limited number of cohorts have also suggested an increased 
prevalence of ventriculomegaly in fetuses with CHD, as assessed by radiologist 
assessment (McConnell et al., 1990) and two-dimensional measurements (Brossard-
Racine et al., 2014). Increased CSF spaces in CHD has only previously been 
described in a limited number of studies (Brossard-Racine et al., 2014; Limperopoulos 
et al., 2010), and may be a marker of cerebral parenchymal growth disturbance. 
Our study has a number of limitations. We did not have phase contrast measurements 
for our control group, limiting analysis of CDO2 against cortical metrics to those infants 
with CHD. In addition, our CDO2 measurements were performed shortly following 
birth, while the majority of brain development until that point occurs in utero with a 
fetal circulation. Delayed brain growth and maturation is more like to reflect CDO2 in 
utero, which was not measured in this study. There are many influences on early brain 
growth, and although currently poorly understood, genetic abnormalities are highly 
prevalent in the CHD population (Blue et al., 2017). It is logical that smaller brains as a 
direct result of genetic factors with lower metabolic demands will require less blood 
flow and oxygen delivery, which may explain part of the association demonstrated in 
this study. We addressed this by calculating the indexed oxygen delivery per unit of 
brain tissue, and our results support the contention that CDO2 is reduced even when 
taking into account differences in brain volume. However, it is not possible to fully 
determine if lower CDO2 as a result of CHD has resulted in the development of a 
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smaller brain, or if extrinsic factors to this analysis (i.e. genetic) have resulted in 
smaller brains with smaller metabolic demands that require less CDO2. 
5.6 CONCLUSIONS 
Cortical folding and cortical grey matter volume is reduced in newborns with 
congenital heart disease when compared to healthy matched controls. Lower CDO2 
measured in newborns with CHD prior to surgery is associated with reduced cortical 
grey matter volume and gyrification. This supports the possibility that strategies to 
improve CDO2 in infants with CHD could modify the derailing trajectory of brain 
development. Our finding of reduced CDO2 may be of greatest importance for children 
with CHD whose heart defects remain unrepaired for long periods of time after birth, 
exacerbating deficits in oxygen and other metabolic substrate supply that may have 
occurred during the prenatal period, and leading to further decrements in brain growth 
and development after birth. 
 115 
Chapter 6 
6 Abnormal microstructural development of 
the cortex in congenital heart disease is 
related to impaired cerebral oxygen delivery 
6.1 ABSTRACT 
Neurodevelopmental impairment has become a major remaining challenge in the 
management of congenital heart disease (CHD). Macroscopic developmental 
abnormalities of the cerebral cortex in CHD have been reported previously, although 
the biological basis for this remains unclear. We use high angular resolution diffusion 
magnetic resonance imaging, phase contrast angiography, and high resolution 
structural imaging to investigate the link between cerebral oxygen delivery and cortical 
microstructure development in vivo, in a prospective cohort of infants with CHD prior 
to surgery. We present evidence that cortical microstructural development is abnormal 
in infants with CHD, with higher fractional anisotropy (FA) and lower orientation 
dispersion index (ODI) compared to healthy age-matched controls, correcting for 
gestational age at birth and scan. There were no differences in mean diffusivity or 
neurite density index. Secondly, we demonstrate that reduced cortical ODI in CHD is 
related to impaired cerebral oxygen delivery, supporting the hypothesis that chronic 
suboptimal cerebral oxygenation is associated with atypical cortical maturation. 
Thirdly, we show that macrostructural gyrification of the cortex occurs in tandem with 
microstructural properties including increasing ODI and reducing FA. These results 
support the interpretation that the primary component of cortical dysmaturation in 
infants with CHD is impaired development of dendritic arborisation, associated with 
reduced cerebral oxygen delivery, which is responsible, at least in part, for 
macrostructural findings in this population.  Cortical ODI may prove to be a valuable 
early indicator of the success of future fetal intervention studies that aim to restore the 
faltering trajectory of cortical development in CHD. 
 
  
This chapter is based upon:, Kelly CJ, Christiaens D, Batalle D, Makropoulos A, Cordero-Grande L, 
Steinweg JK, O'Muircheartaigh J, Khan H, Lee G, Victor S, Alexander DC, Zhang H, Simpson J, Hajnal 
JV, Edwards AD, Rutherford MA, Counsell SJ. Abnormal microstructural development of the cortex in 
congenital heart disease is related to impaired cerebral oxygen delivery. Submitted. 
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6.2 INTRODUCTION 
Congenital heart disease (CHD) is the most common congenital abnormality, affecting 
almost 1% of newborns (van der Bom et al., 2011). Despite improvements in antenatal 
diagnosis, cardiac surgery and perioperative care, infants with CHD often experience 
neurological impairment across a range of developmental domains, both in early 
childhood and later in adult life (Bellinger et al., 2011; Marino et al., 2012), making 
improvement of neurodevelopmental outcomes a major remaining challenge in the 
management of CHD. While early research focused on suspected surgical and 
perioperative factors, it now appears that a more complex set of biological factors 
may be responsible. 
The detrimental effect of CHD on early brain development can be observed via a 
faltering trajectory of brain growth in the third trimester of pregnancy (Clouchoux et al., 
2013; Limperopoulos et al., 2010; Sun et al., 2015; Zeng et al., 2015), and a higher 
incidence of acquired brain lesions in newborn infants prior to cardiac surgery (Mebius 
et al., 2017). The developmental morphology of the cortex has become of increasing 
interest in CHD, with an ‘immature cortical mantle’ first observed in autopsies of 
infants with hypoplastic left heart syndrome (HLHS) (Glauser et al., 1990a). Findings of 
reduced cortical folding have since been quantified in vivo using magnetic resonance 
imaging (MRI) in both fetal (Clouchoux et al., 2013) and pre-surgical neonatal 
populations (Claessens et al., 2016; Kelly et al., 2017; Ortinau et al., 2013). Factors 
including reduced fetal cerebral oxygen delivery (Sun et al., 2015) and cerebral 
metabolic substrate (Rudolph, 2016) are hypothesised to be responsible, at least in 
part, although precise cellular mechanisms remain unclear. 
Linking physiological changes in CHD to brain development is assisted by four recent 
findings. Firstly, oxygen tension has been shown to regulate development of human 
cortical radial glial cells, with hypoxia exerting negative effects on gliogenesis by 
reducing the number of pre-oligodendrocytes while increasing the number of reactive 
astrocytes (Ortega et al., 2017). Secondly, hypoxia has been shown to reduce 
proliferation and neurogenesis in the subventricular zone of the piglet brain, 
accompanied by reduced cortical growth, with preliminary similarities found in the 
subventricular zone cytoarchitecture in human fetal autopsy specimens (Morton et al., 
2017). Thirdly, ascending aorta oxygen saturations have been found to be 10% lower 
in human fetuses with mixed CHD compared to healthy controls, with saturation 
 117 
measurements that correlated with fetal brain size (Sun et al., 2015). Finally, 
microstructural maturation of the cortex, measured using both histology and diffusion 
anisotropy, has been demonstrated to occur in parallel with macrostructural 
development (Wang et al., 2017). Taken together, these studies raise the hypothesis 
that macrostructural changes observed in CHD are the result of altered cortical 
microstructural development, which is in turn hindered by suboptimal oxygen tension 
during fetal life in CHD. Diffusion MRI, with newer multi-compartment models such as 
neurite orientation dispersion and density imaging (NODDI), provides measures that 
enable this hypothesis to be tested. 
Diffusion tensor imaging (DTI) metrics such as fractional anisotropy (FA) are non-
specific and reflect many underlying parameters of brain tissue including neuronal 
density, fibre orientation dispersion, degree of myelination, free-water content, and 
axonal diameter (Winston et al., 2014). The NODDI model aims to disentangle these 
different factors by separating the influence of neurite density and orientation 
dispersion from each other, and from partial volume with CSF, to provide distinct 
indices: orientation dispersion index (ODI), which captures the degree of dispersion of 
axonal fibre orientations (e.g. through fanning, bending, crossing) or dendrite 
orientations, and neurite density index (NDI), represented by the intracellular volume 
fraction (ICVF) (Zhang et al., 2012). Such techniques have already been used in the 
preterm population to quantify cortical development, with findings of reducing FA and 
mean diffusivity (MD) (Ball et al., 2013; McKinstry et al., 2002), and increasing ODI 
(Eaton-Rosen et al., 2015), with increasing brain maturation until term age, and have 
identified that impaired postnatal weight, length, and head growth are associated with 
delayed microstructural development of cortical grey matter (Vinall et al., 2013). 
Additionally, a diminished decline in cortical FA with maturation in a sheep model of 
preterm brain injury has been associated with histological findings of reduced 
dendritic arborisation and dendritic spine density (Dean et al., 2013). 
In this study, we aimed to use high angular resolution diffusion imaging (HARDI) and 
NODDI to test the hypothesis that reduced cerebral oxygen delivery in CHD is 
associated with impaired cortical microstructural development. We predicted that 
infants with complex CHD would exhibit higher cortical FA and lower ODI when 
compared to a group of healthy matched controls, and that infants with the lowest 
cerebral oxygen delivery would exhibit the most severe impairment of cortical 
microstructural development. 
 118 
6.3 MATERIALS AND METHODS 
The project was approved by the National Research Ethics Service West London 
committee (CHD: 07/H0707/105, Controls: 14/LO/1169) and informed written parental 
consent was obtained prior to imaging. All methods and experiments were performed 
in accordance with relevant guidelines and regulations. 
6.3.1 Participants 
A prospective cohort of 54 infants with complex CHD expected to require surgery 
within one year was recruited from the Neonatal Intensive Care Unit at St Thomas’ 
Hospital, London. Six infants were excluded from the analysis: two infants with 
suspected coarctation were later assessed to have a normal circulation following 
postnatal ductus arteriosus closure; two infants were found to have focal arterial 
ischaemic stroke on MRI involving the cortex (both left middle cerebral artery stroke); 
one infant had uncertain gestation due to unknown date of last menstrual period and 
lack of ultrasound dating scan; one infant had incomplete diffusion data due to waking 
during the scan. 
We therefore studied 48 infants with CHD, born at a median GA of 38.8 weeks (IQR 
38.0 – 39.1). A control group of 48 healthy infants was matched by GA at birth and 
scan, recruited contemporaneously from the postnatal ward at St Thomas’ Hospital as 
part of the Developing Human Connectome Project (Hughes et al., 2017b), and born 
at a median GA of 38.5 weeks (38.1 – 38.9). The median GA at scan was 39.1 weeks 
(IQR 38.6 – 39.7) for both the CHD group and control group. 
6.3.2 MR imaging 
T2w, T1w, DWI and PCA MR imaging was performed on a Philips Achieva 3 Tesla 
system (Best, The Netherlands) with a 32-channel neonatal head coil and neonatal 
positioning device (Hughes et al., 2017b), situated on the neonatal intensive care unit 
at St Thomas’ Hospital, London. All examinations were supervised by a paediatrician 
experienced in MR imaging procedures. All infants were scanned in natural sleep 
without sedation. Pulse oximetry, respiratory rate, temperature and 
electrocardiography were monitored throughout. Ear protection comprised earplugs 
moulded from a silicone-based putty (President Putty, Coltene Whaledent, Mahwah, 
NJ, USA) placed in the external auditory meatus, neonatal earmuffs (MiniMuffs, Natus 
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Medical Inc, San Carlos, CA, USA) and an acoustic hood positioned over the infant. All 
sequences included a 5 second initial slow ramp-up in acoustic noise to avoid eliciting 
a startle response. 
T2w images were acquired using a multi-slice turbo spin echo sequence, acquired in 
two stacks of 2D slices (in sagittal and axial planes), using parameters: repetition time 
(TR): 12 s; echo time (TE): 156 ms, flip angle: 90º, slice thickness: 1.6 mm acquired 
with an overlap of 0.8 mm; in-plane resolution: 0.8x0.8 mm, scan time: 3:12 min per 
stack. The T1w volumetric magnetisation prepared rapid acquisition gradient echo 
acquisition parameters were as follows: TR: 11 ms, TE: 4.6 ms, TI:  714 ms, flip 
angle: 9º, acquired voxel size: 0.8 × 0.8 × 0.8 mm, field of view (FOV): 145 × 145 × 108 mm, 
SENSE factor: 1.2, scan time: 4:35 min. DWI with 300 directions was acquired using 
parameters: TR: 3.8 s, TE: 90 ms, multiband: 4; SENSE: 1.2; resolution: 1.5x1.5x3mm 
with 1.5mm slice overlap, diffusion gradient encoding: b=0 s/mm (n=20), b=400 s/mm 
(n=64), b=1000 s/mm (n=88), b=2600 s/mm (n=128) with interleaved phase encoding 
(Hutter et al., 2018). Quantitative flow imaging was performed using velocity-
sensitised phase contrast imaging, with a single-slice T1-weighted fast field echo 
sequence. Scan parameters were: FOV: 100x100 mm, acquisition resolution: 
0.6x0.6x4.0mm, TR: 6.4 ms, TE: 4.3 ms, flip angle: 10º, 20 repetitions, maximal 
encoding velocity (vENC): 140 cm/s, scan time: 71 s (Varela et al., 2012). 
6.3.3 Structural and diffusion-weighted image reconstruction 
T2w images were reconstructed using a dedicated neonatal motion correction 
algorithm. Retrospective motion-corrected reconstruction (Cordero-Grande et al., 
2018; Cordero-Grande et al., 2016) and integration of the information from both 
acquired orientations (Kuklisova-Murgasova et al., 2012) were used to obtain 0.8 mm 
isotropic T2w volumes with significantly reduced motion artefacts. Diffusion images 
were reconstructed following the scan using a dedicated multiband reconstruction 
method described previously (Hutter et al., 2018). 
6.3.4 Structural image processing 
Motion-corrected T2w images were segmented into tissue type using an automated,  
neonatal-specific pipeline (Makropoulos et al., 2018, 2016, 2014), which was 
optimised for our acquisition parameters. Each tissue segmentation was manually 
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inspected for accuracy using ITK-SNAP (Yushkevich et al., 2006), and minor 
corrections performed if necessary. Gyrification index was calculated as described 
previously (Kelly et al., 2017). 
6.3.5 Diffusion-weighted image processing 
High angular resolution diffusion-weighted imaging (HARDI) data was reconstructed 
using a slice-to-volume motion correction technique that uses a bespoke spherical 
harmonics and radial decomposition (SHARD) of multi-shell diffusion data, together 
with outlier rejection, distortion and slice profile correction (Christiaens et al., 2018). 
Data was first processed with image denoising (Veraart et al., 2016) and Gibbs ringing 
suppression (Kellner et al., 2016). A field map was estimated from b=0 images using 
FSL Topup (Andersson et al., 2003). Reconstruction was run for 10 iterations with 
Laplacian regularisation, using a SHARD decomposition of rank = 89 (allowing for 
spherical harmonics order ℓmax = 0, 4, 6, 8 for respective shells), with registration 
operating at a reduced rank = 15. 
Non-brain tissue was removed using FSL BET (Smith, 2002). DTI metrics FA and MD 
were calculated from b=0 and b=1000 DWI data using MRtrix3 (Tournier et al., 2012). 
Neurite orientation dispersion and density imaging (NODDI) parameter maps were 
estimated using NODDI toolbox version 0.9 (Zhang et al., 2012). We used 2.0 x 10-3 
mm2 s-1 as the intrinsic diffusivity for the intracellular compartment in the NODDI model, 
as this diffusivity gave the best quality of fit in our data, according to the Bayesian 
Information Criterion (BIC) (Figure 31). This is consistent with previous NODDI studies 
in neonates (Eaton-Rosen et al., 2015; Jelescu et al., 2015; Kunz et al., 2014), with the 
higher value compared to adults (usually 1.7 x 10-3 mm2 s-1) likely reflecting the higher 
water content of the neonatal brain. 
6.3.6 Group template generation and image registration 
A multivariate group template was generated from both T1w and T2w images, using 
symmetric diffeomorphic normalisation for multivariate neuroanatomy and a cross-
correlation similarity metric (B. Avants et al., 2008). Each subject’s diffusion data were 
rigidly registered to each subject’s T2w image using the MD map (Jenkinson and 
Smith, 2001). DTI and NODDI maps were then transformed into template space in a 
single step using concatenated linear and diffeomorphic transformations. Tissue 
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segmentations from T2w images were also transformed into template space using 
nearest neighbour interpolation. 
6.3.7 Cortical analysis of microstructure 
We used an approach for aligning cortical data from multiple subjects into a common 
space to provide voxel-wise spatial characterisation of FA, MD, NDI and ODI, as 
previously described (Ball et al., 2013; Smith et al., 2006). A mean cortical map was 
produced by merging cortical grey matter segmentations that had been previously 
 
 
Figure 31 Orientation dispersion index maps for different model values of intrinsic diffusivity 
Optimising NODDI model parameters for neonatal data. Figure shows ODI maps for varying intrinsic 
diffusivity values, of which 2.0 x 10-3 mm2 s-1 was found to provide the best fit across the brain. Arrow 










transformed into template space. This was then skeletonised to retain only a core of 
highly-probable cortical voxels, represented as a thin curved surface at the centre of 
the cortex. FA, MD, NDI and ODI measurements from each individual were projected 
onto the cortical skeleton by searching in a direction perpendicular to the cortical 
skeleton to identify voxels with the highest probability of being cortical. 
6.3.8 Calculation of cerebral oxygen delivery (CDO2) 
For infants with CHD, we calculated their cerebral blood flow using a previously-
described method (Kelly et al., 2017). Phase contrast angiography was acquired in a 
plane perpendicular to both internal carotids and basilar arteries at the level of the 
sphenoid bone (Varela et al., 2012). Haemoglobin measurements were performed as 
part of routine clinical care, at a median of 3 days (IQR 0 – 5) prior to the scan. Arterial 
oxygen saturation (SaO2) was measured at the time of scan using a Masimo Radical-7 
monitor (Masimo Corp, Irvine, CA) applied to the right hand. 
Cerebral oxygen delivery (CDO2) was calculated using the following formulae 
(McLellan and Walsh, 2004): 
CDO2 (ml O2/min) = SaO2 x [Hb] (g/dL) x 1.36 x [CBF] (ml/min) 
where 1.36 is the amount of oxygen bound per gram of haemoglobin at 1 atmosphere 
(Hüfner's constant) (Lim et al., 2016). 
6.3.9 Statistical analysis 
Healthy infants were matched to the CHD group by both GA at birth and scan using 
an R implementation (Leisch, 2017) of the daisy algorithm (Kaufman and Rousseeuw, 
1990). In order to investigate the relationship between DWI metrics in the cortical grey 
matter and clinical factors, cross-subject voxel-wise statistical analysis was performed 
using FSL Randomise v2.9 (Smith et al., 2006). A general linear model (GLM) was used 
to assess group differences between diffusion measures of infants with CHD and 
healthy controls, including both GA at birth and scan as covariates in each model. The 
effect of CDO2 on cortical diffusion metrics was performed using a GLM that selected 
only infants with CHD who had a successful CDO2 measurement (n=39). All images 
were subject to family-wise error (FWE) correction for multiple comparisons following 
threshold-free cluster enhancement (TFCE) (Smith and Nichols, 2009) and are shown 
at P < 0.05. Linear regression was used to investigate the association between GI and 
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diffusion metrics. To assess the relationship of GI and ODI independently of advancing 
brain maturity, GA at scan was included as a variable in the multiple linear regression 
model. 
Categorical clinical variables were compared using Fisher’s exact tests. For 
continuous clinical variables, we determined medians and interquartile ranges, and 
compared groups using the Mann-Whitney U test. All analyses of clinical variables 
were performed using SPSS V24 (IBM, New York). 
6.4 RESULTS  
The analysis included 96 newborn infants: 48 infants with confirmed complex CHD 
scanned prior to surgery without evidence of arterial ischaemic stroke, and 48 age-
matched healthy infants. Clinical characteristics of both groups are shown in Table 7. 





n = 48 
Newborns  
with CHD 
n = 48 
P-value 
Gestational age at birth (weeks) 38.8 (38.0 – 39.1) 38.5 (38.1 – 38.9) 0.543 
Post-menstrual age at scan 
(weeks) 39.1 (38.6 – 39.7) 39.1 (38.6 – 39.7) 0.595 
Male sex – no. (%) 26 (54%) 27 (56%) 1.0 
Birth weight (kg) 3.17 (2.83 – 3.41) 3.10 (2.81 – 3.47) 0.809 
Birth head circumference (cm) 34.0 (33.0 – 35.0) 34.0 (33.0 – 35.0) 0.5 
Heart lesion – no. (%)    
- Transposition of the great arteries 
(TGA) - 21 (44%)  
- TGA requiring septostomy  
  (% TGA) - 9 (43%)  
- Coarctation of the aorta - 9 (19%)  
- Tetralogy of Fallot - 7 (15%)  
- Pulmonary stenosis - 3 (6%)  
- Hypoplastic left heart syndrome - 3 (6%)  
- Pulmonary atresia - 3 (6%)  
- Truncus arteriosus - 1 (2%)  
- Tricuspid atresia  1 (2%)  
Table 7 Clinical characteristics of the cortical diffusion cohort 
GA at birth and PMA at scan are presented as median (interquartile range). P-values calculated using 
Mann–Whitney U test for continuous data, and Fisher’s exact test for categorical variables. Septostomy in 
TGA was performed prior to imaging in all cases. 
 
 124 
sex between groups. T1-weighted (T1w), T2-weighted (T2w), and diffusion-weighted 
images (DWI) were acquired in all infants. Phase contrast angiography (PCA) was 
acquired with acceptable quality in 81% of infants with CHD (n=39).  
6.4.1 Cortical orientation dispersion index (ODI) is reduced in infants with 
complex CHD 
Infants with CHD demonstrated widespread changes in cortical ODI, with the most 
significant reductions observed posteriorly in the posterior parietal cortex, insula 
cortex, cingulate cortex, primary motor cortex, supplementary motor area, and 
occipital regions (Figure 32a, corrected for GA at birth and scan). There were no 
regions where ODI was higher in infants with CHD. There were no differences in NDI 
between groups. GA at scan was positively associated with cortical ODI. 
6.4.2 Cortical fractional anisotropy (FA) is higher in infants with CHD 
Cortical FA was higher in infants with CHD with effects seen in predominantly midline 
cortical structures (Figure 32b, corrected for GA at birth and scan). There were no 
regions where FA was lower in infants with CHD. There were no differences in mean 
diffusivity between groups. Cortical FA was negatively associated with GA at scan. 
6.4.3 Reduced cerebral oxygen delivery is associated with impaired ODI 
Cerebral oxygen delivery (CDO2) at time of scan was positively associated with cortical 
ODI across many regions of the cortex (FWE-corrected for multiple comparisons, p < 
0.05), with the most significant associations found in the bilateral temporal lobes, 
occipital lobes, cingulate cortex, and right insula cortex (Figure 33). To demonstrate 
this linear relationship, mean ODI data were extracted for each subject from significant 
voxels in the grey matter skeleton and plotted against CDO2 at time of scan (R2 = 
0.637, Figure 34). There were no voxels with a negative association between the two 
variables. To assess the relative contribution of each component of CDO2, we 
repeated the analysis substituting CDO2 for either cerebral blood flow (CBF) or pre-
ductal arterial saturation at time of scan. Considered alone, neither component 
demonstrated voxels that reached significance for either a positive or negative 
relationship with ODI. There were no significant associations between CDO2 and FA, 




Figure 32 Infants with CHD (n=48) exhibit impaired microstructural development compared to healthy 
age-matched controls (n=48). 
(A) Regions where ODI is significantly reduced in infants with CHD, overlaid on the mean ODI template. (B) 
Regions where cortical FA is significantly increased in infants with CHD, overlaid on the mean FA template. 
Red-Yellow indicates p<0.05 after FWE correction for multiple comparisons following TFCE. Results are 
shown overlaid on the mean cortical skeleton (green). Both analyses included GA at birth and at scan in the 







Figure 33 Regions where cerebral oxygen delivery is positively associated with cortical orientation dispersion in 
infants with CHD (n=40) 
Red-Yellow indicates p<0.05 after FWE correction for multiple comparisons following TFCE. Results are shown overlaid 
on the group T2-weighted template and the mean cortical skeleton (green). Number of permutations was 10,000. Left–




Figure 34 Visualisation of the linear 
relationship between CDO2 and cortical ODI 
within significant voxels from analysis 
displayed in Figure 33. 
Mean ODI data were extracted for each subject 
from significant voxels in the statistic image after 
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6.4.4 Relationship between cortical microstructure and macrostructure in CHD 
We have previously reported reduced gyrification index (GI) in our cohort of infants 
with CHD in Chapter 5. However, the relationship between cortical microstructure and 
macrostructure has not been assessed in this group. We found that GI was 
significantly positively associated with mean cortical ODI (R2 = 0.589, P < 0.0001) and 
negatively with FA (R2 = 0.175, P = 0.003) (Figure 35). The linear relationship between 
GI and cortical ODI persisted following inclusion of GA at scan in the linear regression 
model (b = 0.642, P < 0.0001), but not for cortical FA (b = -0.304, P = 0.09). Cortical 
grey matter volume was significantly positively correlated with cortical ODI (R2 = 
0.170, P = 0.004), but not with cortical FA. There was no relationship between total 
brain volume and microstructural measures (FA: R2 = 0.011, P = 0.49; ODI: R2 = 0.034, 
P = 0.207). 
6.5 DISCUSSION  
Long-term neurodevelopmental impairment is a major remaining challenge for infants 
with congenital heart disease, yet our understanding of the underlying biological 
substrate remains limited. Our study establishes that the microstructural development 
of the cerebral cortex in infants with CHD is atypical in the newborn period compared 
to healthy controls, and importantly that the degree of impairment is related to 
reduced cerebral oxygen delivery. We speculate that hindered microstructural 
 
 
Figure 35  The linear relationship between gyrification index (GI) and cortical diffusion measures ODI 
and FA in newborn infants with CHD (n = 48). 
GI is (a) positively associated with cortical ODI and (b) negatively associated with cortical FA. 
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b) GI negatively associated with cortical FA
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development underlies the abnormal macrostructural changes in brain development 
that have been observed through reduced birth head circumference (Matthiesen et al., 
2016), smaller brain volumes (Limperopoulos et al., 2010) and immature cortical 
folding (Claessens et al., 2016; Clouchoux et al., 2013; Glauser et al., 1990b; Kelly et 
al., 2017; Ortinau et al., 2013), and that strategies to optimise cerebral oxygenation in 
utero may offer the potential to ameliorate brain development in this population. 
We found that cortical ODI was widely reduced in the CHD group, with associated but 
more sparsely distributed areas of higher FA. These findings suggest a hindered 
trajectory of normal brain development, with increased sensitivity to tissue changes 
using the more advanced NODDI model. As the brain matures in utero, cortical 
neurons migrate outwards towards the pial surface, populating the cortex (Bystron et 
al., 2008) and resulting in a highly directional, parallel, columnar microstructure. This 
can be observed with diffusion tensor imaging (DTI) as tensors with high FA, oriented 
radially to the cortical surface (McKinstry et al., 2002).  As the cortex matures (Figure 
36), an increasingly dense and complex cytoarchitecture forms, with dendritic 
arborisation, glial proliferation, differentiation of radial glia and synapse formation 
(Bystron et al., 2008; Mrzljak et al., 1988; Rakic, 2003), associated with an observed 
increase in cortical ODI (Eaton-Rosen et al., 2015). Increasing cytoarchitecture 
complexity also restricts water diffusion more evenly in all directions, with a 
 
 
Figure 36 Schematic diagram depicting the development of cortical layers with increasing maturation 
Demonstration of cortical and subplate neurons, with increasing elaboration of their dendritic spines. Adapted from Mrzljak 
et al., 1988 with permission of John Wiley and Sons. 





































consequent reduction in FA (Ball et al., 2013; McKinstry et al., 2002). The link between 
diffusion imaging studies and underlying tissue biology is supported by prior evidence 
that NODDI-derived dispersion measures match their histological counterparts in adult 
postmortem specimens (Grussu et al., 2017), and by correlations found between 
maturation of dendritic arbors at the cellular level and loss of diffusion anisotropy with 
cortical development in the rhesus macaque (Wang et al., 2017) and fetal sheep (Dean 
et al., 2013).  
While reduced cortical folding complexity in newborns with CHD has previously been 
reported in our cohort (Kelly et al., 2017), and others (Claessens et al., 2016; Licht et 
al., 2009; Ortinau et al., 2012), the link between cortical macrostructural and 
microstructural development in these infants has not been investigated previously. We 
found that gyrification index (GI) was positively associated with mean cortical ODI, 
independent of their association with increasing maturity. GI was also negatively but 
more weakly associated with mean cortical FA. Of interest, total brain volume was not 
associated with either FA or ODI. Taken together, these results suggest that 
macrostructural abnormalities observed in infants with CHD may be related to 
underlying impairments in dendritic arborisation. 
Changes in cortical orientation dispersion were more pronounced posteriorly than 
frontally, which is consistent with previously described sequence of cortical 
development maturing earlier in the occipital cortex, and completing later in frontal 
regions (Armstrong et al., 1995; DeIpolyi et al., 2005; van der Knaap et al., 1996). 
Differences were also seen prominently in the region of the operculum, a region that 
has been repeatedly highlighted in infants with CHD. Findings of an ‘open operculum’ 
with exposed insular cortex have been reported in CHD (Awate et al., 2010; Glauser et 
al., 1990b; Licht et al., 2004; Mahle et al., 2002; Tatum et al., 1989), and has been 
associated with a poor outcome (Chen et al., 1996). 
Having established group differences between infants with CHD and healthy controls, 
we investigated the effect of CDO2 on development of cortical ODI. There was a 
widespread positive relationship between ODI and CDO2, supporting the hypothesis 
that impaired oxygen delivery to the developing brain may be associated with delayed 
cortical microstructural development. There was no relationship between cerebral 
blood flow alone and ODI, suggesting that impaired CDO2 rather than alternative 
proposed metabolic substrates (Rudolph, 2016) may be most influential. These results 
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support recent laboratory studies, with oxygen tension shown to regulate the 
development of human cortical radial glia cells. Moderate and severe levels of hypoxia 
exert negative effects on gliogenesis, mediated via reduced numbers of pre-
oligodendrocytes and increased numbers of reactive astrocytes derived from cortical 
radial glia cells (Ortega et al., 2017). Equally, diminished subventricular zone 
neurogenesis as a result of chronic hypoxia may represent a cellular mechanism that 
underlies immature cortical development in the CHD population (Morton et al., 2017). 
Taken together, these studies support the view that oxygenation of the developing 
brain is a crucial factor to optimise in order to restore the derailing trajectory of 
cortical development in this population. Future serial imaging to assess cortical 
development in CHD through infancy and early childhood would allow us to 
understand if microstructural differences observed in the newborn period are simply 
delayed with potential for catch-up in later childhood, or if such abnormalities are 
permanent and persist into childhood. Such work may offer insights into whether early 
surgical repair may help prevent further divergence, resulting in better long-term 
neurodevelopmental outcomes. 
There were limitations to our study. Firstly, quantitative estimates obtained from 
microstructural studies are invariably model-dependent, exhibiting biases and 
limitations that are related to model assumptions. Despite this, NODDI indices have 
been shown to correlate with histological changes in neurite geometrical configuration 
(Grussu et al., 2017), and offers a valuable proxy to underlying biological changes in 
microstructure. Secondly, CDO2 was also measured in the postnatal period, while the 
most influential period on brain growth would have been in utero, and particularly 
during the third trimester. Despite this, we feel that postnatal CDO2 remains a useful 
surrogate for severity of cardiac circulatory compromise to date, taking into account 
both measures of cerebral blood flow and degree of hypoxia as a result of structural 
changes in congenital heart disease. Thirdly, the underlying genetic basis of CHD is 
becoming increasingly better-understood (Zaidi and Brueckner, 2017), and may 
represent a key contributor not only to structural heart disease and associated 
impaired CDO2, but also to intrinsic abnormalities in microstructural development of 
the brain. 
There are currently no validated neuroprotective therapies available for infants with 
CHD. Our demonstration that reduced CDO2 is associated with impaired cortical 
maturation in this population supports the development of strategies to optimise fetal 
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CDO2. Strategies including the provision of supplemental oxygen to mothers during 
pregnancy may enable restoration of fetal cerebral oxygen tension to levels required 
to prevent or reverse abnormal corticogenesis. In addition, the use of newer 
microstructural measures such as ODI may provide a crucial leading indicator in the 
postnatal period to assess the impact of novel interventions on cortical development 





With the increasing survival of infants with complex CHD, greater attention is turning 
to long-term outcomes and quality of life in this important population (Marino et al., 
2012). Neurodevelopmental outcomes have not improved at the same pace as 
surgical and medical advances in recent decades (Gaynor et al., 2015), emphasising 
the need to better-understand the neural substrate that underlies poorer 
neurodevelopmental outcomes in children with CHD. Through this understanding, we 
hope to make progress towards identifying interventions with the potential to restore 
early brain development to a normal healthy trajectory, while establishing more 
sensitive imaging tools to quantify abnormalities in brain macro- and microstructural 
development. There is also considerable potential to discover valuable improvements 
in clinical practice through large-scale collaborations to compare existing variable 
practices across different institutions. 
The primary hypothesis of this thesis was that infants with CHD have impaired early 
brain development and are more susceptible to injury. This was tested using two 
methodological approaches. Firstly, qualitative radiological analysis of a prospective 
cohort of 70 infants with complex CHD was performed in Chapter 4, which found 
evidence of brain lesions in 39% of subjects. The prevalence of punctate white matter 
lesions was consistent with previously reported cohorts, distributed widely throughout 
the brain, including frontal white matter, optic radiations and corona radiata. However, 
a low rate of ischaemic stroke was found compared to previously studied cohorts. 
Relevant clinical variables were considered, suggesting that clinical variables related 
to haemodynamic stability at birth may be most related to arterial infarction. There 
were no cases of venous sinus thrombosis in our group, which is interesting in the 
context of a recent previous study that reported thrombosis in 8% (Claessens et al., 
2017). Differences may be due to local variation in clinical practice, where our 
institution uses entirely different vascular access routes for central lines while 
preparing our infants for surgery. This difference alone provides insight into the 
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potential benefits of a wider collaborative project and offers encouragement for the 
future. 
As a second approach to address the primary hypothesis, quantitative analysis was 
performed using analysis of both structural and diffusion data. In Chapter 5, both total 
brain volume and cortical grey matter volume were found to be reduced in infants with 
CHD compared to healthy age-matched controls. Cortical surface analysis showed 
that cortical folding, quantified using gyrification index, was reduced in CHD, primarily 
affecting parietal, temporal and occipital regions. In Chapter 6, diffusion analysis of 
the cortex demonstrated that infants with CHD have regions of increased FA and 
reduced ODI compared to healthy age-matched controls. The effect was most 
pronounced posteriorly and affected frontal regions least. The link between 
macrostructural abnormalities found in this thesis and by other groups (Claessens et 
al., 2016; Clouchoux et al., 2013; Limperopoulos et al., 2010; Miller et al., 2007; 
Ortinau et al., 2013) and microstructural findings was established through the 
demonstration of a strong positive relationship between gyrification index and ODI. 
Overall, these findings support the interpretation that impaired microstructural 
development of the cortex in CHD is predominantly due to abnormal dendritic 
arborisation, which is in turn related to impaired development of cortical gyrification. 
Such results corroborate animal studies in the fetal macaque showing that 
microstructural development of the cortex is coupled to the formation of gyri and sulci 
(Wang et al., 2017), and make progress towards understanding the macrostructural 
abnormalities that have been well-reported in the newborn population with CHD. 
The second hypothesis of this thesis was that reduced cerebral oxygen delivery 
(CDO2) in CHD is associated with impaired development of the cerebral cortex. In 
Chapter 5, the macrostructure of the cortex was investigated, with both cortical grey 
matter volume and gyrification index found to be positively associated with CDO2. In 
Chapter 6, cortical microstructure was investigated, with widespread regions of the 
brain showing a linear association between CDO2 and ODI. Interestingly, there was no 
association between cerebral blood flow alone and ODI, suggesting that the role of 
alternative metabolic substrates (e.g. Rudolph, 2016) may be less influential. Taken 
together, these in vivo studies suggest that CDO2 plays an important role in the normal 
development of cortical microstructure, which in turn is associated with development 
of cortical macrostructure. 
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The findings in this thesis are potentially valuable for the development of future 
therapies for CHD. Animal studies have suggested that oxygen plays a key role in 
brain development (Morton et al., 2017; Yuen et al., 2014), but there have been limited 
studies investigating this in vivo (Sun et al., 2015). The associations shown in this 
thesis between CDO2 and markers of brain development offer support to potential 
therapies to improve cerebral oxygenation during the crucial third trimester of 
pregnancy, such as maternal oxygen supplementation. In addition, macrostructural 
and microstructural measures described in this thesis could potentially act as markers 
of brain dysmaturation for interventional trials, providing a leading indicator in the 
newborn period while waiting for long-term neurodevelopmental follow-up. Earlier 
indicators enable faster feedback and iteration, while better sensitivity through tools 
including diffusion MRI reduce the chance of an avoidable type II error. 
7.2 FUTURE PERSPECTIVES 
Below are some possible directions for future study, to extend upon the work 
presented in this thesis: 
7.2.1 Follow up of our prospective cohort 
The infants presented in this thesis undertook a comprehensive range of novel 
structural and diffusion imaging examinations, developed for the Developing Human 
Connectome Project, that have not been performed in a cohort with CHD before. 
Follow-up of this cohort is ongoing at around the children’s second birthday. Once 
this phase is complete, we will begin to understand the predictive value and clinical 
utility of these newer imaging techniques. 
7.2.2 Further uses of acquired neonatal diffusion data 
There are a number of different biophysical models that attempt to model tissue 
microstructure from diffusion-weighted imaging. While this thesis considered only 
diffusion tensor and NODDI methods, it may be interesting to compare additional 
models using this dataset. In particular, Spherical Mean Technique (Kaden et al., 
2016) provides a new way to estimate tissue microstructure that is not confounded by 
the effects of fibre crossings and orientation dispersion, which are ubiquitous in the 
brain. It also avoids some of the limitations of NODDI such as the use of a fixed 
intrinsic diffusivity. 
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Structural network analysis using diffusion-weighted imaging has demonstrated global 
differences in white matter network topology in adolescents with CHD (Panigrahy et 
al., 2015). Functional MRI has already been used in neonates to show that the density 
of rich club nodes in CHD was diminished, with reduced connectivity among some 
critical brain hubs (De Asis-Cruz et al., 2017).  
While this thesis did not acquire functional MRI data, there is an exciting opportunity 
to interrogate the network structure of the white matter using diffusion tractography, 
and relate these to subsequent outcomes. 
7.2.3 Genetic influences in CHD 
CHD has been known to be associated with a number of genetic conditions for many 
years. More recently, it has been suggested that up to 30% of children with CHD have 
manifestations of a multi-systemic syndrome (Marino et al., 2012). Common 
associations include Trisomy 21 and 22q11.2 deletion (DiGeorge syndrome), which 
are both independently associated with poorer neurodevelopmental outcome (Atallah 
et al., 2007; Visootsak et al., 2011). Others include CHARGE syndrome, Noonan’s 
syndrome, Williams syndrome, VACTERL, and many others (Pierpont et al., 2007). 
Through more advanced genetic sequencing, we may begin to understand the genetic 
underpinnings of CHD in those who do not appear to have an overt genetic syndrome. 
For example, recent studies have shown that previously unknown copy number 
variants (CNVs) may be present and potentially causative in up to 20% of non-
syndromic children (Soemedi et al., 2012; Thienpont et al., 2007). Another example is 
how the apolipoprotein E (APOE) e2 allele, which encodes the APOE E2 protein, is 
associated with poor neurological outcome in children with CHD following 
cardiopulmonary bypass. Infants with this allele have been shown to have significantly 
worse BSID scores, independent of cardiac defect, ethnicity of socioeconomic status 
(Gaynor et al., 2003, 2014). Whole-exome sequencing will bring even greater insights. 
One study of 1200 CHD patients found that patients with both CHD and 
neurodevelopmental disorders had a much higher burden of damaging de novo 
mutations, particularly in genes with likely roles in both heart and brain development 
(Homsy et al., 2015). This suggests that clinical phenotyping may help to identify those 
at greatest risk of neurodevelopmental impairment, enabling earlier intervention. 
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However, studies performed to date have highlighted that CHD is extremely 
heterogeneous, which is further complicated by the relative lack of observed 
genotype-phenotype correlations (Zaidi and Brueckner, 2017). 
Genetic material has been collected from most infants recruited as part of this thesis, 
although our sample size is not yet of a size typically required for genetic group 
studies. Aggregation of genetic testing and analysis with other centres, using the 
latest sequencing techniques and linked to MR imaging, could help to further identify 
the genetic underpinning of a greater proportion of CHD and its effect on 
neurodevelopmental outcomes, and help translate these findings into precision 
medicine for the care of children born with CHD. 
7.2.4 Future management of children with CHD at St Thomas’ 
Work presented in this thesis highlights that children with CHD are at greater risk of 
brain injury and dysmaturation. Through incidental findings in asymptomatic infants, 
the research presented in this thesis has enabled early referral for specialist 
neurological follow up in a number of cases. There is a strong argument that all infants 
with CHD should undergo neurodevelopmental follow-up, including early brain 
imaging (ideally fetal and neonatal), as part of their routine clinical care. This would 
offer benefits not only for the individual but would also enable larger studies to be 
performed using the high-quality imaging possible at our institution. Routine 
neurodevelopmental follow-up in infants with complex CHD is recommended by 
American guidelines (Marino et al., 2012), but implementation of such practices in the 
UK has been limited to date. 
7.2.5 Variation in clinical practice 
There is considerable variation in clinical practice between different centres globally. A 
number of research cohorts of infants with CHD exist across the world, which are 
each relatively small individually, but when combined would provide a rich source of 
information about the most influential factors in early brain injury and dysmaturation, 
and subsequent outcome. The aggregation of data through multi-centre 
collaborations would be of great value for the future. 
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7.2.6 The effect of fetal CDO2 on measures of macro- and microstructure 
One key limitation of this thesis is that all imaging was performed in the neonatal 
period. Further work could build upon the results presented in this thesis by obtaining 
measures of CDO2 in utero (e.g. Sun et al, 2015), and correlating these with 
subsequent neonatal structural and diffusion measures of brain development. This 
direct link between fetal environment and subsequent outcome would be very 
valuable. 
7.2.7 Relating fetal haemodynamics to imaging findings and outcome 
As part of the normal fetal clinical service at the Evelina Children’s Hospital, a number 
of measures of fetal haemodynamic status are measured (RI, PI, CPR etc), which were 
not recorded as part of this thesis. By retrospectively collecting this data, there is the 
opportunity to better-understand how autoregulatory mechanisms may impact upon, 
or highlight, ongoing abnormalities in fetal brain development, and correlate this with 
future neurodevelopmental outcome. 
7.2.8 Timing of injury 
Although the weight of evidence suggests that pre-surgical brain injury occurs around 
the time of delivery, there have been few serial imaging studies in CHD to ascertain 
precise timing of injury. In addition, T1-weighted imaging in fetal MRI has historically 
been limited compared to neonatal imaging, due to technical constraints, meaning 
that punctate white matter injury may not have been detected with equally high 
sensitivity. 
New fetal imaging sequences that offer motion-corrected T1-weighted imaging may 
allow a greater insight into timing of injury in the late third trimester, and image 
registration techniques to co-register each individual’s fetal and neonatal imaging may 
reveal subtle changes in fetal imaging that had not been detected previously. 
7.2.9 Identification of candidate therapies to intervene in abnormal brain 
development and injury 
Few studies have found promising neuroprotective effects in CHD. A recent study 
tested the neuroprotective effect of erythropoietin in cardiac surgery (Andropoulos et 
al., 2013). However, although it was found to be safe, there was no difference in 
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neurodevelopmental outcome at 1 year of age. The study was underpowered to 
definitively detect changes in neurodevelopmental outcome, and so the authors 
recommend a larger study. 
Other studies are currently looking at the effect of maternal progesterone therapy 
during pregnancy (https://clinicaltrials.gov/ct2/show/NCT02133573), and the effect of 
anaesthetic agent dexmedetomidine during surgery 
(https://clinicaltrials.gov/ct2/show/NCT01915277). 
There are a number of exciting potential future therapies. Maternal supplemental 
oxygen during pregnancy is an attractive intervention given the results from this thesis 
and others (particularly Sun et al. 2015). Following a recent maternal 
hyperoxygenation study (Porayette et al., 2016), trials are planned to start in Toronto 
shortly. The possibility of SVZ-stabilising therapeutics has been suggested by Morton 
et al. 2017 that are designed to protect or restore the neurogenic potential of NSPCs. 
HIF-stabilisers have been suggested in the context of animal work showing this 
potential (Yuen et al., 2014). There are a large number of neuroprotective agents that 
have shown promise in the preterm/HIE population (e.g. allopurinol, phentolamine, 
dextromethorphan, sodium nitroprusside, ketamine etc), which could be applied to the 
CHD population in future intervention studies. 
7.2.10 Summary 
Ultimately, the challenge of improving neurodevelopmental outcomes in CHD will rely 
on a collaborative and an integrated approach to future research. Through a 
combination of cell biology, molecular biology, genetics, and sophisticated models of 
brain development, we will be able to understand the underlying causes of brain 
dysmaturation in this population, and identify the optimum window and most 
promising therapeutics for treatment to improve long-term neurodevelopmental 
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